Tag: sideEffects

Articles

• Chemo brain symptoms and outcomes
• Factors influencing Adriamycin (doxorubicin) effectiveness
• Gynecological side effects of tamoxifen

News

10/01/17

Exercise during first two years can improve symptoms of chemo brain

08/26/17

Walking can reduce aromatase inhibitor-induced joint pain

11/12/16

Treatment can cause long-term fatigue in breast cancer survivors

09/19/15

Ferritin can protect breast cancer cells from treatment by Adriamycin

01/25/15

Supplemental vitamin C during chemotherapy not shown to be beneficial

07/15/14

Significant improvements in chemo brain are typical within 3 years

08/25/13

Chemo brain can mean impaired decision making, attention and memory

03/04/13

Fasting is more effective than calorie cut in model of chemotherapy

05/30/12

Fish oil might promote Adriamycin-induced heart damage

02/15/12

Grapes might help protect against Adriamycin-induced heart damage

12/15/11

Kaempferol protects against Adriamycin-induced heart damage

12/01/11

Herceptin + anthracycline chemo increases risk of cardiomyopathy

09/28/11

Zoledronic acid might reduce recurrence in postmenopausal women

07/17/11

Increasing aromatase inhibitor side effects make tamoxifen attractive

12/26/10

Muscle and joint pain are common during taxane chemotherapy

02/28/10

Does air travel increase lymphedema in breast cancer survivors?

Studies

• FRUCTOSE EXACERBATES ANTHRACYCLINE AND HER-2 BLOCKING AGENT MEDIATED CARDIOTOXICITY THROUGH NLRP3 AND MYD88 MEDIATED PATHWAYS: NEW ROLES OF SWEETENERS IN CARDIO-ONCOLOGY Cite
  Maurea N, bisceglia i, Iovine M, Giordano V, GIACOBBE I, Arianna R, et al. FRUCTOSE EXACERBATES ANTHRACYCLINE AND HER-2 BLOCKING AGENT MEDIATED CARDIOTOXICITY THROUGH NLRP3 AND MYD88 MEDIATED PATHWAYS: NEW ROLES OF SWEETENERS IN CARDIO-ONCOLOGY. Journal of the American College of Cardiology. Elsevier BV; 2024; 83:2563 10.1016/s0735-1097(24)04553-4
• CRISPRi/a screens in human iPSC-cardiomyocytes identify glycolytic activation as a druggable target for doxorubicin-induced cardiotoxicity Cite
  Liu C, Shen M, Liu Y, Manhas A, Zhao SR, Zhang M, et al. CRISPRi/a screens in human iPSC-cardiomyocytes identify glycolytic activation as a druggable target for doxorubicin-induced cardiotoxicity. Cell Stem Cell. Elsevier BV; 2024; 31:1760-1776.e9 10.1016/j.stem.2024.10.007
• Anthracyclines-induced cardiotoxicity in patients with early breast cancer carrying germline BRCA1/2 mutation: the BRCAN study Cite
  Cortés-Salgado A, Serrano JJ, Cordero Pereda D, Menacho M, Del Rey JM, del Campo-Albendea L, et al. Anthracyclines-induced cardiotoxicity in patients with early breast cancer carrying germline BRCA1/2 mutation: the BRCAN study. The Oncologist. Oxford University Press (OUP); 2024; 10.1093/oncolo/oyae299
• The Effect of High-Intensity Interval Training on Quality of Life and Incidence of Chemotherapy Side Effects in Women With Breast Cancer Cite
  Klavina A, Ceseiko R, Campa M, Jermolenko GF, Eglitis K, Llorente A, et al. The Effect of High-Intensity Interval Training on Quality of Life and Incidence of Chemotherapy Side Effects in Women With Breast Cancer. Integrative Cancer Therapies. SAGE Publications; 2024; 23 10.1177/15347354241297385
• Abstract 4147821: Physical Activity Impacts Cardiac Tissue Mitochondrial Respiration During Anthracycline Chemotherapy Cite
  Riojas A, Harbert S, Lacy J, Piloso J, Kramer P, Weis J, et al. Abstract 4147821: Physical Activity Impacts Cardiac Tissue Mitochondrial Respiration During Anthracycline Chemotherapy. Circulation. Ovid Technologies (Wolters Kluwer Health); 2024; 150 10.1161/circ.150.suppl_1.4147821
• Prediction of menstrual recovery patterns in premenopausal women with breast cancer taking tamoxifen after chemotherapy: an ASTRRA Substudy Cite
  Lee YJ, Noh WC, Gwark S, Kim H, Ryu JM, Kim SI, et al. Prediction of menstrual recovery patterns in premenopausal women with breast cancer taking tamoxifen after chemotherapy: an ASTRRA Substudy. Breast Cancer Research. Springer Science and Business Media LLC; 2024; 26 10.1186/s13058-024-01903-9
• Aerobic exercise and CogniTIVe functioning in women with breAsT cancEr (ACTIVATE): A randomized controlled trial Cite
  Brunet J, Sharma S, Zadravec K, Taljaard M, LeVasseur N, Srikanthan A, et al. Aerobic exercise and CogniTIVe functioning in women with breAsT cancEr (ACTIVATE): A randomized controlled trial. Cancer. Wiley; 2024; 10.1002/cncr.35540
• Symptom Improvements and Adverse Effects with Reishi Mushroom Use: A Cross-Sectional Survey of Cancer Patients Cite
  Li X, Sun L, Chimonas S, Li SQ, Feng P, Yang Y, et al. Symptom Improvements and Adverse Effects with Reishi Mushroom Use: A Cross-Sectional Survey of Cancer Patients. Integrative Medicine Research. Elsevier BV; 2024;:101089 10.1016/j.imr.2024.101089
• Melatonin mitigates doxorubicin induced chemo brain in a rat model in a NRF2/p53–SIRT1 dependent pathway Cite
  Ebrahim NA, Elnagar MR, El-Gamal R, Habotta OA, Albadawi EA, Albadrani M, et al. Melatonin mitigates doxorubicin induced chemo brain in a rat model in a NRF2/p53–SIRT1 dependent pathway. Heliyon. Elsevier BV; 2024; 10:e38081 10.1016/j.heliyon.2024.e38081
• Postmarketing adverse events of tamoxifen in male and female patients with breast cancer Cite
  Ke C, Chen M, Lin L, Huang Y. Postmarketing adverse events of tamoxifen in male and female patients with breast cancer. International Journal of Cancer. Wiley; 2024; 10.1002/ijc.35193
• 287P Cognitive impairment in older breast cancer survivors Cite
  Giordano S, Liao K, Pena J, Kim R, Zorzi D, Li L, et al. 287P Cognitive impairment in older breast cancer survivors. Annals of Oncology. Elsevier BV; 2024; 35:S335 10.1016/j.annonc.2024.08.228
• Scalp Cooling in Preventing Persistent Chemotherapy-Induced Alopecia: A Randomized Controlled Trial Cite
  Kang D, Cho J, Zhao D, Kim J, Kim N, Kim H, et al. Scalp Cooling in Preventing Persistent Chemotherapy-Induced Alopecia: A Randomized Controlled Trial. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2024; 42:3115-3122 10.1200/jco.23.02374
• 52247 Prospective cohort study on hair loss and skin alterations in Asian breast cancer patients during treatment Cite
  Noh H, Kim H, Lee T, Shim J, Oh SJ, Lee JH, et al. 52247 Prospective cohort study on hair loss and skin alterations in Asian breast cancer patients during treatment. Journal of the American Academy of Dermatology. Elsevier BV; 2024; 91:AB288 10.1016/j.jaad.2024.07.1146
• 54000 Epigallocatechin-3-gallate (EGCG) Mitigates Radiation-Induced Dermatitis (RID) in Breast Cancer Patients Undergoing Adjuvant Radiotherapy: A Systematic Review and Meta-Analysis Cite
  Lapenda I, Dias F, Mesquita Y, Marques I, Moraes R, Sarto R, et al. 54000 Epigallocatechin-3-gallate (EGCG) Mitigates Radiation-Induced Dermatitis (RID) in Breast Cancer Patients Undergoing Adjuvant Radiotherapy: A Systematic Review and Meta-Analysis. Journal of the American Academy of Dermatology. Elsevier BV; 2024; 91:AB204 10.1016/j.jaad.2024.07.812
• Promising Roles of Phytocompounds and Nutrients in Interventions to Mitigate Chemotherapy-Induced Peripheral Neuropathy Cite
  Daniel M, Smith EL. Promising Roles of Phytocompounds and Nutrients in Interventions to Mitigate Chemotherapy-Induced Peripheral Neuropathy. Seminars in Oncology Nursing. Elsevier BV; 2024;:151713 10.1016/j.soncn.2024.151713
• Alzheimer Disease and Related Dementia Following Hormone-Modulating Therapy in Patients With Breast Cancer Cite
  Cai C, Strickland K, Knudsen S, Tucker SB, Chidrala CS, Modugno F. Alzheimer Disease and Related Dementia Following Hormone-Modulating Therapy in Patients With Breast Cancer. JAMA Network Open. American Medical Association (AMA); 2024; 7:e2422493 10.1001/jamanetworkopen.2024.22493
• Comprehensive Audiologic Analyses After Cisplatin-Based Chemotherapy Cite
  Sanchez VA, Dinh PC, Monahan PO, Althouse S, Rooker J, Sesso HD, et al. Comprehensive Audiologic Analyses After Cisplatin-Based Chemotherapy. JAMA Oncology. American Medical Association (AMA); 2024; 10.1001/jamaoncol.2024.1233
• Possible protective effect of rosuvastatin in chemotherapy-induced cardiotoxicity in HER2 positive breast cancer patients: a randomized controlled trial Cite
  Kettana KM, El‑Haggar SM, Alm El-Din MA, El‑Afify DR. Possible protective effect of rosuvastatin in chemotherapy-induced cardiotoxicity in HER2 positive breast cancer patients: a randomized controlled trial. Medical Oncology. Springer Science and Business Media LLC; 2024; 41 10.1007/s12032-024-02426-1
• P-317 Risk of endometrial polyps and hyperplasia after tamoxifen treatment in women with breast cancer: a population-based study in Taiwan Cite
  Hsu C, Eing-Mei T, Hui-min H. P-317 Risk of endometrial polyps and hyperplasia after tamoxifen treatment in women with breast cancer: a population-based study in Taiwan. Human Reproduction. Oxford University Press (OUP); 2024; 39 10.1093/humrep/deae108.682
• Effects of different exercise types and cycles on pain and quality of life in breast cancer patients: A systematic review and network meta-analysis Cite
  Dong J, Wang D, Zhong S. Effects of different exercise types and cycles on pain and quality of life in breast cancer patients: A systematic review and network meta-analysis. PLOS ONE. Public Library of Science (PLoS); 2024; 19:e0300176 10.1371/journal.pone.0300176
• Acupuncture for hot flashes in hormone receptor‐positive breast cancer: A pooled analysis of individual patient data from parallel randomized trials Cite
  Lu W, Giobbie‐Hurder A, Tanasijevic A, Kassis SB, Park SH, Jeong YJ, et al. Acupuncture for hot flashes in hormone receptor‐positive breast cancer: A pooled analysis of individual patient data from parallel randomized trials. Cancer. Wiley; 2024; 10.1002/cncr.35374
• Clinical and Genotypic Insights Into Higher Prevalence of Palbociclib Associated Neutropenia in Asian Patients Cite
  Lai J, Kuo T, Huang K, Chai LMX, Lee M, Liu C, et al. Clinical and Genotypic Insights Into Higher Prevalence of Palbociclib Associated Neutropenia in Asian Patients. The Oncologist. Oxford University Press (OUP); 2023; 29:e455-e466 10.1093/oncolo/oyad304
• The role of breast cancer-related arm lymphedema in physical functioning and physical activity participation among long-term African American breast cancer survivors Cite
  Nechuta S, Chen WY, Goerge A, Boopathy D, Sanderson M. The role of breast cancer-related arm lymphedema in physical functioning and physical activity participation among long-term African American breast cancer survivors. Supportive Care in Cancer. Springer Science and Business Media LLC; 2024; 32 10.1007/s00520-024-08648-3
• Statin use is associated with a lower risk of all-cause death in patients with breast cancer treated with anthracycline containing regimens: a global federated health database analysis Cite
  Bucci T, Gue Y, Dobson R, Palmieri C, Pignatelli P, Lip GYH. Statin use is associated with a lower risk of all-cause death in patients with breast cancer treated with anthracycline containing regimens: a global federated health database analysis. Clinical and Experimental Medicine. Springer Science and Business Media LLC; 2024; 24 10.1007/s10238-024-01395-z
• Functional decline in older breast cancer survivors treated with and without chemotherapy and non-cancer controls: results from the Hurria Older PatiEnts (HOPE) prospective study Cite
  Sedrak MS, Sun C, Bae M, Freedman RA, Magnuson A, O’Connor T, et al. Functional decline in older breast cancer survivors treated with and without chemotherapy and non-cancer controls: results from the Hurria Older PatiEnts (HOPE) prospective study. Journal of Cancer Survivorship. Springer Science and Business Media LLC; 2024; 10.1007/s11764-024-01594-3
• Chemotherapy-induced gut microbiome disruption, inflammation, and cognitive decline in female patients with breast cancer Cite
  Otto-Dobos L, Grant C, Lahoud A, Wilcox O, Strehle L, Loman B, et al. Chemotherapy-induced gut microbiome disruption, inflammation, and cognitive decline in female patients with breast cancer. Brain, Behavior, and Immunity. Elsevier BV; 2024; 10.1016/j.bbi.2024.05.039
• 268MO Safety of vaginal estrogen therapy after early-stage breast cancer: A nationwide population-based target trial emulation Cite
  Dumas E, Hamy-Petit A, Gougis P, Laas E, El Ferjaoui S, Jochum F, et al. 268MO Safety of vaginal estrogen therapy after early-stage breast cancer: A nationwide population-based target trial emulation. ESMO Open. Elsevier BV; 2024; 9:103327 10.1016/j.esmoop.2024.103327
• Impact of exercise on chemotherapy-induced peripheral neuropathy in survivors with post-treatment primary breast cancer Cite
  Saint K, Nemirovsky D, Lessing A, Chen Y, Yang M, Underwood WP, et al. Impact of exercise on chemotherapy-induced peripheral neuropathy in survivors with post-treatment primary breast cancer. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2024; 10.1007/s10549-024-07342-6
• Abstract PO2-12-11: Ocular Toxicity of Tamoxifen in Patients with Breast Cancer Cite
  Alhouz H, Azmeh A, Saifo M. Abstract PO2-12-11: Ocular Toxicity of Tamoxifen in Patients with Breast Cancer. Cancer Research. American Association for Cancer Research (AACR); 2024; 84:PO2-12-11-PO2-12-11 10.1158/1538-7445.sabcs23-po2-12-11
• Potential of Natural Phenolic Compounds against Doxorubicin-Induced Chemobrain: Biological and Molecular Mechanisms Involved Cite
  Serini S, Calviello G. Potential of Natural Phenolic Compounds against Doxorubicin-Induced Chemobrain: Biological and Molecular Mechanisms Involved. Antioxidants. MDPI AG; 2024; 13:486 10.3390/antiox13040486
• Prediction of cognitive decline in older breast cancer survivors: the thinking and living with cancer study Cite
  Mcdeed AP, Van Dyk K, Zhou X, Zhai W, Ahles TA, Bethea TN, et al. Prediction of cognitive decline in older breast cancer survivors: the thinking and living with cancer study. JNCI Cancer Spectrum. Oxford University Press (OUP); 2024; 10.1093/jncics/pkae019
• Long-term effects of aromatase inhibitor withdrawal on bone mineral density in early breast cancer patients: 10-year follow-up results of the BREX study Cite
  Blomqvist C, Vehmanen L, Kellokumpu-Lehtinen P, Huovinen R, Ruohola J, Penttinen H, et al. Long-term effects of aromatase inhibitor withdrawal on bone mineral density in early breast cancer patients: 10-year follow-up results of the BREX study. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2024; 10.1007/s10549-024-07252-7
• Abstract 992: The impact of tamoxifen on autophagic and epigenetic regulation in endometrial cancer Cite
  Thota S, Begum R, Chintala N, Pandit A, Sapkota B, Francis J. Abstract 992: The impact of tamoxifen on autophagic and epigenetic regulation in endometrial cancer. Cancer Research. American Association for Cancer Research (AACR); 2024; 84:992-992 10.1158/1538-7445.am2024-992
• The efficacy and safety of exercise regimens to mitigate chemotherapy cardiotoxicity: a systematic review and meta-analysis of randomized controlled trials Cite
  Amin AM, Khlidj Y, Abuelazm M, Ibrahim AA, Tanashat M, Imran M, et al. The efficacy and safety of exercise regimens to mitigate chemotherapy cardiotoxicity: a systematic review and meta-analysis of randomized controlled trials. Cardio-Oncology. Springer Science and Business Media LLC; 2024; 10 10.1186/s40959-024-00208-2
• Gut microbiome in association with chemotherapy‐induced toxicities among patients with breast cancer Cite
  Nguyen SM, Tran HTT, Long J, Shrubsole MJ, Cai H, Yang Y, et al. Gut microbiome in association with chemotherapy‐induced toxicities among patients with breast cancer. Cancer. Wiley; 2024; 10.1002/cncr.35229
• Three-Year Outcomes Following Permissive Cardiotoxicity in Patients on Trastuzumab Cite
  Zhou S, Cirne F, Chow J, Zereshkian A, Bordeleau L, Dhesy-Thind S, et al. Three-Year Outcomes Following Permissive Cardiotoxicity in Patients on Trastuzumab. The Oncologist. Oxford University Press (OUP); 2023; 28:e712-e722 10.1093/oncolo/oyad086
• The Impact of Chemotherapy on Cardiovascular Mortality across Breast Cancer Subtypes Cite
  Ngô TM, Lê ÁN, Đinh DPH. The Impact of Chemotherapy on Cardiovascular Mortality across Breast Cancer Subtypes. Current Oncology. MDPI AG; 2024; 31:649-659 10.3390/curroncol31020047
• Association of Longitudinal Changes in Cerebral Microstructure with Cognitive Functioning in Breast Cancer Survivors after Adjuvant Chemotherapy Cite
  Chen VC, Wu Y, Tsai Y, Weng J. Association of Longitudinal Changes in Cerebral Microstructure with Cognitive Functioning in Breast Cancer Survivors after Adjuvant Chemotherapy. Journal of Clinical Medicine. MDPI AG; 2024; 13:668 10.3390/jcm13030668
• Electroacupuncture use for treatment of taxane-induced peripheral neuropathy in patients with breast cancer: protocol for a pilot, randomised, blinded, sham-controlled trial (EA for CIPN) Cite
  Choi V, Park SB, Lacey J, Kumar S, Heller G, Grimison P. Electroacupuncture use for treatment of taxane-induced peripheral neuropathy in patients with breast cancer: protocol for a pilot, randomised, blinded, sham-controlled trial (EA for CIPN). BMJ Open. BMJ; 2024; 14:e076391 10.1136/bmjopen-2023-076391
• Wnt3a/GSK3β/β-catenin Signalling Modulates Doxorubicin-associated Memory Deficits in Breast Cancer Cite
  Li W, Gan C, Yu S, Xu J, Tang L, Cheng H. Wnt3a/GSK3β/β-catenin Signalling Modulates Doxorubicin-associated Memory Deficits in Breast Cancer. Molecular Neurobiology. Springer Science and Business Media LLC; 2024; 10.1007/s12035-023-03910-x
• Moderate Intensity Exercise Reduces Side Effects of Cancer Therapy and Maintains Cardiorespiratory Fitness in Male Breast Cancer Patients: Findings from the BRECA Male Crossover Study Cite
  Schultz EB, Zubac D, Bloch W, Baurecht H, Rickert J, Baumann FT. Moderate Intensity Exercise Reduces Side Effects of Cancer Therapy and Maintains Cardiorespiratory Fitness in Male Breast Cancer Patients: Findings from the BRECA Male Crossover Study. Breast Care. S. Karger AG; 2023; 18:485-494 10.1159/000534090
• Exercise Training Benefits Health-Related Quality of Life and Functional Capacity during Breast Cancer Chemotherapy: An RCT Cite
  Antunes P, Joaquim A, Sampaio F, Nunes C, Ascensão A, Vilela E, et al. Exercise Training Benefits Health-Related Quality of Life and Functional Capacity during Breast Cancer Chemotherapy: An RCT. Medicine & Science in Sports & Exercise. Ovid Technologies (Wolters Kluwer Health); 2023; 10.1249/mss.0000000000003341
• Voluntary wheel running prevents formation of membrane attack complexes and myelin degradation after peripheral nerve injury Cite
  Green-Fulgham SM, Lacagnina MJ, Willcox KF, Li J, Harland ME, Ciena AP, et al. Voluntary wheel running prevents formation of membrane attack complexes and myelin degradation after peripheral nerve injury. Brain, Behavior, and Immunity. Elsevier BV; 2024; 115:419-431 10.1016/j.bbi.2023.10.027
• Effects of sleep disturbances and circadian rhythms modifications on cognition in breast cancer women before and after adjuvant chemotherapy: the ICANSLEEP-1 protocol Cite
  Elia C, de Girolamo L, Clarisse B, Galin M, Rehel S, Clochon P, et al. Effects of sleep disturbances and circadian rhythms modifications on cognition in breast cancer women before and after adjuvant chemotherapy: the ICANSLEEP-1 protocol. BMC Cancer. Springer Science and Business Media LLC; 2023; 23 10.1186/s12885-023-11664-x
• The lived experience of patients with breast cancer on adjuvant endocrine therapy: side effects and coping strategies during the first year of medication initiation Cite
  Gomaa S, Lopez A, Slamon R, Smith R, Lapitan E, Nightingale G, et al. The lived experience of patients with breast cancer on adjuvant endocrine therapy: side effects and coping strategies during the first year of medication initiation. Supportive Care in Cancer. Springer Science and Business Media LLC; 2023; 31 10.1007/s00520-023-08170-y
• Vitamin D Insufficiency as a Risk Factor for Paclitaxel-Induced Peripheral Neuropathy in SWOG S0221 Cite
  Chen C, Zirpoli G, Barlow WE, Budd GT, McKiver B, Pusztai L, et al. Vitamin D Insufficiency as a Risk Factor for Paclitaxel-Induced Peripheral Neuropathy in SWOG S0221. Journal of the National Comprehensive Cancer Network. Harborside Press, LLC; 2023; 21:1172-1180.e3 10.6004/jnccn.2023.7062
• Efficacy of metformin in prevention of paclitaxel-induced peripheral neuropathy in breast cancer patients: a randomized controlled trial Cite
  Bakry HM, Mansour NO, ElKhodary TR, Soliman MM. Efficacy of metformin in prevention of paclitaxel-induced peripheral neuropathy in breast cancer patients: a randomized controlled trial. Frontiers in Pharmacology. Frontiers Media SA; 2023; 14 10.3389/fphar.2023.1181312
• Early change in fatigue, insomnia, and cognitive impairment and symptom severity at 3-years post-treatment in breast cancer survivors Cite
  Lee RM, Rash JA, Seal M, McCarthy J, Garland SN. Early change in fatigue, insomnia, and cognitive impairment and symptom severity at 3-years post-treatment in breast cancer survivors. Research Square Platform LLC; 2023; 10.21203/rs.3.rs-3581028/v1
• Clinicopathological and molecular pathological characteristics in tamoxifen‑related endometrial cancer Cite
  Saeki H, Horimoto Y, Hlaing M, Men Y, Rong L, Ishizuka Y, et al. Clinicopathological and molecular pathological characteristics in tamoxifen‑related endometrial cancer. Oncology Letters. Spandidos Publications; 2023; 27 10.3892/ol.2023.14142
• Safety of Vaginal Estrogen Therapy for Genitourinary Syndrome of Menopause in Women With a History of Breast Cancer Cite
  Agrawal P, Singh SM, Able C, Dumas K, Kohn J, Kohn TP, et al. Safety of Vaginal Estrogen Therapy for Genitourinary Syndrome of Menopause in Women With a History of Breast Cancer. Obstetrics & Gynecology. Ovid Technologies (Wolters Kluwer Health); 2023; 142:660-668 10.1097/aog.0000000000005294
• Assessment of ultrasonographic endometrial changes following discontinuation of tamoxifen treatment in postmenopausal breast cancer patients receiving tamoxifen as hormonal adjuvant therapy Cite
  Babin M, Gluck O, Yeruham I, Keidar R, Kerner R, Weiner E, et al. Assessment of ultrasonographic endometrial changes following discontinuation of tamoxifen treatment in postmenopausal breast cancer patients receiving tamoxifen as hormonal adjuvant therapy. Research Square Platform LLC; 2023; 10.21203/rs.3.rs-3319956/v1
• Omega-3 fatty acids as adjuvant therapy in the adverse effects of antineoplastic treatment for breast cancer: a systematic review Cite
  Delmicon NE, Brandão-Lima PN, Rogero MM, Miranda MLP. Omega-3 fatty acids as adjuvant therapy in the adverse effects of antineoplastic treatment for breast cancer: a systematic review. Nutrire. Springer Science and Business Media LLC; 2023; 48 10.1186/s41110-023-00231-w
• Curcumin for Aromatase Inhibitor-Induced Joint Pain in Breast Cancer Survivors - The CurPain Trial: A Randomized, Double-Blind, Phase III, Multicenter Clinical Trial Cite
  Apostolou M, Mery T, Aivasovsky I, Akamatsu M, Daibes M, Araujo W, et al. Curcumin for Aromatase Inhibitor-Induced Joint Pain in Breast Cancer Survivors - The CurPain Trial: A Randomized, Double-Blind, Phase III, Multicenter Clinical Trial. Principles and Practice of Clinical Research Journal. Principles and Practice of Clinical Research; 2023; 9 10.21801/ppcrj.2023.92.10
• Anti-breast cancer-induced cardiomyopathy: Mechanisms and future directions Cite
  Liu C, Chen H, Guo S, Liu Q, Chen Z, Huang H, et al. Anti-breast cancer-induced cardiomyopathy: Mechanisms and future directions. Biomedicine & Pharmacotherapy. Elsevier BV; 2023; 166:115373 10.1016/j.biopha.2023.115373
• Efficacy and safety of epigallocatechin-3-gallate in treatment acute severe dermatitis in patients with cancer receiving radiotherapy: a phase I clinical trial Cite
  Xie J, Jia L, Xie P, Yin X, Zhu W, Zhao H, et al. Efficacy and safety of epigallocatechin-3-gallate in treatment acute severe dermatitis in patients with cancer receiving radiotherapy: a phase I clinical trial. Scientific Reports. Springer Science and Business Media LLC; 2023; 13 10.1038/s41598-023-40881-4
• Racial Disparity in Anthracycline-induced Cardiotoxicity in Breast Cancer Patients Cite
  Balaji S, Antony AK, Tonchev H, Scichilone G, Morsy M, Deen H, et al. Racial Disparity in Anthracycline-induced Cardiotoxicity in Breast Cancer Patients. Biomedicines. MDPI AG; 2023; 11:2286 10.3390/biomedicines11082286
• Prospective Exploratory Study of the Effects of Postoperative Endocrine Medication on the Endometrium in Breast Cancer Patients Cite
  He Y, Li Y, Geng Y, Liu A, Gao F, Ji C, et al. Prospective Exploratory Study of the Effects of Postoperative Endocrine Medication on the Endometrium in Breast Cancer Patients. International Journal of General Medicine. Informa UK Limited; 2023; Volume 16:3677-3687 10.2147/ijgm.s417965
• CBD-oil as a potential solution in case of severe tamoxifen-related side effects Cite
  Buijs SM, Braal CL, Buck SAJ, van Maanen NF, van der Meijden-Erkelens LM, Kuijper-Tissot van Patot HA, et al. CBD-oil as a potential solution in case of severe tamoxifen-related side effects. npj Breast Cancer. Springer Science and Business Media LLC; 2023; 9 10.1038/s41523-023-00570-x
• Delayed versus immediate use of zoledronic acid for postmenopausal patients with ER/PR positive early breast cancer who are using adjuvant letrozole. Cite
  Abdel Gelil M. Delayed versus immediate use of zoledronic acid for postmenopausal patients with ER/PR positive early breast cancer who are using adjuvant letrozole.. JCO Global Oncology. American Society of Clinical Oncology (ASCO); 2023; 9:8-8 10.1200/go.2023.9.supplement_1.8
• Assessment of thyme honey oral gel for the prevention of adriamycin and cyclophosphamide chemotherapy-induced oral mucositis in patients with breast cancer Cite
  Jahanbani Mazraeh E, Sadighi S, Manifar S, Bakhshandeh H, Rajabi M. Assessment of thyme honey oral gel for the prevention of adriamycin and cyclophosphamide chemotherapy-induced oral mucositis in patients with breast cancer. Supportive Care in Cancer. Springer Science and Business Media LLC; 2023; 31 10.1007/s00520-023-07943-9
• Effects of letrozole on serum estradiol and estrone in postmenopausal breast cancer patients and tolerability of treatment: a prospective trial using a highly sensitive LC–MS/MS (liquid chromatography–tandem mass spectrometry) method for estrogen measurement Cite
  Faltinová M, Vehmanen L, Lyytinen H, Haanpää M, Hämäläinen E, Tiitinen A, et al. Effects of letrozole on serum estradiol and estrone in postmenopausal breast cancer patients and tolerability of treatment: a prospective trial using a highly sensitive LC–MS/MS (liquid chromatography–tandem mass spectrometry) method for estrogen measurement. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2023; 10.1007/s10549-023-07054-3
• Adjuvant endocrine therapy uptake, toxicity, quality of life, and prediction of early discontinuation Cite
  Balazard F, Bertaut A, Bordet É, Mulard S, Blanc J, Briot N, et al. Adjuvant endocrine therapy uptake, toxicity, quality of life, and prediction of early discontinuation. JNCI: Journal of the National Cancer Institute. Oxford University Press (OUP); 2023; 10.1093/jnci/djad109
• The beneficial effects of tamoxifen on arteries: a key player for cardiovascular health of breast cancer patient Cite
  Davezac M, Meneur C, Buscato M, Zahreddine R, Arnal J, Dalenc F, et al. The beneficial effects of tamoxifen on arteries: a key player for cardiovascular health of breast cancer patient. Biochemical Pharmacology. Elsevier BV; 2023;:115677 10.1016/j.bcp.2023.115677
• Side effects of low-dose tamoxifen: results from a six-armed randomised controlled trial in healthy women Cite
  Hammarström M, Gabrielson M, Crippa A, Discacciati A, Eklund M, Lundholm C, et al. Side effects of low-dose tamoxifen: results from a six-armed randomised controlled trial in healthy women. British Journal of Cancer. Springer Science and Business Media LLC; 2023; 129:61-71 10.1038/s41416-023-02293-z
• (Pre)treatment risk factors for late fatigue and fatigue trajectories following radiotherapy for breast cancer Cite
  Rosas JC, Aguado‐Barrera ME, Azria D, Briers E, Elliott R, Farcy‐Jacquet M, et al. (Pre)treatment risk factors for late fatigue and fatigue trajectories following radiotherapy for breast cancer. International Journal of Cancer. Wiley; 2023; 10.1002/ijc.34640
• The Role of EGCG on the Expression of p38 MAPK, IL-6 and TNF-α Biomarker Proteins in the Cisplatin Induced Kidney Damage in Rats Cite
  Nuran Toprakoglu , Aslan A, Beyaz S, Gok O, Erman O, Tan F, et al. The Role of EGCG on the Expression of p38 MAPK, IL-6 and TNF-α Biomarker Proteins in the Cisplatin Induced Kidney Damage in Rats. Biology Bulletin. Pleiades Publishing Ltd; 2023; 10.1134/s1062359022602336
• Association between insulin resistance and cardiac remodeling in HER2-positive breast cancer patients: a real-world study Cite
  Shi Y, Qiu Z, Yu J, Li Z, Hua S, Chen Y, et al. Association between insulin resistance and cardiac remodeling in HER2-positive breast cancer patients: a real-world study. BMC Cancer. Springer Science and Business Media LLC; 2023; 23 10.1186/s12885-023-11102-y
• Association of self-directed walking with toxicity moderation during chemotherapy for the treatment of early breast cancer Cite
  Nyrop K, Page A, Deal A, Wagoner C, Kelly E, Kimmick G, et al. Association of self-directed walking with toxicity moderation during chemotherapy for the treatment of early breast cancer. Research Square Platform LLC; 2023; 10.21203/rs.3.rs-3034896/v1
• Chemotherapy induced peripheral neuropathy (CIPN) due to paclitaxel versus docetaxel in patients with early-stage breast cancer receiving taxane therapy: SWOG S1714. Cite
  Trivedi MS, Unger JM, Hershman DL, Darke A, Hertz DL, Brannagan T, et al. Chemotherapy induced peripheral neuropathy (CIPN) due to paclitaxel versus docetaxel in patients with early-stage breast cancer receiving taxane therapy: SWOG S1714.. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2023; 41:12003-12003 10.1200/jco.2023.41.16_suppl.12003
• Safety and efficacy of cannabidiol in the management of chemotherapy-induced peripheral neuropathy. Cite
  Weiss MC, Giaddui M, Kjelstrom S, Erebor E, Meske S, Saeed L, et al. Safety and efficacy of cannabidiol in the management of chemotherapy-induced peripheral neuropathy.. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2023; 41:12020-12020 10.1200/jco.2023.41.16_suppl.12020
• Redefining the “crown”: Approaching chemotherapy‐induced alopecia among Black patients with breast cancer Cite
  Pleasant VA, Purkiss AS, Merjaver SD. Redefining the “crown”: Approaching chemotherapy‐induced alopecia among Black patients with breast cancer. Cancer. Wiley; 2023; 129:1629-1633 10.1002/cncr.34732
• Palmitoylethanolamide in the Treatment of Chronic Pain: A Systematic Review and Meta-Analysis of Double-Blind Randomized Controlled Trials Cite
  Lang-Illievich K, Klivinyi C, Lasser C, Brenna CTA, Szilagyi IS, Bornemann-Cimenti H. Palmitoylethanolamide in the Treatment of Chronic Pain: A Systematic Review and Meta-Analysis of Double-Blind Randomized Controlled Trials. Nutrients. MDPI AG; 2023; 15:1350 10.3390/nu15061350
• Structural Brain Changes After a Mindfulness-Based Intervention in Breast Cancer Survivors with Cognitive Complaints Cite
  Melis M, Blommaert J, Radwan A, Smeets A, Van der Gucht K, Deprez S, et al. Structural Brain Changes After a Mindfulness-Based Intervention in Breast Cancer Survivors with Cognitive Complaints. Mindfulness. Springer Science and Business Media LLC; 2023; 10.1007/s12671-023-02140-5
• Tamoxifen or aromatase inhibitors: which one is the culprit of urinary incontinence in premenopausal breast cancer patients receiving adjuvant hormone therapy? Cite
  Karaboyun K, Cavdar E, Irıagac Y, Celebı A, Kapagan T, Gulturk I, et al. Tamoxifen or aromatase inhibitors: which one is the culprit of urinary incontinence in premenopausal breast cancer patients receiving adjuvant hormone therapy?. Supportive Care in Cancer. Springer Science and Business Media LLC; 2023; 31 10.1007/s00520-023-07791-7
• Efficacy of curcumin for amelioration of radiotherapy-induced oral mucositis: a preliminary randomized controlled clinical trial Cite
  Ramezani V, Ghadirian S, Shabani M, Boroumand MA, Daneshvar R, Saghafi F. Efficacy of curcumin for amelioration of radiotherapy-induced oral mucositis: a preliminary randomized controlled clinical trial. BMC Cancer. Springer Science and Business Media LLC; 2023; 23 10.1186/s12885-023-10730-8
• Rutin and Hesperidin Alleviate Paclitaxel-Induced Nephrocardiotoxicity in Wistar Rats via Suppressing the Oxidative Stress and Enhancing the Antioxidant Defense Mechanisms Cite
  Ali YA, Ahmed OM, Soliman HA, Abdel-Gabbar M, Al-Dossari M, El-Gawaad NSA, et al. Rutin and Hesperidin Alleviate Paclitaxel-Induced Nephrocardiotoxicity in Wistar Rats via Suppressing the Oxidative Stress and Enhancing the Antioxidant Defense Mechanisms. Evidence-Based Complementary and Alternative Medicine. Hindawi Limited; 2023; 2023:1-15 10.1155/2023/5068304
• Risk of Secondary Cancer after Adjuvant Tamoxifen Treatment for Ductal Carcinoma In Situ: A Nationwide Cohort Study in South Korea Cite
  Kim D, Oh J, Seok J, Lee HS, Jeon S, Yoon CI. Risk of Secondary Cancer after Adjuvant Tamoxifen Treatment for Ductal Carcinoma In Situ: A Nationwide Cohort Study in South Korea. Diagnostics. MDPI AG; 2023; 13:792 10.3390/diagnostics13040792
• The impact of endoxifen-guided tamoxifen dose reductions on endocrine side-effects in patients with primary breast cancer Cite
  Buijs S, Hoop EO, Braal C, van Rosmalen M, Drooger J, van Rossum-Schornagel Q, et al. The impact of endoxifen-guided tamoxifen dose reductions on endocrine side-effects in patients with primary breast cancer. ESMO Open. Elsevier BV; 2023; 8:100786 10.1016/j.esmoop.2023.100786
• Association of Anthracycline With Heart Failure in Patients Treated for Breast Cancer or Lymphoma, 1985-2010 Cite
  Larsen CM, Garcia Arango M, Dasari H, Arciniegas Calle M, Adjei E, Rico Mesa J, et al. Association of Anthracycline With Heart Failure in Patients Treated for Breast Cancer or Lymphoma, 1985-2010. JAMA Network Open. American Medical Association (AMA); 2023; 6:e2254669 10.1001/jamanetworkopen.2022.54669
• Thymoquinone may alleviate cisplatin-induced muscle atrophy in rats by regulating mitofusin 2 and meteorin-like levels Cite
  Yalçın T, Kaya S. Thymoquinone may alleviate cisplatin-induced muscle atrophy in rats by regulating mitofusin 2 and meteorin-like levels. Comparative Clinical Pathology. Springer Science and Business Media LLC; 2023; 10.1007/s00580-023-03442-9
• Factors associated with weight gain after breast cancer: Results from a community-based survey of Australian women Cite
  Ee C, Cave A, Vaddiparthi V, Naidoo D, Boyages J. Factors associated with weight gain after breast cancer: Results from a community-based survey of Australian women. The Breast. Elsevier BV; 2023; 10.1016/j.breast.2023.01.012
• Relationship between tamoxifen and cataracts: a nationwide cohort study of women in South Korea Cite
  Yoon CI, Lee HS, Jeon S, Kim D, Park W. Relationship between tamoxifen and cataracts: a nationwide cohort study of women in South Korea. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2022; 197:603-612 10.1007/s10549-022-06765-3
• Melatonin and metformin ameliorated trastuzumab-induced cardiotoxicity through the modulation of mitochondrial function and dynamics without reducing its anticancer efficacy Cite
  Arinno A, Maneechote C, Khuanjing T, Prathumsap N, Chunchai T, Arunsak B, et al. Melatonin and metformin ameliorated trastuzumab-induced cardiotoxicity through the modulation of mitochondrial function and dynamics without reducing its anticancer efficacy. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. Elsevier BV; 2023; 1869:166618 10.1016/j.bbadis.2022.166618
• Açai Berry Attenuates Cyclophosphamide-Induced Damage in Genitourinary Axis-Modulating Nrf-2/HO-1 Pathways Cite
  Siracusa R, D’Amico R, Fusco R, Impellizzeri D, Peritore AF, Gugliandolo E, et al. Açai Berry Attenuates Cyclophosphamide-Induced Damage in Genitourinary Axis-Modulating Nrf-2/HO-1 Pathways. Antioxidants. MDPI AG; 2022; 11:2355 10.3390/antiox11122355
• Risk of Endometrial Polyps, Hyperplasia, Carcinoma, and Uterine Cancer After Tamoxifen Treatment in Premenopausal Women With Breast Cancer Cite
  Ryu K, Kim MS, Lee JY, Nam S, Jeong HG, Kim T, et al. Risk of Endometrial Polyps, Hyperplasia, Carcinoma, and Uterine Cancer After Tamoxifen Treatment in Premenopausal Women With Breast Cancer. JAMA Network Open. American Medical Association (AMA); 2022; 5:e2243951 10.1001/jamanetworkopen.2022.43951
• Early skeletal muscle deconditioning and reduced exercise capacity during (neo)adjuvant chemotherapy in patients with breast cancer Cite
  Mallard J, Hucteau E, Schott R, Trensz P, Pflumio C, Kalish‐Weindling M, et al. Early skeletal muscle deconditioning and reduced exercise capacity during (neo)adjuvant chemotherapy in patients with breast cancer. Cancer. Wiley; 2022; 10.1002/cncr.34533
• Exercise for the Prevention of Anthracycline-induced Functional Disability and Cardiac Dysfunction: The BReast Cancer Randomized EXercise InTervention (BREXIT) Study Cite
  Foulkes SJ, Howden EJ, Haykowsky MJ, Antill Y, Salim A, Nightingale SS, et al. Exercise for the Prevention of Anthracycline-induced Functional Disability and Cardiac Dysfunction: The BReast Cancer Randomized EXercise InTervention (BREXIT) Study. Circulation. Ovid Technologies (Wolters Kluwer Health); 2022; 10.1161/circulationaha.122.062814
• Roasted cashew (Anacardium occidentale L.) nut-enhanced diet forestalls cisplatin-initiated brain harm in rats Cite
  Akomolafe SF, Asowata-Ayodele AM. Roasted cashew (Anacardium occidentale L.) nut-enhanced diet forestalls cisplatin-initiated brain harm in rats. Heliyon. Elsevier BV; 2022;:e11066 10.1016/j.heliyon.2022.e11066
• Association of raloxifene and tamoxifen therapy with cognitive performance, odds of mild cognitive impairment, and brain MRI markers of neurodegeneration Cite
  Kara F, Lohse CM, Castillo AM, Tosakulwong N, Lesnick TG, Jack CR, et al. Association of raloxifene and tamoxifen therapy with cognitive performance, odds of mild cognitive impairment, and brain MRI markers of neurodegeneration. Cancer Medicine. Wiley; 2022; 10.1002/cam4.5175
• Potential Cardioprotective Effects and Lipid Mediator Differences in Long-Chain Omega-3 Polyunsaturated Fatty Acid Supplemented Mice Given Chemotherapy Cite
  Angelotti A, Snoke DB, Ormiston K, Cole RM, Borkowski K, Newman JW, et al. Potential Cardioprotective Effects and Lipid Mediator Differences in Long-Chain Omega-3 Polyunsaturated Fatty Acid Supplemented Mice Given Chemotherapy. Metabolites. MDPI AG; 2022; 12:782 10.3390/metabo12090782
• Neural correlates in functional brain mapping among breast cancer survivors receiving different chemotherapy regimens: a qEEG/HEG-based investigation Cite
  Vasaghi Gharamaleki M, Mousavi SZ, Owrangi M, Gholamzadeh MJ, Kamali A, Dehghani M, et al. Neural correlates in functional brain mapping among breast cancer survivors receiving different chemotherapy regimens: a qEEG/HEG-based investigation. Japanese Journal of Clinical Oncology. Oxford University Press (OUP); 2022; 10.1093/jjco/hyac121
• Supplemental Vitamin D and Incident Fractures in Midlife and Older Adults Cite
  LeBoff MS, Chou SH, Ratliff KA, Cook NR, Khurana B, Kim E, et al. Supplemental Vitamin D and Incident Fractures in Midlife and Older Adults. New England Journal of Medicine. Massachusetts Medical Society; 2022; 387:299-309 10.1056/nejmoa2202106
• Vaginal Estrogen Therapy for the Genitourinary Symptoms of Menopause: Caution or Reassurance? Cite
  Cathcart-Rake EJ, Ruddy KJ. Vaginal Estrogen Therapy for the Genitourinary Symptoms of Menopause: Caution or Reassurance?. JNCI: Journal of the National Cancer Institute. Oxford University Press (OUP); 2022; 10.1093/jnci/djac113
• A Systematic Review of the Benefit of B-Vitamins as a Complementary Treatment in Cancer Patients Cite
  Heilfort L, Kutschan S, Dörfler J, Freuding M, Büntzel J, Münstedt K, et al. A Systematic Review of the Benefit of B-Vitamins as a Complementary Treatment in Cancer Patients. Nutrition and Cancer. Informa UK Limited; 2022;:1-15 10.1080/01635581.2022.2098348
• Adjuvant Hormone Therapy–Related Hot Flashes Predict Treatment Discontinuation and Worse Breast Cancer Prognosis Cite
  Zeng E, He W, Smedby KE, Czene K. Adjuvant Hormone Therapy–Related Hot Flashes Predict Treatment Discontinuation and Worse Breast Cancer Prognosis. Journal of the National Comprehensive Cancer Network. Harborside Press, LLC; 2022; 20:683-689.e2 10.6004/jnccn.2021.7116
• The impact of weight loss on physical function and symptoms in overweight or obese breast cancer survivors: results from POWER-remote Cite
  Sheng JY, Santa-Maria CA, Blackford AL, Lim D, Carpenter A, Smith KL, et al. The impact of weight loss on physical function and symptoms in overweight or obese breast cancer survivors: results from POWER-remote. Journal of Cancer Survivorship. Springer Science and Business Media LLC; 2021; 16:542-551 10.1007/s11764-021-01049-z
• Management of adverse events during cyclin-dependent kinase 4/6 (CDK4/6) inhibitor-based treatment in breast cancer Cite
  Thill M, Schmidt M. Management of adverse events during cyclin-dependent kinase 4/6 (CDK4/6) inhibitor-based treatment in breast cancer. Therapeutic Advances in Medical Oncology. SAGE Publications; 2018; 10:175883591879332 10.1177/1758835918793326
• Effects of exercise during adjuvant chemotherapy for breast cancer on long-term cardiotoxicity. Cite
  Naaktgeboren W, Stuiver MM, van Harten WH, Aaronson NK, Scott J, Sonke GS, et al. Effects of exercise during adjuvant chemotherapy for breast cancer on long-term cardiotoxicity.. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2022; 40:12081-12081 10.1200/jco.2022.40.16_suppl.12081
• Weight Gain after Hormone Receptor-Positive Breast Cancer Cite
  Goyal A, Milner GE, Cimino-Mathews A, Visvanathan K, Wolff AC, Sharma D, et al. Weight Gain after Hormone Receptor-Positive Breast Cancer. Current Oncology. MDPI AG; 2022; 29:4090-4103 10.3390/curroncol29060326
• Role of alpha-lipoic acid in counteracting paclitaxel- and doxorubicin-induced toxicities: a randomized controlled trial in breast cancer patients Cite
  Werida RH, Elshafiey RA, Ghoneim A, Elzawawy S, Mostafa TM. Role of alpha-lipoic acid in counteracting paclitaxel- and doxorubicin-induced toxicities: a randomized controlled trial in breast cancer patients. Supportive Care in Cancer. Springer Science and Business Media LLC; 2022; 10.1007/s00520-022-07124-0
• Adjuvant aromatase inhibitor therapy and early markers for cardiovascular disease in breast cancer survivors Cite
  Nijhof AVO-, Jacobse JN, Steggink LC, Lefrandt JD, Gietema JA, Leeuwen FEV, et al. Adjuvant aromatase inhibitor therapy and early markers for cardiovascular disease in breast cancer survivors. Research Square Platform LLC; 2022; 10.21203/rs.3.rs-1626546/v1
• And It’ll Come Back Real Baby Fine: Black Women’s Experiences With Hair Loss and Regrowth After Chemotherapy for Breast Cancer Treatment Cite
  Wilson KB. And It’ll Come Back Real Baby Fine: Black Women’s Experiences With Hair Loss and Regrowth After Chemotherapy for Breast Cancer Treatment. Qualitative Health Research. SAGE Publications; 2022;:104973232210919 10.1177/10497323221091929
• Protective Effect of Curcumin, Chrysin and Thymoquinone Injection on Trastuzumab-Induced Cardiotoxicity via Mitochondrial Protection Cite
  Shirmard LR, Shabani M, Moghadam AA, Zamani N, Ghanbari H, Salimi A. Protective Effect of Curcumin, Chrysin and Thymoquinone Injection on Trastuzumab-Induced Cardiotoxicity via Mitochondrial Protection. Cardiovascular Toxicology. Springer Science and Business Media LLC; 2022; 10.1007/s12012-022-09750-w
• 398 Does tamoxifen therapy increases occurence of endometrium pathology? Cite
  Wojda K, Kalukiewicz A, Bobeff K, Sieroszewski P. 398 Does tamoxifen therapy increases occurence of endometrium pathology?. European Journal of Obstetrics & Gynecology and Reproductive Biology. Elsevier BV; 2022; 270:e104-e105 10.1016/j.ejogrb.2021.11.339
• Phloretin-induced suppression of oxidative and nitrosative stress attenuates doxorubicin-induced cardiotoxicity in rats Cite
  Patil C, Wagh S, Patil K, Mahajan U, Bagal P, Wadkar A, et al. Phloretin-induced suppression of oxidative and nitrosative stress attenuates doxorubicin-induced cardiotoxicity in rats. Asian Pacific Journal of Tropical Biomedicine. Medknow; 2022; 12:124 10.4103/2221-1691.338921
• The impact of metformin use on the outcomes of locally advanced breast cancer patients receiving neoadjuvant chemotherapy: an open-labelled randomized controlled trial Cite
  Barakat HE, Hussein RRS, Elberry AA, Zaki MA, Ramadan ME. The impact of metformin use on the outcomes of locally advanced breast cancer patients receiving neoadjuvant chemotherapy: an open-labelled randomized controlled trial. Scientific Reports. Springer Science and Business Media LLC; 2022; 12 10.1038/s41598-022-11138-3
• Is screening for endometrial cancer necessary in asymptomatic women treated with tamoxifen for breast cancer? Cite
  Ju UC, Kang WD, Kim SM. Is screening for endometrial cancer necessary in asymptomatic women treated with tamoxifen for breast cancer?. European Journal of Gynaecological Oncology. IMR Press; 2022; 43:169-174 10.31083/j.ejgo4302022
• Grape-Seed-Derived Procyanidin Attenuates Chemotherapy-Induced Cognitive Impairment by Suppressing MMP-9 Activity and Related Blood–Brain-Barrier Damage Cite
  Song C, Gao C, Wang Z. Grape-Seed-Derived Procyanidin Attenuates Chemotherapy-Induced Cognitive Impairment by Suppressing MMP-9 Activity and Related Blood–Brain-Barrier Damage. Brain Sciences. MDPI AG; 2022; 12:571 10.3390/brainsci12050571
• Pilot study to assess prolonged overnight fasting in breast cancer survivors (longfast) Cite
  O’Donnell E, Shapiro Y, Comander A, Isakoff S, Moy B, Spring L, et al. Pilot study to assess prolonged overnight fasting in breast cancer survivors (longfast). Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2022; 10.1007/s10549-022-06594-4
• Comparing Flaxseed and Perindopril in the Prevention of Doxorubicin and Trastuzumab-Induced Cardiotoxicity in C57Bl/6 Mice Cite
  Eekhoudt CR, Bortoluzzi T, Varghese SS, Cheung DYC, Christie S, Eastman S, et al. Comparing Flaxseed and Perindopril in the Prevention of Doxorubicin and Trastuzumab-Induced Cardiotoxicity in C57Bl/6 Mice. Current Oncology. MDPI AG; 2022; 29:2941-2953 10.3390/curroncol29050241
• Isoorientin attenuates doxorubicin-induced cardiac injury via the activation of MAPK, Akt, and Caspase-dependent signaling pathways Cite
  Li S, Liu H, Lin Z, Li Z, Chen Y, Chen B, et al. Isoorientin attenuates doxorubicin-induced cardiac injury via the activation of MAPK, Akt, and Caspase-dependent signaling pathways. Phytomedicine. Elsevier BV; 2022; 101:154105 10.1016/j.phymed.2022.154105
• Does the toxicity of endocrine therapy persist into long-term survivorship? – Patient-reported outcome results from a follow-up study beyond a 10-year-survival Cite
  Albertini C, Oberguggenberger A, Sztankay M, Egle D, Giesinger J, Meraner V, et al. Does the toxicity of endocrine therapy persist into long-term survivorship? – Patient-reported outcome results from a follow-up study beyond a 10-year-survival. Research Square Platform LLC; 2022; 10.21203/rs.3.rs-1526913/v1
• Prevalence and correlates of cancer-related fatigue in breast cancer survivors Cite
  Álvarez-Bustos A, de Pedro CG, Romero-Elías M, Ramos J, Osorio P, Cantos B, et al. Prevalence and correlates of cancer-related fatigue in breast cancer survivors. Supportive Care in Cancer. Springer Science and Business Media LLC; 2021; 29:6523-6534 10.1007/s00520-021-06218-5
• Alteration in glucose metabolism in the brain associated with tamoxifen treatment: Study in postmenopausal animal model Cite
  Koerich S, Silva FC, Itinose AM, Bellozi PMQ, Sandrini F, Schneider SCS, et al. Alteration in glucose metabolism in the brain associated with tamoxifen treatment: Study in postmenopausal animal model. Toxicology and Applied Pharmacology. Elsevier BV; 2022; 442:116002 10.1016/j.taap.2022.116002
• Abstract P5-18-12: Cardioprotective effects of walnuts against aromatase inhibitor: Pilot study in a zebrafish model Cite
  Hilakivi-Clarke L, Da Silva JL, Blaes A, Hoeppner L. Abstract P5-18-12: Cardioprotective effects of walnuts against aromatase inhibitor: Pilot study in a zebrafish model. Cancer Research. American Association for Cancer Research (AACR); 2022; 82:P5-18-12-P5-18-12 10.1158/1538-7445.sabcs21-p5-18-12
• Gynecologic Symptoms among Hormone Receptor-Positive Breast Cancer Patients on Oral Endocrine Therapy: A Cross-Sectional Study Cite
  Moskalewicz A, Di Tomaso A, Kachura JJ, Scime S, Nisenbaum R, Lee R, et al. Gynecologic Symptoms among Hormone Receptor-Positive Breast Cancer Patients on Oral Endocrine Therapy: A Cross-Sectional Study. Current Oncology. MDPI AG; 2022; 29:1813-1827 10.3390/curroncol29030149
• Natural Polysaccharide β-Glucan Protects against Doxorubicin-Induced Cardiotoxicity by Suppressing Oxidative Stress Cite
  Wang X, Ji Y, Jin D, Qi J, Hou X, Zhao W, et al. Natural Polysaccharide β-Glucan Protects against Doxorubicin-Induced Cardiotoxicity by Suppressing Oxidative Stress. Nutrients. MDPI AG; 2022; 14:906 10.3390/nu14040906
• Trends in heart disease mortality among breast cancer survivors in the US, 1975–2017 Cite
  Vo JB, Ramin C, Barac A, Berrington de Gonzalez A, Veiga L. Trends in heart disease mortality among breast cancer survivors in the US, 1975–2017. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2022; 10.1007/s10549-022-06515-5
• The effect of trastuzumab on taxane-induced peripheral neuropathy in women with breast cancer: a population-based cohort study Cite
  Patel R, Lyne-Ethier J, Brogly S, Griffiths R, Hendry JM. The effect of trastuzumab on taxane-induced peripheral neuropathy in women with breast cancer: a population-based cohort study. Research Square Platform LLC; 2022; 10.21203/rs.3.rs-1254626/v1
• Prevention of doxorubicin-induced experimental cardiotoxicity by Nigella sativa in rats Cite
  Adıyaman MŞ, Adıyaman ÖA, Dağlı AF, Karahan MZ, Dağlı MN. Prevention of doxorubicin-induced experimental cardiotoxicity by Nigella sativa in rats. Revista Portuguesa de Cardiologia. Elsevier BV; 2022; 10.1016/j.repc.2020.12.015
• Beneficial effects of exercise on chemotherapy-induced peripheral neuropathy and sleep disturbance: A review of literature and proposed mechanisms Cite
  Brett Whalen L, Zachary Wright W, Kundur P, Angadi S, Modesitt SC. Beneficial effects of exercise on chemotherapy-induced peripheral neuropathy and sleep disturbance: A review of literature and proposed mechanisms. Gynecologic Oncology Reports. Elsevier BV; 2022; 39:100927 10.1016/j.gore.2022.100927
• Use of beta‐blockers and risk of contralateral breast cancer Cite
  Gottschau M, Bens A, Friis S, Cronin‐Fenton D, Aalborg GL, Jensen M, et al. Use of beta‐blockers and risk of contralateral breast cancer. International Journal of Cancer. Wiley; 2022; 10.1002/ijc.33923
• Letrozole Accelerates Metabolic Remodeling through Activation of Glycolysis in Cardiomyocytes: A Role beyond Hormone Regulation Cite
  Heo JH, Lee SR, Jo SL, Yang H, Lee HW, Hong E. Letrozole Accelerates Metabolic Remodeling through Activation of Glycolysis in Cardiomyocytes: A Role beyond Hormone Regulation. International Journal of Molecular Sciences. MDPI AG; 2022; 23:547 10.3390/ijms23010547
• Kaempferol attenuates doxorubicin-mediated nephropathy in rats by activating SIRT1 signaling Cite
  Alagal RI, AlFaris NA, Alshammari GM, ALTamimi JZ, AlMousa LA, Yahya MA. Kaempferol attenuates doxorubicin-mediated nephropathy in rats by activating SIRT1 signaling. Journal of Functional Foods. Elsevier BV; 2022; 89:104918 10.1016/j.jff.2021.104918
• Insights into the Protective Effects of Thymoquinone against Toxicities Induced by Chemotherapeutic Agents Cite
  Farooq J, Sultana R, Taj T, Asdaq SMB, Alsalman AJ, Mohaini MA, et al. Insights into the Protective Effects of Thymoquinone against Toxicities Induced by Chemotherapeutic Agents. Molecules. MDPI AG; 2021; 27:226 10.3390/molecules27010226
• Overexpression of Neuron-Derived Orphan Receptor 1 (NOR-1) Rescues Cardiomyocytes from Cell Death and Improves Viability after Doxorubicin Induced Stress Cite
  Berg P, Hansson ÅML, Røsand Ø, Marwarha G, Høydal MA. Overexpression of Neuron-Derived Orphan Receptor 1 (NOR-1) Rescues Cardiomyocytes from Cell Death and Improves Viability after Doxorubicin Induced Stress. Biomedicines. MDPI AG; 2021; 9:1233 10.3390/biomedicines9091233
• Coenzyme Q10 protects against doxorubicin-induced cardiomyopathy via antioxidant and anti-apoptotic pathway Cite
  Shabaan DA, Mostafa N, El-Desoky MM, Arafat EA. Coenzyme Q10 protects against doxorubicin-induced cardiomyopathy via antioxidant and anti-apoptotic pathway. Tissue Barriers. Informa UK Limited; 2021; 10.1080/21688370.2021.2019504
• Randomised controlled trial of intermittent vs continuous energy restriction during chemotherapy for early breast cancer Cite
  Harvie M, Pegington M, Howell SJ, Bundred N, Foden P, Adams J, et al. Randomised controlled trial of intermittent vs continuous energy restriction during chemotherapy for early breast cancer. British Journal of Cancer. Springer Science and Business Media LLC; 2021; 10.1038/s41416-021-01650-0
• Caffeic acid phenethyl ester protects against doxorubicin-induced cardiotoxicity and increases chemotherapeutic efficacy by regulating the unfolded protein response Cite
  Zhang Y, Kong D, Han H, Cao Y, Zhu H, Cui G. Caffeic acid phenethyl ester protects against doxorubicin-induced cardiotoxicity and increases chemotherapeutic efficacy by regulating the unfolded protein response. Food and Chemical Toxicology. Elsevier BV; 2022; 159:112770 10.1016/j.fct.2021.112770
• Adverse health effects after breast cancer up to 14 years after diagnosis Cite
  Heins MJ, de Ligt KM, Verloop J, Siesling S, Korevaar JC, Berendsen A, et al. Adverse health effects after breast cancer up to 14 years after diagnosis. The Breast. Elsevier BV; 2022; 61:22-28 10.1016/j.breast.2021.12.001
• Curcumin Ameliorates Doxorubicin-Induced Cardiotoxicity and Hepatotoxicity Via Suppressing Oxidative Stress and Modulating iNOS, NF-κB, and TNF-α in Rats Cite
  Ibrahim Fouad G, Ahmed KA. Curcumin Ameliorates Doxorubicin-Induced Cardiotoxicity and Hepatotoxicity Via Suppressing Oxidative Stress and Modulating iNOS, NF-κB, and TNF-α in Rats. Cardiovascular Toxicology. Springer Science and Business Media LLC; 2021; 10.1007/s12012-021-09710-w
• Evaluating chronotypically tailored light therapy for breast cancer survivors: Preliminary findings on fatigue and disrupted sleep Cite
  Wu H, Gao F, Yan L, Given C. Evaluating chronotypically tailored light therapy for breast cancer survivors: Preliminary findings on fatigue and disrupted sleep. Chronobiology International. Informa UK Limited; 2021;:1-12 10.1080/07420528.2021.1992419
• Chemotherapy-Induced Changes in the Lung Microenvironment: The Role of MMP-2 in Facilitating Intravascular Arrest of Breast Cancer Cells Cite
  Middleton JD, Sivakumar S, Hai T. Chemotherapy-Induced Changes in the Lung Microenvironment: The Role of MMP-2 in Facilitating Intravascular Arrest of Breast Cancer Cells. International Journal of Molecular Sciences. MDPI AG; 2021; 22:10280 10.3390/ijms221910280
• The protective effects of hesperidin against paclitaxel-induced peripheral neuropathy in rats Cite
  Semis HS, Kandemir FM, Kaynar O, Dogan T, Arikan SM. The protective effects of hesperidin against paclitaxel-induced peripheral neuropathy in rats. Life Sciences. Elsevier BV; 2021; 287:120104 10.1016/j.lfs.2021.120104
• Cognitive Functioning and Health in Hispanic/Latina Breast Cancer Survivors Cite
  Marín-Chollom AM, Hale C, Koch P, Gaffney AO, Contento I, Shen H, et al. Cognitive Functioning and Health in Hispanic/Latina Breast Cancer Survivors. Journal of Immigrant and Minority Health. Springer Science and Business Media LLC; 2021; 10.1007/s10903-021-01300-w
• Is it necessary to measure basal serum lipid levels in cancer patients prior to tamoxifen treatment? Cite
  Sütcüoğlu O, Yazıcı O, Özet A. Is it necessary to measure basal serum lipid levels in cancer patients prior to tamoxifen treatment?. Future Oncology. Future Medicine Ltd; 2021; 10.2217/fon-2021-1107
• Chemotherapy-Induced Peripheral Neuropathy: Epidemiology, Pathomechanisms and Treatment Cite
  Burgess J, Ferdousi M, Gosal D, Boon C, Matsumoto K, Marshall A, et al. Chemotherapy-Induced Peripheral Neuropathy: Epidemiology, Pathomechanisms and Treatment. Oncology and Therapy. Springer Science and Business Media LLC; 2021; 10.1007/s40487-021-00168-y
• Exercise to Reduce Anthracycline-Mediated Cardiovascular Complications in Breast Cancer Survivors Cite
  Varghese SS, Johnston WJ, Eekhoudt CR, Keats MR, Jassal DS, Grandy SA. Exercise to Reduce Anthracycline-Mediated Cardiovascular Complications in Breast Cancer Survivors. Current Oncology. MDPI AG; 2021; 28:4139-4156 10.3390/curroncol28050351
• Cardioprotective effect of allyl isothiocyanate in a rat model of doxorubicin acute toxicity Cite
  Waz S, Matouk AI. Cardioprotective effect of allyl isothiocyanate in a rat model of doxorubicin acute toxicity. Toxicology Mechanisms and Methods. Informa UK Limited; 2021;:1-25 10.1080/15376516.2021.1992064
• The beneficial efficacy of liposomal resveratrol against doxorubicin-induced hepatotoxicity in rats: Role of TGF-β1 and SIRT1 Cite
  Alhusaini AM, Alanazi AM, Fadda LM, Alqahtani QH, Sarawi WS, Hasan IH. The beneficial efficacy of liposomal resveratrol against doxorubicin-induced hepatotoxicity in rats: Role of TGF-β1 and SIRT1. Journal of King Saud University - Science. Elsevier BV; 2021;:101640 10.1016/j.jksus.2021.101640
• A careful reassessment of anthracycline use in curable breast cancer Cite
  Hurvitz SA, McAndrew NP, Bardia A, Press MF, Pegram M, Crown JP, et al. A careful reassessment of anthracycline use in curable breast cancer. npj Breast Cancer. Springer Science and Business Media LLC; 2021; 7 10.1038/s41523-021-00342-5
• Association between cardiac autonomic modulation and sedentary behavior in breast cancer survivors: a 12-month cohort study Cite
  Palma MR, Tebar WR, Vanderlei LCM, Fregonesi CEPT, Ribeiro FE, Caldeira DT, et al. Association between cardiac autonomic modulation and sedentary behavior in breast cancer survivors: a 12-month cohort study. Supportive Care in Cancer. Springer Science and Business Media LLC; 2021; 10.1007/s00520-021-06602-1
• Focal white matter microstructural alteration after anthracycline-based systemic treatment in long-term breast cancer survivors: a structural magnetic resonance imaging study Cite
  Zhang H, Li P, Liu T, Wang X, Feng W, Chen R, et al. Focal white matter microstructural alteration after anthracycline-based systemic treatment in long-term breast cancer survivors: a structural magnetic resonance imaging study. Brain Imaging and Behavior. Springer Science and Business Media LLC; 2021; 10.1007/s11682-021-00551-3
• Coronary Artery Disease in Young Women After Radiation Therapy for Breast Cancer Cite
  Carlson LE, Watt GP, Tonorezos ES, Chow EJ, Yu AF, Woods M, et al. Coronary Artery Disease in Young Women After Radiation Therapy for Breast Cancer. JACC: CardioOncology. Elsevier BV; 2021; 3:381-392 10.1016/j.jaccao.2021.07.008
• Trigger point injection for post-mastectomy pain: a simple intervention with high rate of long-term relief Cite
  Khoury AL, Keane H, Varghese F, Hosseini A, Mukhtar R, Eder SE, et al. Trigger point injection for post-mastectomy pain: a simple intervention with high rate of long-term relief. npj Breast Cancer. Springer Science and Business Media LLC; 2021; 7 10.1038/s41523-021-00321-w
• Paclitaxel chemotherapy disrupts behavioral and molecular circadian clocks in mice Cite
  Sullivan KA, Grant CV, Jordan KR, Obrietan K, Pyter LM. Paclitaxel chemotherapy disrupts behavioral and molecular circadian clocks in mice. Brain, Behavior, and Immunity. Elsevier BV; 2021; 10.1016/j.bbi.2021.09.011
• 125P Cognitive impairment in breast cancer patients up to 18 months after cancer treatments: The French multicentric longitudinal CANTO-Cog cohort substudy Cite
  Lobbedez FJ, Hardy-Léger I, Arbogast SL, Rigal O, Le Fel J, Pistilli B, et al. 125P Cognitive impairment in breast cancer patients up to 18 months after cancer treatments: The French multicentric longitudinal CANTO-Cog cohort substudy. Annals of Oncology. Elsevier BV; 2021; 32:S412-S413 10.1016/j.annonc.2021.08.406
• Fatty Liver in Hormone Receptor-Positive Breast Cancer and Its Impact on Patient's Survival Cite
  Taroeno-Hariadi KW, Putra YR, Choridah L, Widodo I, Hardianti MS, Aryandono T. Fatty Liver in Hormone Receptor-Positive Breast Cancer and Its Impact on Patient's Survival. Journal of Breast Cancer. Korean Breast Cancer Society; 2021; 24 10.4048/jbc.2021.24.e41
• The effects of exercise on the bone health of people with cancer: a systematic review and meta-analysis Cite
  Rose GL, Skinner TL, Keating SE, Friedrich NK, Bolam KA. The effects of exercise on the bone health of people with cancer: a systematic review and meta-analysis. Osteoporosis International. Springer Science and Business Media LLC; 2021; 10.1007/s00198-021-06131-x
• Protective effects of hesperidin through attenuation of Ki67 expression against DMBA-induced breast cancer in female rats Cite
  Patel P, Shah J. Protective effects of hesperidin through attenuation of Ki67 expression against DMBA-induced breast cancer in female rats. Life Sciences. Elsevier BV; 2021; 285:119957 10.1016/j.lfs.2021.119957
• Epigallocatechin gallate and theaflavins independently alleviate cyclophosphamide-induced ovarian damage by inhibiting the overactivation of primordial follicles and follicular atresia Cite
  Chen Q, Xu Z, Li X, Du D, Wu T, Zhou S, et al. Epigallocatechin gallate and theaflavins independently alleviate cyclophosphamide-induced ovarian damage by inhibiting the overactivation of primordial follicles and follicular atresia. Phytomedicine. Elsevier BV; 2021;:153752 10.1016/j.phymed.2021.153752
• Occurrence and perceived effectiveness of activities used to decrease chemotherapy-induced peripheral neuropathy symptoms in the feet Cite
  Ogle T, Alexander K, Yates P, Paul SM, Kober KM, Conley YP, et al. Occurrence and perceived effectiveness of activities used to decrease chemotherapy-induced peripheral neuropathy symptoms in the feet. European Journal of Oncology Nursing. Elsevier BV; 2021; 54:102025 10.1016/j.ejon.2021.102025
• Effects of tamoxifen on cognition and language in women with breast cancer: A systematic search and a scoping review Cite
  Jebahi F, Sharma S, Bloss JE, Wright HH. Effects of tamoxifen on cognition and language in women with breast cancer: A systematic search and a scoping review. Psycho-Oncology. Wiley; 2021; 30:1262-1277 10.1002/pon.5696
• Chemo-Brain: An Activation Likelihood Estimation Meta-Analysis of Functional Magnetic Resonance Imaging Studies Cite
  Bernstein LJ, Edelstein K, Sharma A, Alain C. Chemo-Brain: An Activation Likelihood Estimation Meta-Analysis of Functional Magnetic Resonance Imaging Studies. Neuroscience & Biobehavioral Reviews. Elsevier BV; 2021; 10.1016/j.neubiorev.2021.08.024
• Paclitaxel Chemotherapy Induces Long-Term Memory Impairment and Neuroinflammation in a Mouse Model of Breast Cancer Survivorship Cite
  Chung N, Chang A, Gillis R, Sloan E, Walker AK. Paclitaxel Chemotherapy Induces Long-Term Memory Impairment and Neuroinflammation in a Mouse Model of Breast Cancer Survivorship. Research Square Platform LLC; 2021; 10.21203/rs.3.rs-783452/v1
• Cognitive Dysfunction after Heart Disease: A Manifestation of the Heart-Brain Axis Cite
  Xu C, Tao X, Ma X, Zhao R, Cao Z. Cognitive Dysfunction after Heart Disease: A Manifestation of the Heart-Brain Axis. Oxidative Medicine and Cellular Longevity. Hindawi Limited; 2021; 2021:1-10 10.1155/2021/4899688
• Physical Activity Patterns and Relationships With Cognitive Function in Patients With Breast Cancer Before, During, and After Chemotherapy in a Prospective, Nationwide Study Cite
  Salerno EA, Culakova E, Kleckner AS, Heckler CE, Lin P, Matthews CE, et al. Physical Activity Patterns and Relationships With Cognitive Function in Patients With Breast Cancer Before, During, and After Chemotherapy in a Prospective, Nationwide Study. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2021;:JCO.20.03514 10.1200/jco.20.03514
• Prevalence and predictors of peripheral neuropathy after breast cancer treatment Cite
  Kamgar M, Greenwald MK, Assad H, Hastert TA, McLaughlin EM, Reding KW, et al. Prevalence and predictors of peripheral neuropathy after breast cancer treatment. Cancer Medicine. Wiley; 2021; 10.1002/cam4.4202
• Acute toxicity and tolerability of anthracycline-based chemotherapy regimens in older versus younger patients with breast cancer: real-world data Cite
  Monteiro AR, Garcia AR, Póvoa S, Soares RF, Macedo F, Pereira TC, et al. Acute toxicity and tolerability of anthracycline-based chemotherapy regimens in older versus younger patients with breast cancer: real-world data. Supportive Care in Cancer. Springer Science and Business Media LLC; 2020; 29:2347-2353 10.1007/s00520-020-05766-6
• Antioxidant, anti-inflammatory, and anti-apoptotic effects of crocin against doxorubicin-induced myocardial toxicity in rats Cite
  Abdulkareem Aljumaily SA, Demir M, Elbe H, Yigitturk G, Bicer Y, Altinoz E. Antioxidant, anti-inflammatory, and anti-apoptotic effects of crocin against doxorubicin-induced myocardial toxicity in rats. Environmental Science and Pollution Research. Springer Science and Business Media LLC; 2021; 10.1007/s11356-021-15409-w
• Effect of Tart Cherry on Aromatase Inhibitor-Induced Arthralgia (AIA) in Nonmetastatic Hormone-Positive Breast Cancer Patients: A Randomized Double-Blind Placebo-Controlled Trial Cite
  Shenouda M, Copley R, Pacioles T, Lebowicz Y, Jamil M, Akpanudo S, et al. Effect of Tart Cherry on Aromatase Inhibitor-Induced Arthralgia (AIA) in Nonmetastatic Hormone-Positive Breast Cancer Patients: A Randomized Double-Blind Placebo-Controlled Trial. Clinical Breast Cancer. Elsevier BV; 2021; 10.1016/j.clbc.2021.06.007
• The influence of hormone therapy on secondary diabetes mellitus in breast cancer: a meta-analysis Cite
  Ye F, Wen J, Yang A, Wang Y, Li N, Yu P, et al. The influence of hormone therapy on secondary diabetes mellitus in breast cancer: a meta-analysis. Clinical Breast Cancer. Elsevier BV; 2021; 10.1016/j.clbc.2021.06.014
• Estimating long-term health risks after breast cancer radiotherapy: merging evidence from low and high doses Cite
  Simonetto C, Wollschläger D, Kundrát P, Ulanowski A, Becker J, Castelletti N, et al. Estimating long-term health risks after breast cancer radiotherapy: merging evidence from low and high doses. Radiation and Environmental Biophysics. Springer Science and Business Media LLC; 2021; 60:459-474 10.1007/s00411-021-00924-8
• Aromatase inhibitors use and risk for cardiovascular disease in breast cancer patients: A population-based cohort study Cite
  Sund M, Garcia-Argibay M, Garmo H, Ahlgren J, Wennstig A, Fredriksson I, et al. Aromatase inhibitors use and risk for cardiovascular disease in breast cancer patients: A population-based cohort study. The Breast. Elsevier BV; 2021; 59:157-164 10.1016/j.breast.2021.07.004
• Cognitive dysfunction prevalence and associated factors in older breast cancer survivors Cite
  Crouch A, Champion VL, Unverzagt FW, Pressler SJ, Huber L, Moser LR, et al. Cognitive dysfunction prevalence and associated factors in older breast cancer survivors. Journal of Geriatric Oncology. Elsevier BV; 2021; 10.1016/j.jgo.2021.07.001
• Vaginal Laser Therapy for Genitourinary Syndrome of Menopause – Systematic Review Cite
  Mension E, Alonso I, Tortajada M, Matas I, Gómez S, Ribera L, et al. Vaginal Laser Therapy for Genitourinary Syndrome of Menopause – Systematic Review. Maturitas. Elsevier BV; 2021; 10.1016/j.maturitas.2021.06.005
• Impact of chemotherapy on cognitive functioning in older patients with HER2-positive breast cancer: a sub-study in the RESPECT trial Cite
  Hagiwara Y, Sawaki M, Uemura Y, Kawahara T, Shimozuma K, Ohashi Y, et al. Impact of chemotherapy on cognitive functioning in older patients with HER2-positive breast cancer: a sub-study in the RESPECT trial. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2021; 10.1007/s10549-021-06253-0
• Trajectories of cognitive performance over five years in a prospective cohort of patients with breast cancer (NEON-BC) Cite
  Araújo N, Severo M, Lopes-Conceição L, Fontes F, Dias T, Branco M, et al. Trajectories of cognitive performance over five years in a prospective cohort of patients with breast cancer (NEON-BC). The Breast. Elsevier BV; 2021; 10.1016/j.breast.2021.05.006
• Antioxidant, anti-inflammatory and anti-apoptotic effects of crocin against doxorubicin-induced myocardial toxicity in rats Cite
  ALJUMAILY SAA, Demir M, Elbe H, Yigitturk G, Bicer Y, Altinoz E. Antioxidant, anti-inflammatory and anti-apoptotic effects of crocin against doxorubicin-induced myocardial toxicity in rats. Research Square Platform LLC; 2021; 10.21203/rs.3.rs-418902/v1
• Risk of venous thromboembolism and endocrine therapy in older women with breast cancer in the United States Cite
  Faiz AS, Guo S, Kaveney A, Philipp CS. Risk of venous thromboembolism and endocrine therapy in older women with breast cancer in the United States. Blood Coagulation & Fibrinolysis. Ovid Technologies (Wolters Kluwer Health); 2021; Publish Ahead of Print 10.1097/mbc.0000000000001043
• Effects of local laser treatment on vulvovaginal atrophy among women with breast cancer: a prospective study with long-term follow-up Cite
  Veron L, Wehrer D, Annerose-Zéphir G, Suciu V, Delaloge S, Pistilli B, et al. Effects of local laser treatment on vulvovaginal atrophy among women with breast cancer: a prospective study with long-term follow-up. Breast Cancer Research and Treatment. Breast Cancer Research and Treatment; 2021; 10.1007/s10549-021-06226-3
• Incidence of cardiotoxicity and validation of the Heart Failure Association-International Cardio-Oncology Society risk stratification tool in patients treated with trastuzumab for HER2-positive early breast cancer Cite
  Battisti NML, Andres MS, Lee KA, Ramalingam S, Nash T, Mappouridou S, et al. Incidence of cardiotoxicity and validation of the Heart Failure Association-International Cardio-Oncology Society risk stratification tool in patients treated with trastuzumab for HER2-positive early breast cancer. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2021; 10.1007/s10549-021-06192-w
• Association of Endocrine Therapy and Dementia in Women with Breast Cancer Cite
  Thompson MR, Niu J, Lei X, Nowakowska M, Wehner MR, Giordano SH, et al. Association of Endocrine Therapy and Dementia in Women with Breast Cancer. Breast Cancer: Targets and Therapy. Informa UK Limited; 2021; Volume 13:219-224 10.2147/bctt.s300455
• Morphine Deteriorates Cisplatin-Induced Cardiotoxicity in Rats and Induces Dose-Dependent Cisplatin Chemoresistance in MCF-7 Human Breast Cancer Cells Cite
  El-Sheikh AAK, Khired Z. Morphine Deteriorates Cisplatin-Induced Cardiotoxicity in Rats and Induces Dose-Dependent Cisplatin Chemoresistance in MCF-7 Human Breast Cancer Cells. Cardiovascular Toxicology. Springer Science and Business Media LLC; 2021; 10.1007/s12012-021-09646-1
• Fractional CO₂ vaginal laser for the genitourinary syndrome of menopause in breast cancer survivors Cite
  Siliquini GP, Bounous VE, Novara L, Giorgi M, Bert F, Biglia N. Fractional CO₂ vaginal laser for the genitourinary syndrome of menopause in breast cancer survivors. The Breast Journal. Wiley; 2021; 10.1111/tbj.14211
• Curcumin Promotes Anti-Tumor Effect of Cisplatin and Protects Against Cisplatin-Induced Kidney Injury in Lung Cancer Cite
  Zhao M, Ma Y, Hu X, Sun Y, Liu Z, Dong S, et al. Curcumin Promotes Anti-Tumor Effect of Cisplatin and Protects Against Cisplatin-Induced Kidney Injury in Lung Cancer. Research Square; 2021; 10.21203/rs.3.rs-306571/v1
• Distribution of dyslipidemia in Chinese early breast cancer patients at diagnosis and comparison of dyslipidemia incidence following different endocrine therapies: a population-based cohort study Cite
  Wang J, Yin J, Qiu J, Jiang J, Hu Y, Zheng H, et al. Distribution of dyslipidemia in Chinese early breast cancer patients at diagnosis and comparison of dyslipidemia incidence following different endocrine therapies: a population-based cohort study. Research Square; 2021; 10.21203/rs.3.rs-298866/v1
• Cognitive Impairment Resulting from Treatment with Docetaxel, Doxorubicin, and Cyclophosphamide Cite
  Brown T, McElroy T, Simmons P, Walters H, Ntagwabira F, Wang J, et al. Cognitive Impairment Resulting from Treatment with Docetaxel, Doxorubicin, and Cyclophosphamide. Brain Research. Elsevier BV; 2021;:147397 10.1016/j.brainres.2021.147397
• From Theory to Practice: Bone Health in Women with Early Breast Cancer Treated with Aromatase Inhibitors Cite
  Vasconcelos de Matos L, Fernandes L, Neves MT, Alves F, Baleiras M, Ferreira A, et al. From Theory to Practice: Bone Health in Women with Early Breast Cancer Treated with Aromatase Inhibitors. Current Oncology. MDPI AG; 2021; 28:1067-1076 10.3390/curroncol28020104
• High intensity exercise during breast cancer chemotherapy - effects on long-term myocardial damage and physical capacity - data from the OptiTrain RCT Cite
  Ansund J, Mijwel S, Bolam KA, Altena R, Wengström Y, Rullman E, et al. High intensity exercise during breast cancer chemotherapy - effects on long-term myocardial damage and physical capacity - data from the OptiTrain RCT. Cardio-Oncology. Springer Science and Business Media LLC; 2021; 7 10.1186/s40959-021-00091-1
• Racial and Socioeconomic Disparities in Cardiotoxicity among Women with HER2-Positive Breast Cancer Cite
  Al-Sadawi M, Hussain Y, Copeland-Halperin RS, Tobin JN, Moskowitz CS, Dang CT, et al. Racial and Socioeconomic Disparities in Cardiotoxicity among Women with HER2-Positive Breast Cancer. The American Journal of Cardiology. Elsevier BV; 2021; 10.1016/j.amjcard.2021.02.013
• CAN ANTIOXIDANT VITAMINS AVOID THE DOXORUBICIN CARDIOTOXICITY IN THE BREAST CANCER TREATMENT? Cite
  Lima Cavalcanti ID, Santos Soares JC, de Fátima Ramos dos Santos Medeiros SM, Ferro Cavalcanti IM, de Britto Lira Nogueira MC. CAN ANTIOXIDANT VITAMINS AVOID THE DOXORUBICIN CARDIOTOXICITY IN THE BREAST CANCER TREATMENT?. PharmaNutrition. Elsevier BV; 2021;:100259 10.1016/j.phanu.2021.100259
• Abstract PD12-07: Incidences of endometrial events and frequencies of endometrial invasive diagnostic procedures in breast cancer survivors on tamoxifen: A nationwide study Cite
  Choi S, Jeong Jh, Jung J, Lee YJ, Lee JW, Ko BS, et al. Abstract PD12-07: Incidences of endometrial events and frequencies of endometrial invasive diagnostic procedures in breast cancer survivors on tamoxifen: A nationwide study. Poster Spotlight Session Abstracts. American Association for Cancer Research; 2021; 10.1158/1538-7445.sabcs20-pd12-07
• Apigenin ameliorates doxorubicin-induced renal injury via inhibition of oxidative stress and inflammation Cite
  Wu Q, Li W, Zhao J, Sun W, Yang Q, Chen C, et al. Apigenin ameliorates doxorubicin-induced renal injury via inhibition of oxidative stress and inflammation. Biomedicine & Pharmacotherapy. Elsevier BV; 2021; 137:111308 10.1016/j.biopha.2021.111308
• Off-treatment bone mineral density changes in postmenopausal women receiving anastrozole for 5 years: 7-year results from the IBIS-II prevention trial Cite
  Sestak I, Blake G, Patel R, Cuzick J, Howell A, Coleman R, et al. Off-treatment bone mineral density changes in postmenopausal women receiving anastrozole for 5 years: 7-year results from the IBIS-II prevention trial. British Journal of Cancer. Springer Science and Business Media LLC; 2021; 10.1038/s41416-020-01228-2
• Scalp cooling in breast cancer patients treated with docetaxel–cyclophosphamide: patient- and nurse-reported results Cite
  Coolbrandt A, T’Jonck A, Blauwens K, Dejaeger E, Neven P, Punie K, et al. Scalp cooling in breast cancer patients treated with docetaxel–cyclophosphamide: patient- and nurse-reported results. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2021; 10.1007/s10549-020-06063-w
• Statin Exposure and Risk of Heart Failure After Anthracycline‐ or Trastuzumab‐Based Chemotherapy for Early Breast Cancer: A Propensity Score‒Matched Cohort Study Cite
  Abdel‐Qadir H, Bobrowski D, Zhou L, Austin PC, Calvillo‐Argüelles O, Amir E, et al. Statin Exposure and Risk of Heart Failure After Anthracycline‐ or Trastuzumab‐Based Chemotherapy for Early Breast Cancer: A Propensity Score‒Matched Cohort Study. Journal of the American Heart Association. Ovid Technologies (Wolters Kluwer Health); 2021; 10.1161/jaha.119.018393
• Clinical applicability of natural products for prevention and treatment of oral mucositis: a systematic review and meta-analysis Cite
  Lima ICGdS, de Fátima Souto Maior L, Gueiros LAM, Leão JC, Higino JS, Carvalho AAT. Clinical applicability of natural products for prevention and treatment of oral mucositis: a systematic review and meta-analysis. Clinical Oral Investigations. Springer Science and Business Media LLC; 2021; 10.1007/s00784-020-03743-1
• Permanent hair loss associated with taxane chemotherapy use in breast cancer: A retrospective survey at two tertiary UK cancer centres Cite
  Chan J, Adderley H, Alameddine M, Armstrong A, Arundell D, Fox R, et al. Permanent hair loss associated with taxane chemotherapy use in breast cancer: A retrospective survey at two tertiary UK cancer centres. European Journal of Cancer Care. Wiley; 2020; 10.1111/ecc.13395
• Melatonin prevents doxorubicin-induced cardiotoxicity through suppression of AMPKα2-dependent mitochondrial damage Cite
  Yang G, Song M, Hoang DH, Tran QH, Choe W, Kang I, et al. Melatonin prevents doxorubicin-induced cardiotoxicity through suppression of AMPKα2-dependent mitochondrial damage. Experimental & Molecular Medicine. Springer Science and Business Media LLC; 2020; 10.1038/s12276-020-00541-3
• Physical activity and menopausal symptoms in women who have received menopause-inducing cancer treatments Cite
  Bailey TG, Mielke GI, Skinner TS, Anderson D, Porter-Steele J, Balaam S, et al. Physical activity and menopausal symptoms in women who have received menopause-inducing cancer treatments. Menopause. Ovid Technologies (Wolters Kluwer Health); 2020; Publish Ahead of Print 10.1097/gme.0000000000001677
• Persistent taxane‐induced neuropathy in elderly patients treated for localized breast cancer Cite
  Pabst L, Velten M, Fischbach C, Kalish M, Pflumio C, Pivot X, et al. Persistent taxane‐induced neuropathy in elderly patients treated for localized breast cancer. The Breast Journal. Wiley; 2020; 26:2376-2382 10.1111/tbj.14123
• Comorbidity burden in long‐term breast cancer survivors compared with a cohort of population‐based controls from the MARIE study Cite
  Möhl A, Orban E, Jung AY, Behrens S, Obi N, Chang‐Claude J, et al. Comorbidity burden in long‐term breast cancer survivors compared with a cohort of population‐based controls from the MARIE study. Cancer. Wiley; 2020; 10.1002/cncr.33363
• Most women with breast cancer about to initiate aromatase inhibitors already have bone loss Cite
  Gil RHS, Rodríguez ER, Rodríguez LR, Delgado HR, Jurado JC, Pérez MS, et al. Most women with breast cancer about to initiate aromatase inhibitors already have bone loss. Medicina Clínica Práctica. Elsevier BV; 2020; 4:100156 10.1016/j.mcpsp.2020.100156
• Letrozole and zoledronic acid changed signalling pathways involved in the apoptosis of breast cancer cells Cite
  Sheweita SA, Ammar RG, Sabra SA, Sultan AS. Letrozole and zoledronic acid changed signalling pathways involved in the apoptosis of breast cancer cells. Journal of Taibah University Medical Sciences. Elsevier BV; 2020; 10.1016/j.jtumed.2020.10.017
• CDK4/6 inhibitors in breast cancer: differences in toxicity profiles and impact on agent choice. A systematic review and meta-analysis Cite
  Onesti CE, Jerusalem G. CDK4/6 inhibitors in breast cancer: differences in toxicity profiles and impact on agent choice. A systematic review and meta-analysis. Expert Review of Anticancer Therapy. Informa UK Limited; 2020;:1-16 10.1080/14737140.2021.1852934
• Value of Nutrition-Based Therapies for Hair Growth, Color, and Quality Cite
  Trüeb RM. Value of Nutrition-Based Therapies for Hair Growth, Color, and Quality. Nutrition for Healthy Hair. Springer International Publishing; 2020;:225-255 10.1007/978-3-030-59920-1_6
• Scalp Cooling Impact in Alopecia of Patients Under Treatment for Breast Cancer—Literature Review Cite
  Wiethan GÁ, Sari MHM, Ferreira LM. Scalp Cooling Impact in Alopecia of Patients Under Treatment for Breast Cancer—Literature Review. SN Comprehensive Clinical Medicine. Springer Science and Business Media LLC; 2020; 2:2825-2833 10.1007/s42399-020-00653-x
• Patient‐reported symptom severity, interference with daily activities, and adverse events in older and younger women receiving chemotherapy for early breast cancer Cite
  Nyrop KA, Deal AM, Chen YT, Reeve BB, Basch EM, Wood WA, et al. Patient‐reported symptom severity, interference with daily activities, and adverse events in older and younger women receiving chemotherapy for early breast cancer. Cancer. Wiley; 2020; 10.1002/cncr.33329
• The Potential Role of Nutraceuticals as an Adjuvant in Breast Cancer Patients to Prevent Hair Loss Induced by Endocrine Therapy Cite
  Dell’Acqua G, Richards A, Thornton MJ. The Potential Role of Nutraceuticals as an Adjuvant in Breast Cancer Patients to Prevent Hair Loss Induced by Endocrine Therapy. Nutrients. MDPI AG; 2020; 12:3537 10.3390/nu12113537
• Physical activity, cardiorespiratory fitness, and cognitive function in postmenopausal women with breast cancer Cite
  Bender CM, Sereika SM, Gentry AL, Duquette JE, Casillo FE, Marsland A, et al. Physical activity, cardiorespiratory fitness, and cognitive function in postmenopausal women with breast cancer. Supportive Care in Cancer. Springer Science and Business Media LLC; 2020; 10.1007/s00520-020-05865-4
• Long-term effects of adjuvant treatment for breast cancer on carotid plaques and brain perfusion Cite
  Koppelmans V, van der Willik KD, Aleman BMP, van Leeuwen FE, Kavousi M, Arshi B, et al. Long-term effects of adjuvant treatment for breast cancer on carotid plaques and brain perfusion. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2020; 10.1007/s10549-020-05990-y
• Brief Hospital Supervision of Exercise and Diet During Adjuvant Breast Cancer Therapy Is Not Enough to Relieve Fatigue: A Multicenter Randomized Controlled Trial Cite
  Jacot W, Arnaud A, Jarlier M, Lefeuvre-Plesse C, Dalivoust P, Senesse P, et al. Brief Hospital Supervision of Exercise and Diet During Adjuvant Breast Cancer Therapy Is Not Enough to Relieve Fatigue: A Multicenter Randomized Controlled Trial. Nutrients. MDPI AG; 2020; 12:3081 10.3390/nu12103081
• Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update Cite
  Loprinzi CL, Lacchetti C, Bleeker J, Cavaletti G, Chauhan C, Hertz DL, et al. Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2020; 38:3325-3348 10.1200/jco.20.01399
• Caffeic acid phenethyl ester counteracts doxorubicin-induced chemobrain in Sprague-Dawley rats: Emphasis on the modulation of oxidative stress and neuroinflammation Cite
  Ali MA, Menze ET, Tadros MG, Tolba MF. Caffeic acid phenethyl ester counteracts doxorubicin-induced chemobrain in Sprague-Dawley rats: Emphasis on the modulation of oxidative stress and neuroinflammation. Neuropharmacology. Elsevier BV; 2020; 181:108334 10.1016/j.neuropharm.2020.108334
• Risk of heart failure after systemic treatment for early breast cancer: results of a cohort study Cite
  Jacobse JN, Schaapveld M, Boekel NB, Hooning MJ, Jager A, Baaijens MHA, et al. Risk of heart failure after systemic treatment for early breast cancer: results of a cohort study. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2020; 10.1007/s10549-020-05930-w
• Progressive muscle relaxation is effective in preventing and alleviating of chemotherapy-induced nausea and vomiting among cancer patients: a systematic review of six randomized controlled trials Cite
  Tian X, Tang R, Xu L, Xie W, Chen H, Pi Y, et al. Progressive muscle relaxation is effective in preventing and alleviating of chemotherapy-induced nausea and vomiting among cancer patients: a systematic review of six randomized controlled trials. Supportive Care in Cancer. Springer Science and Business Media LLC; 2020; 28:4051-4058 10.1007/s00520-020-05481-2
• Cardioprotective effect of grape polyphenol extract against doxorubicin induced cardiotoxicity Cite
  Sergazy S, Shulgau Z, Fedotovskikh G, Chulenbayeva L, Nurgozhina A, Nurgaziyev M, et al. Cardioprotective effect of grape polyphenol extract against doxorubicin induced cardiotoxicity. Scientific Reports. Springer Science and Business Media LLC; 2020; 10 10.1038/s41598-020-71827-9
• Tamoxifen and Endometrial Cancer: A Janus-Headed Drug Cite
  Emons G, Mustea A, Tempfer C. Tamoxifen and Endometrial Cancer: A Janus-Headed Drug. Cancers. MDPI AG; 2020; 12:2535 10.3390/cancers12092535
• Five-year follow-up results of aerobic and impact training on bone mineral density in early breast cancer patients Cite
  Vehmanen L, Sievänen H, Kellokumpu-Lehtinen P, Nikander R, Huovinen R, Ruohola J, et al. Five-year follow-up results of aerobic and impact training on bone mineral density in early breast cancer patients. Osteoporosis International. Springer Science and Business Media LLC; 2020; 10.1007/s00198-020-05611-w
• Breast cancer endocrine therapy exhausts adipocyte progenitors promoting weight gain and glucose intolerance Cite
  Scalzo RL, Foright RM, Hull SE, Knaub LA, Johnson-Murguia S, Kinanee F, et al. Breast cancer endocrine therapy exhausts adipocyte progenitors promoting weight gain and glucose intolerance. Cold Spring Harbor Laboratory; 2020; 10.1101/2020.08.21.259440
• Language impairment among patients with different types of cancer. Comparison with healthy adults Cite
  Megari K. Language impairment among patients with different types of cancer. Comparison with healthy adults. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2020; 184:779-782 10.1007/s10549-020-05898-7
• The combined effect of creatine and resistance training on doxorubicin-induced muscle dysfunction Cite
  Bredahl EC, Busekrus RB, Hydock DS. The combined effect of creatine and resistance training on doxorubicin-induced muscle dysfunction. Nutrition and Cancer. Informa UK Limited; 2019; 72:939-947 10.1080/01635581.2019.1670852
• Side effects of adjuvant chemotherapy and their impact on outcome in elderly breast cancer patients: a cohort study Cite
  Zanuso V, Fregoni V, Gervaso L. Side effects of adjuvant chemotherapy and their impact on outcome in elderly breast cancer patients: a cohort study. Future Science OA. Future Science Ltd; 2020;:FSO617 10.2144/fsoa-2020-0076
• Physiologic vasomotor symptoms are associated with verbal memory dysfunction in breast cancer survivors Cite
  Fogel J, Rubin LH, Kilic E, Walega DR, Maki PM. Physiologic vasomotor symptoms are associated with verbal memory dysfunction in breast cancer survivors. Menopause. Ovid Technologies (Wolters Kluwer Health); 2020; 27:1209-1219 10.1097/gme.0000000000001608
• Risk of fatty liver after long-term use of tamoxifen in patients with breast cancer Cite
  Yoo J, Lim YS, Kim MS, Lee B, Kim B, Kim Z, et al. Risk of fatty liver after long-term use of tamoxifen in patients with breast cancer. PLOS ONE. Public Library of Science (PLoS); 2020; 15:e0236506 10.1371/journal.pone.0236506
• Exercise as a diagnostic and therapeutic tool for preventing cardiovascular morbidity in breast cancer patients– the BReast cancer EXercise InTervention (BREXIT) trial protocol Cite
  Foulkes SJ, Howden EJ, Antill Y, Loi S, Salim A, Haykowsky MJ, et al. Exercise as a diagnostic and therapeutic tool for preventing cardiovascular morbidity in breast cancer patients– the BReast cancer EXercise InTervention (BREXIT) trial protocol. BMC Cancer. Springer Science and Business Media LLC; 2020; 20 10.1186/s12885-020-07123-6
• Skin toxicity following radiotherapy in patients with breast carcinoma: is anthocyanin supplementation beneficial? Cite
  Bracone F, De Curtis A, Di Castelnuovo A, Pilu R, Boccardi M, Cilla S, et al. Skin toxicity following radiotherapy in patients with breast carcinoma: is anthocyanin supplementation beneficial?. Clinical Nutrition. Elsevier BV; 2020; 10.1016/j.clnu.2020.09.030
• Physical activity, health‐related quality of life, and adjuvant endocrine therapy–related symptoms in women with hormone receptor–positive breast cancer Cite
  Sheppard VB, Dash C, Nomura S, Sutton AL, Franco RL, Lucas A, et al. Physical activity, health‐related quality of life, and adjuvant endocrine therapy–related symptoms in women with hormone receptor–positive breast cancer. Cancer. Wiley; 2020; 126:4059-4066 10.1002/cncr.33054
• The impact of smoking on adjuvant breast cancer radiation treatment: A systematic review Cite
  Wong G, Lam E, Karam I, Yee C, Drost L, Tam S, et al. The impact of smoking on adjuvant breast cancer radiation treatment: A systematic review. Cancer Treatment and Research Communications. Elsevier BV; 2020; 24:100185 10.1016/j.ctarc.2020.100185
• Skeletal muscle reprogramming by breast cancer regardless of treatment history or tumor molecular subtype Cite
  Wilson HE, Stanton DA, Montgomery C, Infante AM, Taylor M, Hazard-Jenkins H, et al. Skeletal muscle reprogramming by breast cancer regardless of treatment history or tumor molecular subtype. npj Breast Cancer. Springer Science and Business Media LLC; 2020; 6 10.1038/s41523-020-0162-2
• The Cardioprotective Role of Flaxseed in the Prevention of Doxorubicin- and Trastuzumab-Mediated Cardiotoxicity in C57BL/6 Mice Cite
  Asselin CY, Lam A, Cheung DYC, Eekhoudt CR, Zhu A, Mittal I, et al. The Cardioprotective Role of Flaxseed in the Prevention of Doxorubicin- and Trastuzumab-Mediated Cardiotoxicity in C57BL/6 Mice. The Journal of Nutrition. Oxford University Press (OUP); 2020; 150:2353-2363 10.1093/jn/nxaa144
• A Polyphenol-Rich Muscadine Grape Extract Inhibits HER + Breast Cancer and Protects Against Trastuzumab-Induced Cardiotoxicity Cite
  Mackert J, Gallagher P, Tallant E. A Polyphenol-Rich Muscadine Grape Extract Inhibits HER + Breast Cancer and Protects Against Trastuzumab-Induced Cardiotoxicity. Current Developments in Nutrition. Oxford University Press (OUP); 2020; 4:334-334 10.1093/cdn/nzaa044_033
• Paclitaxel-induced peripheral neuropathy in early-stage breast cancer patients. Cite
  Liu J, Sorooshian H. Paclitaxel-induced peripheral neuropathy in early-stage breast cancer patients.. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2020; 38:e12503-e12503 10.1200/jco.2020.38.15_suppl.e12503
• Dementia risk among post-menopausal women treated with endocrine therapy for early-stage breast cancer in Ontario, Canada. Cite
  Blanchette PS, Lam M, Le B, Richard L, Shariff S, Pritchard KI, et al. Dementia risk among post-menopausal women treated with endocrine therapy for early-stage breast cancer in Ontario, Canada.. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2020; 38:521-521 10.1200/jco.2020.38.15_suppl.521
• Cumulative incidence of chemotherapy-induced cardiotoxicity during a 2-year follow-up period in breast cancer patients Cite
  Cho H, Lee S, Sim SH, Park IH, Lee KS, Kwak MH, et al. Cumulative incidence of chemotherapy-induced cardiotoxicity during a 2-year follow-up period in breast cancer patients. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2020; 182:333-343 10.1007/s10549-020-05703-5
• A Phase II Prospective, Randomized, Double‐Blind, Placebo‐Controlled and Multicenter Clinical Trial to Assess the Safety of 0.005% Estriol Vaginal Gel in Hormone Receptor‐Positive Postmenopausal Women with Early Stage Breast Cancer in Treatment with Aromatase Inhibitor in the Adjuvant Setting Cite
  Sánchez‐Rovira P, Hirschberg AL, Gil‐Gil M, Bermejo‐De Las Heras B, Nieto‐Magro C. A Phase II Prospective, Randomized, Double‐Blind, Placebo‐Controlled and Multicenter Clinical Trial to Assess the Safety of 0.005% Estriol Vaginal Gel in Hormone Receptor‐Positive Postmenopausal Women with Early Stage Breast Cancer in Treatment with Aromatase Inhibitor in the Adjuvant Setting. The Oncologist. Wiley; 2020; 25 10.1634/theoncologist.2020-0417
• Physical activity among patients with breast cancer receiving aromatase inhibitors is associated with bone health: a cross-sectional observational study Cite
  Saito T, Ono R, Kono S, Asano M, Fukuta A, Tanaka Y, et al. Physical activity among patients with breast cancer receiving aromatase inhibitors is associated with bone health: a cross-sectional observational study. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2020; 182:187-193 10.1007/s10549-020-05668-5
• Clinical impact of melatonin on breast cancer patients undergoing chemotherapy; effects on cognition, sleep and depressive symptoms: A randomized, double-blind, placebo-controlled trial Cite
  Palmer ACS, Zortea M, Souza A, Santos V, Biazús JV, Torres ILS, et al. Clinical impact of melatonin on breast cancer patients undergoing chemotherapy; effects on cognition, sleep and depressive symptoms: A randomized, double-blind, placebo-controlled trial. PLOS ONE. Public Library of Science (PLoS); 2020; 15:e0231379 10.1371/journal.pone.0231379
• Nonhormonal Hot Flash Management for Breast Cancer Survivors: A Systematic Review and Network Meta-Analysis Cite
  Liu J, Nie G, Li Y, Wen Z, Lu L, Xie L, et al. Nonhormonal Hot Flash Management for Breast Cancer Survivors: A Systematic Review and Network Meta-Analysis. Evidence-Based Complementary and Alternative Medicine. Hindawi Limited; 2020; 2020:1-13 10.1155/2020/4243175
• Vitamin D deficiency increases severity of paclitaxel-induced peripheral neuropathy Cite
  Jennaro TS, Fang F, Kidwell KM, Smith EML, Vangipuram K, Burness ML, et al. Vitamin D deficiency increases severity of paclitaxel-induced peripheral neuropathy. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2020; 180:707-714 10.1007/s10549-020-05584-8
• Self-reported cognitive decline in Japanese patients with breast cancer treated with endocrine therapy Cite
  Yamamoto S, Masutani E, Arao H. Self-reported cognitive decline in Japanese patients with breast cancer treated with endocrine therapy. Breast Cancer. Springer Science and Business Media LLC; 2020; 27:670-682 10.1007/s12282-020-01062-7
• Changes in hot flash experiences and related factors in women with breast cancer Cite
  Li C, Lin Y, Yang T, Chen S, Chang H, Shen W, et al. Changes in hot flash experiences and related factors in women with breast cancer. Menopause. Ovid Technologies (Wolters Kluwer Health); 2020; 27:535-542 10.1097/gme.0000000000001507
• Abstract P2-12-14: A pilot evaluation of cold-capping efficacy under real world conditions for the prevention of chemotherapy-induced alopecia in early stage breast cancer Cite
  Rezayee M, Conlin AK, Ruzich J, Fredrich N, Seino AY, Mulligan S, et al. Abstract P2-12-14: A pilot evaluation of cold-capping efficacy under real world conditions for the prevention of chemotherapy-induced alopecia in early stage breast cancer. Poster Session Abstracts. American Association for Cancer Research; 2020; 10.1158/1538-7445.sabcs19-p2-12-14
• Changes in bone mineral density during 5 years of adjuvant treatment in premenopausal breast cancer patients Cite
  Kim M, Kim H, Ahn SH, Tabatabaie V, Choi SW, Sohn G, et al. Changes in bone mineral density during 5 years of adjuvant treatment in premenopausal breast cancer patients. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2020; 180:657-663 10.1007/s10549-020-05566-w
• Cardiac mortality after radiotherapy, chemotherapy and endocrine therapy for breast cancer: Cohort study of 2 million women from 57 cancer registries in 22 countries Cite
  Henson KE, McGale P, Darby SC, Parkin M, Wang Y, Taylor CW. Cardiac mortality after radiotherapy, chemotherapy and endocrine therapy for breast cancer: Cohort study of 2 million women from 57 cancer registries in 22 countries. International Journal of Cancer. Wiley; 2020; 147:1437-1449 10.1002/ijc.32908
• Exercise Intolerance in Anthracycline‐Treated Breast Cancer Survivors: The Role of Skeletal Muscle Bioenergetics, Oxygenation, and Composition Cite
  Beaudry RI, Kirkham AA, Thompson RB, Grenier JG, Mackey JR, Haykowsky MJ. Exercise Intolerance in Anthracycline‐Treated Breast Cancer Survivors: The Role of Skeletal Muscle Bioenergetics, Oxygenation, and Composition. The Oncologist. Wiley; 2020; 25 10.1634/theoncologist.2019-0777
• Randomized controlled trial of high-dose versus standard-dose vitamin D3 for prevention of aromatase inhibitor-induced arthralgia Cite
  Niravath P, Hilsenbeck SG, Wang T, Jiralerspong S, Nangia J, Pavlick A, et al. Randomized controlled trial of high-dose versus standard-dose vitamin D3 for prevention of aromatase inhibitor-induced arthralgia. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2019; 177:427-435 10.1007/s10549-019-05319-4
• Serum bone markers and risk of osteoporosis and fragility fractures in women who received endocrine therapy for breast cancer: a prospective study Cite
  Yao S, Laurent CA, Roh JM, Lo J, Tang L, Hahn T, et al. Serum bone markers and risk of osteoporosis and fragility fractures in women who received endocrine therapy for breast cancer: a prospective study. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2020; 180:187-195 10.1007/s10549-019-05518-z
• Association of body mass index and cardiotoxicity related to anthracyclines and trastuzumab in early breast cancer: French CANTO cohort study Cite
  Kaboré EG, Guenancia C, Vaz-Luis I, Di Meglio A, Pistilli B, Coutant C, et al. Association of body mass index and cardiotoxicity related to anthracyclines and trastuzumab in early breast cancer: French CANTO cohort study. PLOS Medicine. Public Library of Science (PLoS); 2019; 16:e1002989 10.1371/journal.pmed.1002989
• Vitamin D and selenium blood levels and acute skin toxicity during radiotherapy for breast cancer Cite
  Männle H, Momm F, Münstedt K. Vitamin D and selenium blood levels and acute skin toxicity during radiotherapy for breast cancer. Complementary Therapies in Medicine. Elsevier BV; 2019; 49:102291 10.1016/j.ctim.2019.102291
• Effects of combined exercise training on the inflammatory profile of older cancer patients treated with systemic therapy Cite
  Parent-Roberge H, Fontvieille A, Maréchal R, Wagner R, Fülöp T, Pavic M, et al. Effects of combined exercise training on the inflammatory profile of older cancer patients treated with systemic therapy. Brain, Behavior, & Immunity - Health. Elsevier BV; 2020; 2:100016 10.1016/j.bbih.2019.100016
• Curcumin attenuates cognitive impairment by enhancing autophagy in chemotherapy Cite
  Yi L, Dong S, Wang S, Chen M, Li C, Geng D, et al. Curcumin attenuates cognitive impairment by enhancing autophagy in chemotherapy. Neurobiology of Disease. Elsevier BV; 2019; 136:104715 10.1016/j.nbd.2019.104715
• Doxorubicin and cisplatin induced cognitive impairment: The possible mechanisms and interventions Cite
  Ongnok B, Chattipakorn N, Chattipakorn SC. Doxorubicin and cisplatin induced cognitive impairment: The possible mechanisms and interventions. Experimental Neurology. Elsevier BV; 2020; 324:113118 10.1016/j.expneurol.2019.113118
• Cognitive impairments in breast cancer survivors treated with chemotherapy: a study based on event-related potentials Cite
  Xu Z, Luo F, Wang Y, Zou B, Man Y, Liu J, et al. Cognitive impairments in breast cancer survivors treated with chemotherapy: a study based on event-related potentials. Cancer Chemotherapy and Pharmacology. Springer Science and Business Media LLC; 2019; 85:61-67 10.1007/s00280-019-03994-0
• A single exercise session improves side-effects of chemotherapy in women with breast cancer: an observational study Cite
  Johnsson A, Demmelmaier I, Sjövall K, Wagner P, Olsson H, Tornberg ÅB. A single exercise session improves side-effects of chemotherapy in women with breast cancer: an observational study. BMC Cancer. Springer Science and Business Media LLC; 2019; 19 10.1186/s12885-019-6310-0
• Chemosensory Changes from Cancer Treatment and Their Effects on Patients’ Food Behavior: A Scoping Review Cite
  Nolden AA, Hwang L, Boltong A, Reed DR. Chemosensory Changes from Cancer Treatment and Their Effects on Patients’ Food Behavior: A Scoping Review. Nutrients. MDPI AG; 2019; 11:2285 10.3390/nu11102285
• Role of Curcumin in reducing toxicity and adverse effects in locally advanced and metastatic breast cancer patients Cite
  Goyal S, Beniwal SK, Kumar H, Kumar D, Das B. Role of Curcumin in reducing toxicity and adverse effects in locally advanced and metastatic breast cancer patients. Annals of Oncology. Elsevier BV; 2019; 30:vi126-vi127 10.1093/annonc/mdz343.041
• Characteristics of adverse events of endocrine therapies among older patients with breast cancer Cite
  Honma N, Makita M, Saji S, Mikami T, Ogata H, Horii R, et al. Characteristics of adverse events of endocrine therapies among older patients with breast cancer. Supportive Care in Cancer. Society for Mining, Metallurgy and Exploration Inc.; 2019; 27:3813-3822 10.1007/s00520-019-04674-8
• Protective Role of Epigallocatechin Gallate in a Rat Model of Cisplatin-Induced Cerebral Inflammation and Oxidative Damage: Impact of Modulating NF-κB and Nrf2 Cite
  Arafa MH, Atteia HH. Protective Role of Epigallocatechin Gallate in a Rat Model of Cisplatin-Induced Cerebral Inflammation and Oxidative Damage: Impact of Modulating NF-κB and Nrf2. Neurotoxicity Research. Springer Science and Business Media LLC; 2019; 37:380-396 10.1007/s12640-019-00095-x
• Coenzyme Q10 Cardioprotective Effects Against Doxorubicin-Induced Cardiotoxicity in Wistar Rat Cite
  Botelho AFM, Lempek MR, Branco SEMT, Nogueira MM, de Almeida ME, Costa AG, et al. Coenzyme Q10 Cardioprotective Effects Against Doxorubicin-Induced Cardiotoxicity in Wistar Rat. Cardiovascular Toxicology. Springer Science and Business Media LLC; 2019; 20:222-234 10.1007/s12012-019-09547-4
• The relationship between diet and cognitive function in adult cancer survivors: a systematic review Cite
  Coro D, Hutchinson A, Dahlenburg S, Banks S, Coates A. The relationship between diet and cognitive function in adult cancer survivors: a systematic review. Journal of Cancer Survivorship. Springer Science and Business Media LLC; 2019; 13:773-791 10.1007/s11764-019-00796-4
• Effects of Exercise on Chemotherapy Completion and Hospitalization Rates: The OptiTrain Breast Cancer Trial Cite
  Mijwel S, Bolam KA, Gerrevall J, Foukakis T, Wengström Y, Rundqvist H. Effects of Exercise on Chemotherapy Completion and Hospitalization Rates: The OptiTrain Breast Cancer Trial. The Oncologist. Wiley; 2019; 25:23-32 10.1634/theoncologist.2019-0262
• Vaginal CO2 laser for the treatment of vulvovaginal atrophy in women with breast cancer: LAAVA pilot study Cite
  Pearson A, Booker A, Tio M, Marx G. Vaginal CO2 laser for the treatment of vulvovaginal atrophy in women with breast cancer: LAAVA pilot study. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2019; 178:135-140 10.1007/s10549-019-05384-9
• Risk of dementia among postmenopausal breast cancer survivors treated with aromatase inhibitors versus tamoxifen: a cohort study using primary care data from the UK Cite
  Bromley SE, Matthews A, Smeeth L, Stanway S, Bhaskaran K. Risk of dementia among postmenopausal breast cancer survivors treated with aromatase inhibitors versus tamoxifen: a cohort study using primary care data from the UK. Journal of Cancer Survivorship. Springer Science and Business Media LLC; 2019; 13:632-640 10.1007/s11764-019-00782-w
• The effect of ginger ( Zingiber officinale ) on chemotherapy‐induced nausea and vomiting in breast cancer patients: A systematic literature review of randomized controlled trials Cite
  Saneei Totmaj A, Emamat H, Jarrahi F, Zarrati M. The effect of ginger ( Zingiber officinale ) on chemotherapy‐induced nausea and vomiting in breast cancer patients: A systematic literature review of randomized controlled trials. Phytotherapy Research. Wiley; 2019; 33:1957-1965 10.1002/ptr.6377
• Randomized Trial of Lisinopril Versus Carvedilol to Prevent Trastuzumab Cardiotoxicity in Patients With Breast Cancer Cite
  Guglin M, Krischer J, Tamura R, Fink A, Bello-Matricaria L, McCaskill-Stevens W, et al. Randomized Trial of Lisinopril Versus Carvedilol to Prevent Trastuzumab Cardiotoxicity in Patients With Breast Cancer. Journal of the American College of Cardiology. Elsevier BV; 2019; 73:2859-2868 10.1016/j.jacc.2019.03.495
• Bisphosphonate use in geriatric breast cancer patients on aromatase inhibitors in a rural population. Cite
  Johnson A, Agbisit C, Robinson K, Delfino K, Desai MR. Bisphosphonate use in geriatric breast cancer patients on aromatase inhibitors in a rural population.. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2019; 37:e12048-e12048 10.1200/jco.2019.37.15_suppl.e12048
• Cardioprotective Effect of Marine Astaxanthin on Doxorubicin-Induced Cardiotoxicity in Normal Rats Cite
  AlQahtani AA, Osman AM, Damanhouri ZA, Al-Kreathy HM, Al-Malky HS, Ramadan WS, et al. Cardioprotective Effect of Marine Astaxanthin on Doxorubicin-Induced Cardiotoxicity in Normal Rats. Journal of Pharmaceutical Research International. Sciencedomain International; 2019;:1-11 10.9734/jpri/2019/v27i330170
• Thyroid function following breast cancer chemotherapy: A systematic review Cite
  Mortezaee K, Ahmadi A, Haghi‐Aminjan H, Khanlarkhani N, Salehi E, Shabani Nashtaei M, et al. Thyroid function following breast cancer chemotherapy: A systematic review. Journal of Cellular Biochemistry. Wiley; 2019; 120:12101-12107 10.1002/jcb.28771
• Endocrine-related quality of life in a randomized trial of exercise on aromatase inhibitor-induced arthralgias in breast cancer survivors Cite
  Baglia ML, Lin I, Cartmel B, Sanft T, Ligibel J, Hershman DL, et al. Endocrine-related quality of life in a randomized trial of exercise on aromatase inhibitor-induced arthralgias in breast cancer survivors. Cancer. Wiley; 2019; 125:2262-2271 10.1002/cncr.32051
• Efficacy of Internet-Based Cognitive Behavioral Therapy for Treatment-Induced Menopausal Symptoms in Breast Cancer Survivors: Results of a Randomized Controlled Trial Cite
  Atema V, van Leeuwen M, Kieffer JM, Oldenburg HS, van Beurden M, Gerritsma MA, et al. Efficacy of Internet-Based Cognitive Behavioral Therapy for Treatment-Induced Menopausal Symptoms in Breast Cancer Survivors: Results of a Randomized Controlled Trial. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2019; 37:809-822 10.1200/jco.18.00655
• The effect of vitamin D and E vaginal suppositories on tamoxifen-induced vaginal atrophy in women with breast cancer Cite
  Keshavarzi Z, Janghorban R, Alipour S, Tahmasebi S, Jokar A. The effect of vitamin D and E vaginal suppositories on tamoxifen-induced vaginal atrophy in women with breast cancer. Supportive Care in Cancer. Society for Mining, Metallurgy and Exploration Inc.; 2019; 27:1325-1334 10.1007/s00520-019-04684-6
• Ferulic acid ameliorates doxorubicin-induced cardiac toxicity in rats Cite
  Aswar U, Mahajan U, Kandhare A, Aswar M. Ferulic acid ameliorates doxorubicin-induced cardiac toxicity in rats. Naunyn-Schmiedeberg's Archives of Pharmacology. Springer Science and Business Media LLC; 2019; 392:659-668 10.1007/s00210-019-01623-4
• Gait and Balance Impairments in Breast Cancer Survivors: A Systematic Review and Meta-analysis of Observational Studies Cite
  Hsieh KL, Wood TA, An R, Trinh L, Sosnoff JJ. Gait and Balance Impairments in Breast Cancer Survivors: A Systematic Review and Meta-analysis of Observational Studies. Archives of Rehabilitation Research and Clinical Translation. Elsevier BV; 2019; 1:100001 10.1016/j.arrct.2018.12.001
• The effect of chemotherapy on subjective cognitive function in younger early-stage breast cancer survivors treated with chemotherapy compared to older patients Cite
  Gregorowitsch ML, Ghedri A, Young-Afat DA, Bijlsma R, Baas IO, van Schaik-van de Mheen C, et al. The effect of chemotherapy on subjective cognitive function in younger early-stage breast cancer survivors treated with chemotherapy compared to older patients. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2019; 175:429-441 10.1007/s10549-019-05149-4
• Serum erythropoietin levels, breast cancer and breast cancer-initiating cells Cite
  Bhat K, Sandler K, Duhachek-Muggy S, Alli C, Cheng F, Moatamed NA, et al. Serum erythropoietin levels, breast cancer and breast cancer-initiating cells. Breast Cancer Research. Springer Science and Business Media LLC; 2019; 21 10.1186/s13058-019-1100-9
• Tamoxifen treatment for male breast cancer and risk of thromboembolism: prospective cohort analysis Cite
  Eggemann H, Bernreiter A, Reinisch M, Loibl S, Taran F, Costa S, et al. Tamoxifen treatment for male breast cancer and risk of thromboembolism: prospective cohort analysis. British Journal of Cancer. Springer Science and Business Media LLC; 2019; 120:301-305 10.1038/s41416-018-0369-2
• Aromatase inhibitor and tamoxifen use and the risk of venous thromboembolism in breast cancer survivors Cite
  Xu X, Chlebowski RT, Shi J, Barac A, Haque R. Aromatase inhibitor and tamoxifen use and the risk of venous thromboembolism in breast cancer survivors. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2019; 174:785-794 10.1007/s10549-018-05086-8
• A multicenter survey of temporal changes in chemotherapy-induced hair loss in breast cancer patients Cite
  Watanabe T, Yagata H, Saito M, Okada H, Yajima T, Tamai N, et al. A multicenter survey of temporal changes in chemotherapy-induced hair loss in breast cancer patients. PLOS ONE. Public Library of Science (PLoS); 2019; 14:e0208118 10.1371/journal.pone.0208118
• BRCA1/BRCA2 germline mutations and chemotherapy-related hematological toxicity in breast cancer patients Cite
  Friedlaender A, Vuilleumier A, Viassolo V, Ayme A, De Talhouet S, Combes J, et al. BRCA1/BRCA2 germline mutations and chemotherapy-related hematological toxicity in breast cancer patients. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2019; 174:775-783 10.1007/s10549-018-05127-2
• Assessing taste and smell alterations in cancer patients undergoing chemotherapy according to treatment Cite
  Amézaga J, Alfaro B, Ríos Y, Larraioz A, Ugartemendia G, Urruticoechea A, et al. Assessing taste and smell alterations in cancer patients undergoing chemotherapy according to treatment. Supportive Care in Cancer. Springer Science and Business Media LLC; 2018; 26:4077-4086 10.1007/s00520-018-4277-z
• AMPK/PGC1α activation by melatonin attenuates acute doxorubicin cardiotoxicity via alleviating mitochondrial oxidative damage and apoptosis Cite
  Liu D, Ma Z, Di S, Yang Y, Yang J, Xu L, et al. AMPK/PGC1α activation by melatonin attenuates acute doxorubicin cardiotoxicity via alleviating mitochondrial oxidative damage and apoptosis. Free Radical Biology and Medicine. Elsevier BV; 2018; 129:59-72 10.1016/j.freeradbiomed.2018.08.032
• A real-world study of cardiac events in > 3700 patients with HER2-positive early breast cancer treated with trastuzumab: final analysis of the OHERA study Cite
  Lidbrink E, Chmielowska E, Otremba B, Bouhlel A, Lauer S, Liste Hermoso M, et al. A real-world study of cardiac events in > 3700 patients with HER2-positive early breast cancer treated with trastuzumab: final analysis of the OHERA study. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2018; 174:187-196 10.1007/s10549-018-5058-6
• Risk of incident claims for chemotherapy-induced peripheral neuropathy among women with breast cancer in a Medicare population Cite
  Greenwald MK, Ruterbusch JJ, Beebe-Dimmer JL, Simon MS, Albrecht TL, Schwartz AG. Risk of incident claims for chemotherapy-induced peripheral neuropathy among women with breast cancer in a Medicare population. Cancer. Wiley; 2018; 125:269-277 10.1002/cncr.31798
• Weight Evolution During Endocrine Therapy for Breast Cancer in Postmenopausal Patients: Effect of Initial Fat Mass Percentage and Previous Adjuvant Treatments Cite
  Ginzac A, Thivat É, Mouret-Reynier M, Dubray-Longeras P, Van Praagh I, Passildas J, et al. Weight Evolution During Endocrine Therapy for Breast Cancer in Postmenopausal Patients: Effect of Initial Fat Mass Percentage and Previous Adjuvant Treatments. Clinical Breast Cancer. Elsevier BV; 2018; 18:e1093-e1102 10.1016/j.clbc.2018.06.010
• Does walking protect against decline in cognitive functioning among breast cancer patients undergoing chemotherapy? Results from a small randomised controlled trial Cite
  Gokal K, Munir F, Ahmed S, Kancherla K, Wallis D. Does walking protect against decline in cognitive functioning among breast cancer patients undergoing chemotherapy? Results from a small randomised controlled trial. PLOS ONE. Public Library of Science (PLoS); 2018; 13:e0206874 10.1371/journal.pone.0206874
• Decreasing menopausal symptoms of Asian American breast cancer survivors through a technology-based information and coaching/support program Cite
  Im E, Kim S, Lee C, Chee E, Mao JJ, Chee W. Decreasing menopausal symptoms of Asian American breast cancer survivors through a technology-based information and coaching/support program. Menopause. Ovid Technologies (Wolters Kluwer Health); 2019; 26:373-382 10.1097/gme.0000000000001249
• Associations between self-reported diet during treatment and chemotherapy-induced peripheral neuropathy in a cooperative group trial (S0221) Cite
  Mongiovi JM, Zirpoli GR, Cannioto R, Sucheston-Campbell LE, Hershman DL, Unger JM, et al. Associations between self-reported diet during treatment and chemotherapy-induced peripheral neuropathy in a cooperative group trial (S0221). Breast Cancer Research. Springer Science and Business Media LLC; 2018; 20 10.1186/s13058-018-1077-9
• Risk factors for paclitaxel-induced peripheral neuropathy in patients with breast cancer Cite
  Ghoreishi Z, Keshavarz S, Asghari Jafarabadi M, Fathifar Z, Goodman KA, Esfahani A. Risk factors for paclitaxel-induced peripheral neuropathy in patients with breast cancer. BMC Cancer. Springer Science and Business Media LLC; 2018; 18 10.1186/s12885-018-4869-5
• Cancer-Related Cognitive Outcomes Among Older Breast Cancer Survivors in the Thinking and Living With Cancer Study Cite
  Mandelblatt JS, Small BJ, Luta G, Hurria A, Jim H, McDonald BC, et al. Cancer-Related Cognitive Outcomes Among Older Breast Cancer Survivors in the Thinking and Living With Cancer Study. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2018; 36:3211-3222 10.1200/jco.18.00140
• Long term adjuvant endocrine therapy and risk of cardiovascular disease in female breast cancer survivors: systematic review Cite
  Matthews A, Stanway S, Farmer RE, Strongman H, Thomas S, Lyon AR, et al. Long term adjuvant endocrine therapy and risk of cardiovascular disease in female breast cancer survivors: systematic review. BMJ. BMJ; 2018;:k3845 10.1136/bmj.k3845
• Chronic Pain in Breast Cancer Survivors: Nociceptive, Neuropathic, or Central Sensitization Pain? Cite
  Leysen L, Adriaenssens N, Nijs J, Pas R, Bilterys T, Vermeir S, et al. Chronic Pain in Breast Cancer Survivors: Nociceptive, Neuropathic, or Central Sensitization Pain?. Pain Practice. Wiley; 2018; 19:183-195 10.1111/papr.12732
• COOLHAIR: a prospective randomized trial to investigate the efficacy and tolerability of scalp cooling in patients undergoing (neo)adjuvant chemotherapy for early breast cancer Cite
  Smetanay K, Junio P, Feißt M, Seitz J, Hassel JC, Mayer L, et al. COOLHAIR: a prospective randomized trial to investigate the efficacy and tolerability of scalp cooling in patients undergoing (neo)adjuvant chemotherapy for early breast cancer. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2018; 173:135-143 10.1007/s10549-018-4983-8
• Diminished gray matter density mediates chemotherapy dosage-related cognitive impairment in breast cancer patients Cite
  Li X, Chen H, Lv Y, Chao HH, Gong L, Li CR, et al. Diminished gray matter density mediates chemotherapy dosage-related cognitive impairment in breast cancer patients. Scientific Reports. Springer Science and Business Media LLC; 2018; 8 10.1038/s41598-018-32257-w
• Effectiveness of bisphosphonate combined with activated vitamin D in patients with aromatase inhibitor-induced osteoporosis after breast cancer operation Cite
  Tanaka M, Itoh S, Takeuchi Y. Effectiveness of bisphosphonate combined with activated vitamin D in patients with aromatase inhibitor-induced osteoporosis after breast cancer operation. Osteoporosis and Sarcopenia. Elsevier BV; 2018; 4:102-108 10.1016/j.afos.2018.08.002
• Omega-3 fatty acid use for obese breast cancer patients with aromatase inhibitor-related arthralgia (SWOG S0927) Cite
  Shen S, Unger JM, Crew KD, Till C, Greenlee H, Gralow J, et al. Omega-3 fatty acid use for obese breast cancer patients with aromatase inhibitor-related arthralgia (SWOG S0927). Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2018; 172:603-610 10.1007/s10549-018-4946-0
• Permanent Chemotherapy‐Induced Alopecia in Patients with Breast Cancer: A 3‐Year Prospective Cohort Study Cite
  Kang D, Kim I, Choi E, Im YH, Park YH, Ahn JS, et al. Permanent Chemotherapy‐Induced Alopecia in Patients with Breast Cancer: A 3‐Year Prospective Cohort Study. The Oncologist. Wiley; 2018; 24:414-420 10.1634/theoncologist.2018-0184
• Neoadjuvant Endocrine Therapy in Breast Cancer Upregulates the Cytotoxic Drug Pump ABCG2/BCRP, and May Lead to Resistance to Subsequent Chemotherapy Cite
  Baxter DE, Kim B, Hanby AM, Verghese ET, Sims AH, Hughes TA. Neoadjuvant Endocrine Therapy in Breast Cancer Upregulates the Cytotoxic Drug Pump ABCG2/BCRP, and May Lead to Resistance to Subsequent Chemotherapy. Clinical Breast Cancer. Elsevier BV; 2018; 18:481-488 10.1016/j.clbc.2018.07.002
• Cardiotoxicity and Cardiac Monitoring Among Chemotherapy-Treated Breast Cancer Patients Cite
  Henry ML, Niu J, Zhang N, Giordano SH, Chavez-MacGregor M. Cardiotoxicity and Cardiac Monitoring Among Chemotherapy-Treated Breast Cancer Patients. JACC: Cardiovascular Imaging. Elsevier BV; 2018; 11:1084-1093 10.1016/j.jcmg.2018.06.005
• Efficacy of scalp cooling in reducing alopecia in early breast cancer patients receiving contemporary chemotherapy regimens Cite
  Chan A, Bauwens A, Pontre S, Jackson S, McGlone F, Ernenwein T, et al. Efficacy of scalp cooling in reducing alopecia in early breast cancer patients receiving contemporary chemotherapy regimens. The Breast. Elsevier BV; 2018; 41:127-132 10.1016/j.breast.2018.07.006
• Prevalence and risk factors for fatigue among breast cancer survivors on aromatase inhibitors Cite
  Mao H, Bao T, Shen X, Li Q, Seluzicki C, Im E, et al. Prevalence and risk factors for fatigue among breast cancer survivors on aromatase inhibitors. European Journal of Cancer. Elsevier BV; 2018; 101:47-54 10.1016/j.ejca.2018.06.009
• A phase IIA trial of acupuncture to reduce chemotherapy-induced peripheral neuropathy severity during neoadjuvant or adjuvant weekly paclitaxel chemotherapy in breast cancer patients Cite
  Bao T, Seidman AD, Piulson L, Vertosick E, Chen X, Vickers AJ, et al. A phase IIA trial of acupuncture to reduce chemotherapy-induced peripheral neuropathy severity during neoadjuvant or adjuvant weekly paclitaxel chemotherapy in breast cancer patients. European Journal of Cancer. Elsevier BV; 2018; 101:12-19 10.1016/j.ejca.2018.06.008
• Meta-analysis of the cumulative risk of endometrial malignancy and systematic review of endometrial surveillance in extended tamoxifen therapy Cite
  Fleming CA, Heneghan HM, O'Brien D, McCartan DP, McDermott EW, Prichard RS. Meta-analysis of the cumulative risk of endometrial malignancy and systematic review of endometrial surveillance in extended tamoxifen therapy. British Journal of Surgery. Wiley; 2018; 105:1098-1106 10.1002/bjs.10899
• Abstract 601: Cognitive sequelae of adjuvant endocrine therapy in older women treated for early-stage breast cancer Cite
  Underwood EA, Pritchard KI, Jerzak K, Lebovic G, Elser C, Rochon P, et al. Abstract 601: Cognitive sequelae of adjuvant endocrine therapy in older women treated for early-stage breast cancer. Clinical Research (Excluding Clinical Trials). American Association for Cancer Research; 2018; 10.1158/1538-7445.am2018-601
• Melatonin improves cardiac and mitochondrial function during doxorubicin-induced cardiotoxicity: A possible role for peroxisome proliferator-activated receptor gamma coactivator 1-alpha and sirtuin activity? Cite
  Govender J, Loos B, Marais E, Engelbrecht A. Melatonin improves cardiac and mitochondrial function during doxorubicin-induced cardiotoxicity: A possible role for peroxisome proliferator-activated receptor gamma coactivator 1-alpha and sirtuin activity?. Toxicology and Applied Pharmacology. Elsevier BV; 2018; 358:86-101 10.1016/j.taap.2018.06.031
• Replacing sedentary time with physical activity or sleep: effects on cancer-related cognitive impairment in breast cancer survivors Cite
  Ehlers DK, Fanning J, Salerno EA, Aguiñaga S, Cosman J, Severson J, et al. Replacing sedentary time with physical activity or sleep: effects on cancer-related cognitive impairment in breast cancer survivors. BMC Cancer. Springer Science and Business Media LLC; 2018; 18 10.1186/s12885-018-4603-3
• Persistent major alopecia following adjuvant docetaxel for breast cancer: incidence, characteristics, and prevention with scalp cooling Cite
  Martín M, de la Torre-Montero JC, López-Tarruella S, Pinilla K, Casado A, Fernandez S, et al. Persistent major alopecia following adjuvant docetaxel for breast cancer: incidence, characteristics, and prevention with scalp cooling. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2018; 171:627-634 10.1007/s10549-018-4855-2
• Prevention of breast cancer treatment-induced bone loss in premenopausal women treated with zoledronic acid: Final 5-year results from the randomized, double-blind, placebo-controlled ProBONE II trial Cite
  Kyvernitakis I, Kann PH, Thomasius F, Hars O, Hadji P. Prevention of breast cancer treatment-induced bone loss in premenopausal women treated with zoledronic acid: Final 5-year results from the randomized, double-blind, placebo-controlled ProBONE II trial. Bone. Elsevier BV; 2018; 114:109-115 10.1016/j.bone.2018.06.007
• Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial Cite
  Kleckner IR, Kamen C, Gewandter JS, Mohile NA, Heckler CE, Culakova E, et al. Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial. Supportive Care in Cancer. Springer Science and Business Media LLC; 2017; 26:1019-1028 10.1007/s00520-017-4013-0
• Fractures in a nationwide population-based cohort of users of breast cancer hormonal therapy Cite
  Neuner JM, Shi Y, Kong AL, Kamaraju S, Smith EC, Smallwood AJ, et al. Fractures in a nationwide population-based cohort of users of breast cancer hormonal therapy. Journal of Cancer Survivorship. Springer Science and Business Media LLC; 2017; 12:268-275 10.1007/s11764-017-0666-4
• Incidence and risk factors for congestive heart failure in patients with early breast cancer who received anthracycline and/or trastuzumab: a big data analysis of the Korean Health Insurance Review and Assessment service database Cite
  Choi JY, Cho EY, Choi YJ, Lee JH, Jung SP, Cho KR, et al. Incidence and risk factors for congestive heart failure in patients with early breast cancer who received anthracycline and/or trastuzumab: a big data analysis of the Korean Health Insurance Review and Assessment service database. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2018; 171:181-188 10.1007/s10549-018-4809-8
• Effects of anthracycline, cyclophosphamide and taxane chemotherapy on QTc measurements in patients with breast cancer Cite
  Veronese P, Hachul DT, Scanavacca MI, Hajjar LA, Wu TC, Sacilotto L, et al. Effects of anthracycline, cyclophosphamide and taxane chemotherapy on QTc measurements in patients with breast cancer. PLOS ONE. Public Library of Science (PLoS); 2018; 13:e0196763 10.1371/journal.pone.0196763
• Diabetes After Hormone Therapy in Breast Cancer Survivors: A Case-Cohort Study Cite
  Hamood R, Hamood H, Merhasin I, Keinan-Boker L. Diabetes After Hormone Therapy in Breast Cancer Survivors: A Case-Cohort Study. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2018; 36:2061-2069 10.1200/jco.2017.76.3524
• Dosage-dependent reduction of macular pigment optical density in female breast cancer patients receiving tamoxifen adjuvant therapy Cite
  Lim I, Loo AVP, Subrayan V, Khang TF, See MH, Alip A, et al. Dosage-dependent reduction of macular pigment optical density in female breast cancer patients receiving tamoxifen adjuvant therapy. The Breast. Elsevier BV; 2018; 39:117-122 10.1016/j.breast.2018.04.003
• Management of Chemotherapy-Induced Alopecia With Scalp Cooling Cite
  Kruse M, Abraham J. Management of Chemotherapy-Induced Alopecia With Scalp Cooling. Journal of Oncology Practice. American Society of Clinical Oncology (ASCO); 2018; 14:149-154 10.1200/jop.17.00038
• Taxane acute pain syndrome (TAPS) in patients receiving chemotherapy for breast or prostate cancer: a prospective multi-center study Cite
  Fernandes R, Mazzarello S, Joy AA, Pond GR, Hilton J, Ibrahim MFK, et al. Taxane acute pain syndrome (TAPS) in patients receiving chemotherapy for breast or prostate cancer: a prospective multi-center study. Supportive Care in Cancer. Springer Science and Business Media LLC; 2018; 26:3073-3081 10.1007/s00520-018-4161-x
• Fatigability and endurance performance in cancer survivors: Analyses from the Baltimore Longitudinal Study of Aging Cite
  Gresham G, Dy SM, Zipunnikov V, Browner IS, Studenski SA, Simonsick EM, et al. Fatigability and endurance performance in cancer survivors: Analyses from the Baltimore Longitudinal Study of Aging. Cancer. Wiley; 2018; 124:1279-1287 10.1002/cncr.31238
• Chemotherapy Induces Breast Cancer Stemness in Association with Dysregulated Monocytosis Cite
  Liu L, Yang L, Yan W, Zhai J, Pizzo DP, Chu P, et al. Chemotherapy Induces Breast Cancer Stemness in Association with Dysregulated Monocytosis. Clinical Cancer Research. American Association for Cancer Research (AACR); 2018; 24:2370-2382 10.1158/1078-0432.ccr-17-2545
• The risk of cardiovascular disease following breast cancer by Framingham risk score Cite
  Gernaat SAM, Boer JMA, van den Bongard DHJ, Maas AHEM, van der Pol CC, Bijlsma RM, et al. The risk of cardiovascular disease following breast cancer by Framingham risk score. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2018; 170:119-127 10.1007/s10549-018-4723-0
• Quercetin enhances chemotherapeutic effect of doxorubicin against human breast cancer cells while reducing toxic side effects of it Cite
  Li S, Yuan S, Zhao Q, Wang B, Wang X, Li K. Quercetin enhances chemotherapeutic effect of doxorubicin against human breast cancer cells while reducing toxic side effects of it. Biomedicine & Pharmacotherapy. Elsevier BV; 2018; 100:441-447 10.1016/j.biopha.2018.02.055
• Sleep disturbance among Chinese breast cancer survivors living in the USA Cite
  Gonzalez BD, Lu Q. Sleep disturbance among Chinese breast cancer survivors living in the USA. Supportive Care in Cancer. Springer Science and Business Media LLC; 2018; 26:1695-1698 10.1007/s00520-018-4128-y
• Living with chronic pain: perceptions of breast cancer survivors Cite
  Bao T, Seidman A, Li Q, Seluzicki C, Blinder V, Meghani SH, et al. Living with chronic pain: perceptions of breast cancer survivors. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2018; 169:133-140 10.1007/s10549-018-4670-9
• Vitamin D Levels, Vitamin D Receptor Polymorphisms, and Inflammatory Cytokines in Aromatase Inhibitor-Induced Arthralgias: An Analysis of CCTG MA.27 Cite
  Niravath P, Chen B, Chapman JW, Agarwal SK, Welschhans RL, Bongartz T, et al. Vitamin D Levels, Vitamin D Receptor Polymorphisms, and Inflammatory Cytokines in Aromatase Inhibitor-Induced Arthralgias: An Analysis of CCTG MA.27. Clinical Breast Cancer. Elsevier BV; 2018; 18:78-87 10.1016/j.clbc.2017.10.009
• Long-Term Follow-Up of Cardiac Function and Quality of Life for Patients in NSABP Protocol B-31/NRG Oncology: A Randomized Trial Comparing the Safety and Efficacy of Doxorubicin and Cyclophosphamide (AC) Followed by Paclitaxel With AC Followed by Paclitaxel and Trastuzumab in Patients With Node-Positive Breast Cancer With Tumors Overexpressing Human Epidermal Growth Factor Receptor 2 Cite
  Ganz PA, Romond EH, Cecchini RS, Rastogi P, Geyer CE, Swain SM, et al. Long-Term Follow-Up of Cardiac Function and Quality of Life for Patients in NSABP Protocol B-31/NRG Oncology: A Randomized Trial Comparing the Safety and Efficacy of Doxorubicin and Cyclophosphamide (AC) Followed by Paclitaxel With AC Followed by Paclitaxel and Trastuzumab in Patients With Node-Positive Breast Cancer With Tumors Overexpressing Human Epidermal Growth Factor Receptor 2. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2017; 35:3942-3948 10.1200/jco.2017.74.1165
• Prevention of Tamoxifen-related Nonalcoholic Fatty Liver Disease in Breast Cancer Patients Cite
  Chang H, Pan H, Lee C. Prevention of Tamoxifen-related Nonalcoholic Fatty Liver Disease in Breast Cancer Patients. Clinical Breast Cancer. Elsevier BV; 2018; 18:e677-e685 10.1016/j.clbc.2017.11.010
• Cisplatin is retained in the cochlea indefinitely following chemotherapy Cite
  Breglio AM, Rusheen AE, Shide ED, Fernandez KA, Spielbauer KK, McLachlin KM, et al. Cisplatin is retained in the cochlea indefinitely following chemotherapy. Nature Communications. Springer Science and Business Media LLC; 2017; 8 10.1038/s41467-017-01837-1
• Cognitive sequelae of endocrine therapy in women treated for breast cancer: a meta-analysis Cite
  Underwood EA, Rochon PA, Moineddin R, Lee PE, Wu W, Pritchard KI, et al. Cognitive sequelae of endocrine therapy in women treated for breast cancer: a meta-analysis. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2017; 168:299-310 10.1007/s10549-017-4627-4
• Changes in bone mineral density in women with breast cancer receiving aromatase inhibitor therapy Cite
  Kwan ML, Yao S, Laurent CA, Roh JM, Quesenberry CP, Kushi LH, et al. Changes in bone mineral density in women with breast cancer receiving aromatase inhibitor therapy. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2017; 168:523-530 10.1007/s10549-017-4626-5
• Neurobiological Mechanisms of Chemotherapy-induced Cognitive Impairment in a Transgenic Model of Breast Cancer Cite
  Winocur G, Berman H, Nguyen M, Binns MA, Henkelman M, van Eede M, et al. Neurobiological Mechanisms of Chemotherapy-induced Cognitive Impairment in a Transgenic Model of Breast Cancer. Neuroscience. Elsevier BV; 2018; 369:51-65 10.1016/j.neuroscience.2017.10.048
• Persistent pain accelerates xenograft tumor growth of breast cancer in rat Cite
  Li J, Sun Y, Ding G, Jiang F. Persistent pain accelerates xenograft tumor growth of breast cancer in rat. Biochemical and Biophysical Research Communications. Elsevier BV; 2018; 495:2432-2438 10.1016/j.bbrc.2017.12.121
• Associations between adjuvant radiotherapy and different causes of death in a German breast cancer cohort Cite
  Obi N, Eulenburg C, Seibold P, Eilber U, Thöne K, Behrens S, et al. Associations between adjuvant radiotherapy and different causes of death in a German breast cancer cohort. The Breast. Elsevier BV; 2018; 38:75-80 10.1016/j.breast.2017.12.006
• Effects of physical exercise on markers of inflammation in breast cancer patients during adjuvant chemotherapy Cite
  van Vulpen JK, Schmidt ME, Velthuis MJ, Wiskemann J, Schneeweiss A, Vermeulen RCH, et al. Effects of physical exercise on markers of inflammation in breast cancer patients during adjuvant chemotherapy. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2017; 168:421-431 10.1007/s10549-017-4608-7
• Dietary intake of soy and cruciferous vegetables and treatment-related symptoms in Chinese-American and non-Hispanic White breast cancer survivors Cite
  Nomura SJO, Hwang Y, Gomez SL, Fung TT, Yeh S, Dash C, et al. Dietary intake of soy and cruciferous vegetables and treatment-related symptoms in Chinese-American and non-Hispanic White breast cancer survivors. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2017; 168:467-479 10.1007/s10549-017-4578-9
• The occurrence of fractures after adjuvant treatment of breast cancer: a DBCG register study Cite
  Kristensen B, Ejlertsen B, Jensen M, Mouridsen HT. The occurrence of fractures after adjuvant treatment of breast cancer: a DBCG register study. Acta Oncologica. Informa UK Limited; 2017; 57:141-145 10.1080/0284186x.2017.1403043
• Tamoxifen Use Correlates with Increased Risk of the First Episode of Ischemic Cerebrovascular Disease in Older Women with Breast Cancer: A Case-Control Study in Taiwan Cite
  Lai S, Lin C, Liao K. Tamoxifen Use Correlates with Increased Risk of the First Episode of Ischemic Cerebrovascular Disease in Older Women with Breast Cancer: A Case-Control Study in Taiwan. Frontiers in Pharmacology. Frontiers Media SA; 2017; 8 10.3389/fphar.2017.00742
• Effects of Cryotherapy on Objective and Subjective Symptoms of Paclitaxel-Induced Neuropathy: Prospective Self-Controlled Trial Cite
  Hanai A, Ishiguro H, Sozu T, Tsuda M, Yano I, Nakagawa T, et al. Effects of Cryotherapy on Objective and Subjective Symptoms of Paclitaxel-Induced Neuropathy: Prospective Self-Controlled Trial. JNCI: Journal of the National Cancer Institute. Oxford University Press (OUP); 2017; 110:141-148 10.1093/jnci/djx178
• Determinants of physical, affective, and cognitive fatigue during breast cancer therapy and 12 months follow-up Cite
  Schmidt ME, Wiskemann J, Schneeweiss A, Potthoff K, Ulrich CM, Steindorf K. Determinants of physical, affective, and cognitive fatigue during breast cancer therapy and 12 months follow-up. International Journal of Cancer. Wiley; 2017; 142:1148-1157 10.1002/ijc.31138
• Adipose Stem Cells from Obese Individuals Promote Radioresistance of Estrogen Receptor Positive Breast Cancer Cite
  Sabol R, Cote A, Bunnell B. Adipose Stem Cells from Obese Individuals Promote Radioresistance of Estrogen Receptor Positive Breast Cancer. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2017; 99:E615-E616 10.1016/j.ijrobp.2017.06.2084
• 30 years follow-up and increased risks of breast cancer and leukaemia after long-term low-dose-rate radiation exposure Cite
  Hsieh W, Lin I, Ho J, Chang PW. 30 years follow-up and increased risks of breast cancer and leukaemia after long-term low-dose-rate radiation exposure. British Journal of Cancer. Springer Science and Business Media LLC; 2017; 117:1883-1887 10.1038/bjc.2017.350
• Toxicity of Extended Adjuvant Therapy With Aromatase Inhibitors in Early Breast Cancer: A Systematic Review and Meta-analysis Cite
  Goldvaser H, Barnes TA, Šeruga B, Cescon DW, Ocaña A, Ribnikar D, et al. Toxicity of Extended Adjuvant Therapy With Aromatase Inhibitors in Early Breast Cancer: A Systematic Review and Meta-analysis. JNCI: Journal of the National Cancer Institute. Oxford University Press (OUP); 2017; 110:31-39 10.1093/jnci/djx141
• Incidence of permanent alopecia following adjuvant chemotherapy in women with early stage breast cancer Cite
  Crown J, Walshe J, Fennelly D, Long J, Cairney S, McDonnell D, et al. Incidence of permanent alopecia following adjuvant chemotherapy in women with early stage breast cancer. Annals of Oncology. Elsevier BV; 2017; 28:v63 10.1093/annonc/mdx362.056
• Breast cancer, endometrial cancer, and cardiovascular events in participants who used vaginal estrogen in the Womenʼs Health Initiative Observational Study Cite
  Crandall CJ, Hovey KM, Andrews CA, Chlebowski RT, Stefanick ML, Lane DS, et al. Breast cancer, endometrial cancer, and cardiovascular events in participants who used vaginal estrogen in the Womenʼs Health Initiative Observational Study. Menopause. Ovid Technologies (Wolters Kluwer Health); 2017; 25:11-20 10.1097/gme.0000000000000956
• Altered food preferences and chemosensory perception during chemotherapy in breast cancer patients: A longitudinal comparison with healthy controls Cite
  de Vries Y, Winkels R, van den Berg M, de Graaf C, Kelfkens C, de Kruif J, et al. Altered food preferences and chemosensory perception during chemotherapy in breast cancer patients: A longitudinal comparison with healthy controls. Food Quality and Preference. Elsevier BV; 2018; 63:135-143 10.1016/j.foodqual.2017.09.003
• Nationwide Case-Control Study Examining the Association between Tamoxifen Use and Alzheimer’s Disease in Aged Women with Breast Cancer in Taiwan Cite
  Liao K, Lin C, Lai S. Nationwide Case-Control Study Examining the Association between Tamoxifen Use and Alzheimer’s Disease in Aged Women with Breast Cancer in Taiwan. Frontiers in Pharmacology. Frontiers Media SA; 2017; 8 10.3389/fphar.2017.00612
• Temporal influence of endocrine therapy with tamoxifen and chemotherapy on nutritional risk and obesity in breast cancer patients Cite
  Lima MTM, de Carvalho KP, Mazzutti FS, de Almeida Maia M, Canto PPL, Paiva CE, et al. Temporal influence of endocrine therapy with tamoxifen and chemotherapy on nutritional risk and obesity in breast cancer patients. BMC Cancer. Springer Science and Business Media LLC; 2017; 17 10.1186/s12885-017-3559-z
• Chronic pain and other symptoms among breast cancer survivors: prevalence, predictors, and effects on quality of life Cite
  Hamood R, Hamood H, Merhasin I, Keinan-Boker L. Chronic pain and other symptoms among breast cancer survivors: prevalence, predictors, and effects on quality of life. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2017; 167:157-169 10.1007/s10549-017-4485-0
• Vascular function in breast cancer survivors on aromatase inhibitors: a pilot study Cite
  Blaes A, Beckwith H, Florea N, Hebbel R, Solovey A, Potter D, et al. Vascular function in breast cancer survivors on aromatase inhibitors: a pilot study. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2017; 166:541-547 10.1007/s10549-017-4447-6
• Chemotherapy-Associated Peripheral Neuropathy in Patients With Early-Stage Breast Cancer: A Systematic Review Cite
  Rivera DR, Ganz PA, Weyrich MS, Bandos H, Melnikow J. Chemotherapy-Associated Peripheral Neuropathy in Patients With Early-Stage Breast Cancer: A Systematic Review. JNCI: Journal of the National Cancer Institute. Oxford University Press (OUP); 2017; 110 10.1093/jnci/djx140
• Prophylactic effects of ellagic acid and rosmarinic acid on doxorubicin-induced neurotoxicity in rats Cite
  Rizk HA, Masoud MA, Maher OW. Prophylactic effects of ellagic acid and rosmarinic acid on doxorubicin-induced neurotoxicity in rats. Journal of Biochemical and Molecular Toxicology. Wiley; 2017; 31:e21977 10.1002/jbt.21977
• Melatonin limits paclitaxel-induced mitochondrial dysfunction in vitro and protects against paclitaxel-induced neuropathic pain in the rat Cite
  Galley HF, McCormick B, Wilson KL, Lowes DA, Colvin L, Torsney C. Melatonin limits paclitaxel-induced mitochondrial dysfunction in vitro and protects against paclitaxel-induced neuropathic pain in the rat. Journal of Pineal Research. Wiley; 2017; 63:e12444 10.1111/jpi.12444
• Vanillin as a new modulator candidate for renal injury induced by cisplatin in experimental rats Cite
  Elseweidy MM, Askar ME, Elswefy SE, Shawky M. Vanillin as a new modulator candidate for renal injury induced by cisplatin in experimental rats. Cytokine. Elsevier BV; 2017; 99:260-265 10.1016/j.cyto.2017.07.025
• Stress-inducible gene Atf3 in the noncancer host cells contributes to chemotherapy-exacerbated breast cancer metastasis Cite
  Chang YS, Jalgaonkar SP, Middleton JD, Hai T. Stress-inducible gene Atf3 in the noncancer host cells contributes to chemotherapy-exacerbated breast cancer metastasis. Proceedings of the National Academy of Sciences. Proceedings of the National Academy of Sciences; 2017; 114:E7159-E7168 10.1073/pnas.1700455114
• Randomized trial of vitamin D3 to prevent worsening of musculoskeletal symptoms in women with breast cancer receiving adjuvant letrozole. The VITAL trial Cite
  Khan QJ, Kimler BF, Reddy PS, Sharma P, Klemp JR, Nydegger JL, et al. Randomized trial of vitamin D3 to prevent worsening of musculoskeletal symptoms in women with breast cancer receiving adjuvant letrozole. The VITAL trial. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2017; 166:491-500 10.1007/s10549-017-4429-8
• Profiles of lipids, blood pressure and weight changes among premenopausal Chinese breast cancer patients after adjuvant chemotherapy Cite
  Yeo W, Mo FKF, Pang E, Suen JJS, Koh J, Loong HHF, et al. Profiles of lipids, blood pressure and weight changes among premenopausal Chinese breast cancer patients after adjuvant chemotherapy. BMC Women's Health. Springer Science and Business Media LLC; 2017; 17 10.1186/s12905-017-0409-8
• Protective effects of acute exercise prior to doxorubicin on cardiac function of breast cancer patients: A proof-of-concept RCT Cite
  Kirkham A, Shave R, Bland K, Bovard J, Eves N, Gelmon K, et al. Protective effects of acute exercise prior to doxorubicin on cardiac function of breast cancer patients: A proof-of-concept RCT. International Journal of Cardiology. Elsevier BV; 2017; 245:263-270 10.1016/j.ijcard.2017.07.037
• Executive functioning impairment in women treated with chemotherapy for breast cancer: a systematic review Cite
  Yao C, Bernstein LJ, Rich JB. Executive functioning impairment in women treated with chemotherapy for breast cancer: a systematic review. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2017; 166:15-28 10.1007/s10549-017-4376-4
• Cyclophosphamide leads to persistent deficits in physical performance and in vivo mitochondria function in a mouse model of chemotherapy late effects Cite
  Crouch M, Knowels G, Stuppard R, Ericson NG, Bielas JH, Marcinek DJ, et al. Cyclophosphamide leads to persistent deficits in physical performance and in vivo mitochondria function in a mouse model of chemotherapy late effects. PLOS ONE. Public Library of Science (PLoS); 2017; 12:e0181086 10.1371/journal.pone.0181086
• Randomized Controlled Trial of a Home‐Based Walking Program to Reduce Moderate to Severe Aromatase Inhibitor‐Associated Arthralgia in Breast Cancer Survivors Cite
  Nyrop KA, Callahan LF, Cleveland RJ, Arbeeva LL, Hackney BS, Muss HB. Randomized Controlled Trial of a Home‐Based Walking Program to Reduce Moderate to Severe Aromatase Inhibitor‐Associated Arthralgia in Breast Cancer Survivors. The Oncologist. Wiley; 2017; 22:1238-1249 10.1634/theoncologist.2017-0174
• Abstract 4215: Cancer-related fatigue and physical activity vary by age for black women with a history of breast cancer Cite
  Swen MA, Mann A, Paxton R, Dean LT. Abstract 4215: Cancer-related fatigue and physical activity vary by age for black women with a history of breast cancer. Prevention Research. American Association for Cancer Research; 2017; 10.1158/1538-7445.am2017-4215
• Persistent impairments 3 years after (neo)adjuvant chemotherapy for breast cancer: results from the MaTox project Cite
  Hurtz H, Tesch H, Göhler T, Hutzschenreuter U, Harde J, Kruggel L, et al. Persistent impairments 3 years after (neo)adjuvant chemotherapy for breast cancer: results from the MaTox project. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2017; 165:721-731 10.1007/s10549-017-4365-7
• The effects of physical activity and fatigue on cognitive performance in breast cancer survivors Cite
  Ehlers DK, Aguiñaga S, Cosman J, Severson J, Kramer AF, McAuley E. The effects of physical activity and fatigue on cognitive performance in breast cancer survivors. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2017; 165:699-707 10.1007/s10549-017-4363-9
• Sickness Absence and Disability Pension After Breast Cancer Diagnosis: A 5-Year Nationwide Cohort Study Cite
  Kvillemo P, Mittendorfer-Rutz E, Bränström R, Nilsson K, Alexanderson K. Sickness Absence and Disability Pension After Breast Cancer Diagnosis: A 5-Year Nationwide Cohort Study. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2017; 35:2044-2052 10.1200/jco.2015.66.0613
• Chemotherapy-induced changes of cerebral activity in resting-state functional magnetic resonance imaging and cerebral white matter in diffusion tensor imaging Cite
  Mo C, Lin H, Fu F, Lin L, Zhang J, Huang M, et al. Chemotherapy-induced changes of cerebral activity in resting-state functional magnetic resonance imaging and cerebral white matter in diffusion tensor imaging. Oncotarget. Impact Journals, LLC; 2017; 8:81273-81284 10.18632/oncotarget.18111
• Two-year trends of taxane-induced neuropathy in women enrolled in a randomized trial of acetyl-l-carnitine (SWOG S0715). Cite
  Hershman DL, Unger JM, Crew KD, Ebnesajjad C, Greenlee H, Fehrenbacher L, et al. Two-year trends of taxane-induced neuropathy in women enrolled in a randomized trial of acetyl-l-carnitine (SWOG S0715).. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2017; 35:10093-10093 10.1200/jco.2017.35.15_suppl.10093
• Longitudinal assessment of cancer-related cognitive impairment (CRCI) up to six-months post-chemotherapy with multiple cognitive testing methods in 943 breast cancer (BC) patients and controls. Cite
  Janelsins MC, Heckler CE, Peppone LJ, Mohile SG, Mustian KM, Ahles T, et al. Longitudinal assessment of cancer-related cognitive impairment (CRCI) up to six-months post-chemotherapy with multiple cognitive testing methods in 943 breast cancer (BC) patients and controls.. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2017; 35:10014-10014 10.1200/jco.2017.35.15_suppl.10014
• Docetaxel does not impair skeletal muscle force production in a murine model of cancer chemotherapy Cite
  Chaillou T, McPeek A, Lanner JT. Docetaxel does not impair skeletal muscle force production in a murine model of cancer chemotherapy. Physiological Reports. Wiley; 2017; 5:e13261 10.14814/phy2.13261
• Chemotherapy and Post-traumatic Stress in the Causation of Cognitive Dysfunction in Breast Cancer Patients Cite
  Hermelink K, Bühner M, Sckopke P, Neufeld F, Kaste J, Voigt V, et al. Chemotherapy and Post-traumatic Stress in the Causation of Cognitive Dysfunction in Breast Cancer Patients. JNCI: Journal of the National Cancer Institute. Oxford University Press (OUP); 2017; 109 10.1093/jnci/djx057
• Effects of the US Food and Drug Administration Boxed Warning of Erythropoietin-Stimulating Agents on Utilization and Adverse Outcome Cite
  Bian J, Chen B, Hershman DL, Marks N, Norris L, Schulz R, et al. Effects of the US Food and Drug Administration Boxed Warning of Erythropoietin-Stimulating Agents on Utilization and Adverse Outcome. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2017; 35:1945-1951 10.1200/jco.2017.72.6273
• Cognitive functioning and emotion processing in breast cancer survivors and controls: An ERP pilot study Cite
  Wirkner J, Weymar M, Löw A, Hamm C, Struck A, Kirschbaum C, et al. Cognitive functioning and emotion processing in breast cancer survivors and controls: An ERP pilot study. Psychophysiology. Wiley; 2017; 54:1209-1222 10.1111/psyp.12874
• Role of taxanes in chemotherapy-related cognitive impairment: A prospective longitudinal study Cite
  Cerulla N, Arcusa À, Navarro J, Garolera M, Enero C, Chico G, et al. Role of taxanes in chemotherapy-related cognitive impairment: A prospective longitudinal study. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2017; 164:179-187 10.1007/s10549-017-4240-6
• Anthracyclines induce early changes in left ventricular systolic and diastolic function: A single centre study Cite
  Boyd A, Stoodley P, Richards D, Hui R, Harnett P, Vo K, et al. Anthracyclines induce early changes in left ventricular systolic and diastolic function: A single centre study. PLOS ONE. Public Library of Science (PLoS); 2017; 12:e0175544 10.1371/journal.pone.0175544
• Weight change during chemotherapy in breast cancer patients: a meta-analysis Cite
  van den Berg M, Winkels R, de Kruif J, van Laarhoven H, Visser M, de Vries J, et al. Weight change during chemotherapy in breast cancer patients: a meta-analysis. BMC Cancer. Springer Science and Business Media LLC; 2017; 17 10.1186/s12885-017-3242-4
• Rutin protects against neuronal damage in vitro and ameliorates doxorubicin-induced memory deficits in vivo in Wistar rats Cite
  Ramalingayya GV, Cheruku SP, Nayak P, Kishore A, Shenoy R, Rao CM, et al. Rutin protects against neuronal damage in vitro and ameliorates doxorubicin-induced memory deficits in vivo in Wistar rats. Drug Design, Development and Therapy. Informa UK Limited; 2017; Volume11:1011-1026 10.2147/dddt.s103511
• KU32 prevents 5-fluorouracil induced cognitive impairment Cite
  Sofis MJ, Jarmolowicz DP, Kaplan SV, Gehringer RC, Lemley SM, Garg G, et al. KU32 prevents 5-fluorouracil induced cognitive impairment. Behavioural Brain Research. Elsevier BV; 2017; 329:186-190 10.1016/j.bbr.2017.03.042
• Gut microbiota composition associated with alterations in cardiorespiratory fitness and psychosocial outcomes among breast cancer survivors Cite
  Paulsen JA, Ptacek TS, Carter SJ, Liu N, Kumar R, Hyndman L, et al. Gut microbiota composition associated with alterations in cardiorespiratory fitness and psychosocial outcomes among breast cancer survivors. Supportive Care in Cancer. Springer Science and Business Media LLC; 2017; 25:1563-1570 10.1007/s00520-016-3568-5
• Fasting regulates EGR1 and protects from glucose- and dexamethasone-dependent sensitization to chemotherapy Cite
  Di Biase S, Shim HS, Kim KH, Vinciguerra M, Rappa F, Wei M, et al. Fasting regulates EGR1 and protects from glucose- and dexamethasone-dependent sensitization to chemotherapy. PLOS Biology. Public Library of Science (PLoS); 2017; 15:e2001951 10.1371/journal.pbio.2001951
• Gait, balance, and patient-reported outcomes during taxane-based chemotherapy in early-stage breast cancer patients Cite
  Monfort SM, Pan X, Patrick R, Ramaswamy B, Wesolowski R, Naughton MJ, et al. Gait, balance, and patient-reported outcomes during taxane-based chemotherapy in early-stage breast cancer patients. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2017; 164:69-77 10.1007/s10549-017-4230-8
• Neuropathic pain after breast cancer treatment and its impact on sleep quality one year after cancer diagnosis Cite
  Fontes F, Gonçalves M, Pereira S, Lunet N. Neuropathic pain after breast cancer treatment and its impact on sleep quality one year after cancer diagnosis. The Breast. Elsevier BV; 2017; 33:125-131 10.1016/j.breast.2017.03.013
• Chemotherapy-induced-peripheral neuropathy, gait and fall risk in older adults following cancer treatment Cite
  Marshall TF, Zipp GP, Battaglia F, Moss R, Bryan S. Chemotherapy-induced-peripheral neuropathy, gait and fall risk in older adults following cancer treatment. Journal of Cancer Research and Practice. Medknow; 2017; 4:134-138 10.1016/j.jcrpr.2017.03.005
• Interventions for preventing cardiomyopathy due to anthracyclines: a Bayesian network meta-analysis Cite
  Abdel-Qadir H, Ong G, Fazelzad R, Amir E, Lee D, Thavendiranathan P, et al. Interventions for preventing cardiomyopathy due to anthracyclines: a Bayesian network meta-analysis. Annals of Oncology. Elsevier BV; 2017; 28:628-633 10.1093/annonc/mdw671
• Vaginal Testosterone Cream vs Estradiol Vaginal Ring for Vaginal Dryness or Decreased Libido in Women Receiving Aromatase Inhibitors for Early-Stage Breast Cancer Cite
  Melisko ME, Goldman ME, Hwang J, De Luca A, Fang S, Esserman LJ, et al. Vaginal Testosterone Cream vs Estradiol Vaginal Ring for Vaginal Dryness or Decreased Libido in Women Receiving Aromatase Inhibitors for Early-Stage Breast Cancer. JAMA Oncology. American Medical Association (AMA); 2017; 3:313 10.1001/jamaoncol.2016.3904
• Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO, IMS, and SIOG Cite
  Hadji P, Aapro MS, Body J, Gnant M, Brandi ML, Reginster JY, et al. Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO, IMS, and SIOG. Journal of Bone Oncology. Elsevier BV; 2017; 7:1-12 10.1016/j.jbo.2017.03.001
• Estimating the Risks of Breast Cancer Radiotherapy: Evidence From Modern Radiation Doses to the Lungs and Heart and From Previous Randomized Trials Cite
  Taylor C, Correa C, Duane FK, Aznar MC, Anderson SJ, Bergh J, et al. Estimating the Risks of Breast Cancer Radiotherapy: Evidence From Modern Radiation Doses to the Lungs and Heart and From Previous Randomized Trials. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2017; 35:1641-1649 10.1200/jco.2016.72.0722
• Chemotherapy-induced irreversible alopecia in early breast cancer patients Cite
  Kim GM, Kim S, Park HS, Kim JY, Nam S, Park S, et al. Chemotherapy-induced irreversible alopecia in early breast cancer patients. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2017; 163:527-533 10.1007/s10549-017-4204-x
• Changes in brain white matter integrity after systemic treatment for breast cancer: a prospective longitudinal study Cite
  Menning S, de Ruiter MB, Veltman DJ, Boogerd W, Oldenburg HSA, Reneman L, et al. Changes in brain white matter integrity after systemic treatment for breast cancer: a prospective longitudinal study. Brain Imaging and Behavior. Springer Science and Business Media LLC; 2017; 12:324-334 10.1007/s11682-017-9695-x
• Permanent alopecia in patients with breast cancer after taxane chemotherapy and adjuvant hormonal therapy: Clinicopathologic findings in a cohort of 10 patients Cite
  Fonia A, Cota C, Setterfield JF, Goldberg LJ, Fenton DA, Stefanato CM. Permanent alopecia in patients with breast cancer after taxane chemotherapy and adjuvant hormonal therapy: Clinicopathologic findings in a cohort of 10 patients. Journal of the American Academy of Dermatology. Elsevier BV; 2017; 76:948-957 10.1016/j.jaad.2016.12.027
• Changes in brain activation in breast cancer patients depend on cognitive domain and treatment type Cite
  Menning S, de Ruiter MB, Veltman DJ, Boogerd W, Oldenburg HSA, Reneman L, et al. Changes in brain activation in breast cancer patients depend on cognitive domain and treatment type. PLOS ONE. Public Library of Science (PLoS); 2017; 12:e0171724 10.1371/journal.pone.0171724
• Chemotherapy-induced amenorrhea and the resumption of menstruation in premenopausal women with hormone receptor-positive early breast cancer Cite
  Koga C, Akiyoshi S, Ishida M, Nakamura Y, Ohno S, Tokunaga E. Chemotherapy-induced amenorrhea and the resumption of menstruation in premenopausal women with hormone receptor-positive early breast cancer. Breast Cancer. Springer Science and Business Media LLC; 2017; 24:714-719 10.1007/s12282-017-0764-1
• Abstract P4-19-03: A meta-analysis of cognitive impairment in breast cancer survivors treated with chemotherapy Cite
  Bernstein L, McCreath G, Rich J. Abstract P4-19-03: A meta-analysis of cognitive impairment in breast cancer survivors treated with chemotherapy. Poster Session Abstracts. American Association for Cancer Research; 2017; 10.1158/1538-7445.sabcs16-p4-19-03
• Nicotinamide riboside, a form of vitamin B3 and NAD+ precursor, relieves the nociceptive and aversive dimensions of paclitaxel-induced peripheral neuropathy in female rats Cite
  Hamity MV, White SR, Walder RY, Schmidt MS, Brenner C, Hammond DL. Nicotinamide riboside, a form of vitamin B3 and NAD+ precursor, relieves the nociceptive and aversive dimensions of paclitaxel-induced peripheral neuropathy in female rats. PAIN. Ovid Technologies (Wolters Kluwer Health); 2017; 158:962-972 10.1097/j.pain.0000000000000862
• Effects of paclitaxel on the development of neuropathy and affective behaviors in the mouse Cite
  Toma W, Kyte SL, Bagdas D, Alkhlaif Y, Alsharari SD, Lichtman AH, et al. Effects of paclitaxel on the development of neuropathy and affective behaviors in the mouse. Neuropharmacology. Elsevier BV; 2017; 117:305-315 10.1016/j.neuropharm.2017.02.020
• Use of an alpha lipoic, methylsulfonylmethane and bromelain dietary supplement (Opera®) for chemotherapy-induced peripheral neuropathy management, a prospective study Cite
  Desideri I, Francolini G, Becherini C, Terziani F, Delli Paoli C, Olmetto E, et al. Use of an alpha lipoic, methylsulfonylmethane and bromelain dietary supplement (Opera®) for chemotherapy-induced peripheral neuropathy management, a prospective study. Medical Oncology. Springer Science and Business Media LLC; 2017; 34 10.1007/s12032-017-0907-4
• Sleep duration and breast cancer prognosis: perspectives from the Women’s Healthy Eating and Living Study Cite
  Marinac CR, Nelson SH, Flatt SW, Natarajan L, Pierce JP, Patterson RE. Sleep duration and breast cancer prognosis: perspectives from the Women’s Healthy Eating and Living Study. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2017; 162:581-589 10.1007/s10549-017-4140-9
• Association Between Use of a Scalp Cooling Device and Alopecia After Chemotherapy for Breast Cancer Cite
  Rugo HS, Klein P, Melin SA, Hurvitz SA, Melisko ME, Moore A, et al. Association Between Use of a Scalp Cooling Device and Alopecia After Chemotherapy for Breast Cancer. JAMA. American Medical Association (AMA); 2017; 317:606 10.1001/jama.2016.21038
• Effect of a Scalp Cooling Device on Alopecia in Women Undergoing Chemotherapy for Breast Cancer Cite
  Nangia J, Wang T, Osborne C, Niravath P, Otte K, Papish S, et al. Effect of a Scalp Cooling Device on Alopecia in Women Undergoing Chemotherapy for Breast Cancer. JAMA. American Medical Association (AMA); 2017; 317:596 10.1001/jama.2016.20939
• Randomized trial of aromatherapy versus conventional care for breast cancer patients during perioperative periods Cite
  Tamaki K, Fukuyama AK, Terukina S, Kamada Y, Uehara K, Arakaki M, et al. Randomized trial of aromatherapy versus conventional care for breast cancer patients during perioperative periods. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2017; 162:523-531 10.1007/s10549-017-4134-7
• Time-of-Day Dictates Transcriptional Inflammatory Responses to Cytotoxic Chemotherapy Cite
  Borniger JC, Walker II WH, Gaudier-Diaz MM, Stegman CJ, Zhang N, Hollyfield JL, et al. Time-of-Day Dictates Transcriptional Inflammatory Responses to Cytotoxic Chemotherapy. Scientific Reports. Springer Science and Business Media LLC; 2017; 7 10.1038/srep41220
• Moderators of acupuncture effectiveness in breast cancer survivors: Randomized clinical trial (RCT). Cite
  Palesh O, Haddad N, Schnyer R, Neri E, Packer MM, Zeitzer JM, et al. Moderators of acupuncture effectiveness in breast cancer survivors: Randomized clinical trial (RCT).. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2016; 34:162-162 10.1200/jco.2016.34.3_suppl.162
• Treatment-associated toxicities reported by patients with early-stage invasive breast cancer Cite
  Friese CR, Harrison JM, Janz NK, Jagsi R, Morrow M, Li Y, et al. Treatment-associated toxicities reported by patients with early-stage invasive breast cancer. Cancer. Wiley; 2017; 123:1925-1934 10.1002/cncr.30547
• Trade-offs Between Efficacy and Cardiac Toxicity of Adjuvant Chemotherapy in Early-Stage Breast Cancer Patients: Do Competing Risks Matter? Cite
  Alarid-Escudero F, Blaes AH, Kuntz KM. Trade-offs Between Efficacy and Cardiac Toxicity of Adjuvant Chemotherapy in Early-Stage Breast Cancer Patients: Do Competing Risks Matter?. The Breast Journal. Wiley; 2017; 23:401-409 10.1111/tbj.12757
• Body Composition as a Predictor of Toxicity in Patients Receiving Anthracycline and Taxane–Based Chemotherapy for Early-Stage Breast Cancer Cite
  Shachar SS, Deal AM, Weinberg M, Williams GR, Nyrop KA, Popuri K, et al. Body Composition as a Predictor of Toxicity in Patients Receiving Anthracycline and Taxane–Based Chemotherapy for Early-Stage Breast Cancer. Clinical Cancer Research. American Association for Cancer Research (AACR); 2017; 23:3537-3543 10.1158/1078-0432.ccr-16-2266
• Anti-müllerian hormone levels and evolution in women of reproductive age with breast cancer treated with chemotherapy Cite
  Fréour T, Barrière P, Masson D. Anti-müllerian hormone levels and evolution in women of reproductive age with breast cancer treated with chemotherapy. European Journal of Cancer. Elsevier BV; 2017; 74:1-8 10.1016/j.ejca.2016.12.008
• Statins in anthracycline-induced cardiotoxicity: Rac and Rho, and the heartbreakers Cite
  Henninger C, Fritz G. Statins in anthracycline-induced cardiotoxicity: Rac and Rho, and the heartbreakers. Cell Death & Disease. Springer Science and Business Media LLC; 2017; 8:e2564-e2564 10.1038/cddis.2016.418
• Relationships among psychoneurological symptoms and levels of C-reactive protein over 2 years in women with early-stage breast cancer Cite
  Starkweather A, Kelly DL, Thacker L, Wright ML, Jackson-Cook CK, Lyon DE. Relationships among psychoneurological symptoms and levels of C-reactive protein over 2 years in women with early-stage breast cancer. Supportive Care in Cancer. Springer Science and Business Media LLC; 2016; 25:167-176 10.1007/s00520-016-3400-2
• Long-term effect of aromatase inhibitors on bone microarchitecture and macroarchitecture in non-osteoporotic postmenopausal women with breast cancer Cite
  Hong AR, Kim JH, Lee KH, Kim TY, Im SA, Kim TY, et al. Long-term effect of aromatase inhibitors on bone microarchitecture and macroarchitecture in non-osteoporotic postmenopausal women with breast cancer. Osteoporosis International. Springer Science and Business Media LLC; 2017; 28:1413-1422 10.1007/s00198-016-3899-6
• Objective physical and mental markers of self-reported fatigue in women undergoing (neo)adjuvant chemotherapy for early-stage breast cancer Cite
  Mortimer JE, Waliany S, Dieli-Conwright CM, Patel SK, Hurria A, Chao J, et al. Objective physical and mental markers of self-reported fatigue in women undergoing (neo)adjuvant chemotherapy for early-stage breast cancer. Cancer. Wiley; 2017; 123:1810-1816 10.1002/cncr.30426
• Rutin attenuates doxorubicin-induced cardiotoxicity via regulating autophagy and apoptosis Cite
  Ma Y, Yang L, Ma J, Lu L, Wang X, Ren J, et al. Rutin attenuates doxorubicin-induced cardiotoxicity via regulating autophagy and apoptosis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. Elsevier BV; 2017; 1863:1904-1911 10.1016/j.bbadis.2016.12.021
• Severe fatigue after treatment of ductal carcinoma in situ: A comparison with age-matched breast cancer survivors and healthy controls Cite
  Abrahams H, Smits L, Lugt Md, Roos Wd, Kamm Y, Heins M, et al. Severe fatigue after treatment of ductal carcinoma in situ: A comparison with age-matched breast cancer survivors and healthy controls. The Breast. Elsevier BV; 2017; 31:76-81 10.1016/j.breast.2016.10.020
• Specific adverse events are associated with response to exemestane therapy in postmenopausal breast cancer patients: Results from the TEAMIIA study (BOOG2006-04) Cite
  Fontein D, Charehbili A, Nortier J, Putter H, Kranenbarg EM, Kroep J, et al. Specific adverse events are associated with response to exemestane therapy in postmenopausal breast cancer patients: Results from the TEAMIIA study (BOOG2006-04). European Journal of Surgical Oncology (EJSO). Elsevier BV; 2017; 43:619-624 10.1016/j.ejso.2016.07.146
• The effect of exercise on body composition and bone mineral density in breast cancer survivors taking aromatase inhibitors Cite
  Thomas GA, Cartmel B, Harrigan M, Fiellin M, Capozza S, Zhou Y, et al. The effect of exercise on body composition and bone mineral density in breast cancer survivors taking aromatase inhibitors. Obesity. Wiley; 2016; 25:346-351 10.1002/oby.21729
• Radiation therapy targets and the risk of breast cancer-related lymphedema: a systematic review and network meta-analysis Cite
  Shaitelman SF, Chiang Y, Griffin KD, DeSnyder SM, Smith BD, Schaverien MV, et al. Radiation therapy targets and the risk of breast cancer-related lymphedema: a systematic review and network meta-analysis. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2016; 162:201-215 10.1007/s10549-016-4089-0
• Dietary Inflammatory Index, Bone Mineral Density, and Risk of Fracture in Postmenopausal Women: Results From the Women's Health Initiative Cite
  Orchard T, Yildiz V, Steck SE, Hébert JR, Ma Y, Cauley JA, et al. Dietary Inflammatory Index, Bone Mineral Density, and Risk of Fracture in Postmenopausal Women: Results From the Women's Health Initiative. Journal of Bone and Mineral Research. Wiley; 2017; 32:1136-1146 10.1002/jbmr.3070
• Cardiotoxicity of aromatase inhibitors and tamoxifen in postmenopausal women with breast cancer: a systematic review and meta-analysis of randomized controlled trials Cite
  Khosrow-Khavar F, Filion K, Al-Qurashi S, Torabi N, Bouganim N, Suissa S, et al. Cardiotoxicity of aromatase inhibitors and tamoxifen in postmenopausal women with breast cancer: a systematic review and meta-analysis of randomized controlled trials. Annals of Oncology. Elsevier BV; 2017; 28:487-496 10.1093/annonc/mdw673
• A Difference in the Incidences of Hypersensitivity Reactions to Original and Generic Taxanes Cite
  Ratanajarusiri T, Sriuranpong V, Sitthideatphaiboon P, Poovoravan N, Vinayanuwat C, Parinyanitikul N, et al. A Difference in the Incidences of Hypersensitivity Reactions to Original and Generic Taxanes. Chemotherapy. S. Karger AG; 2016; 62:134-139 10.1159/000450748
• (−)-Epigallocatechin-3-gallate alleviates doxorubicin-induced cardiotoxicity in sarcoma 180 tumor-bearing mice Cite
  Yao Y, Liu X, Li W, Shi Z, Yan Y, Wang L, et al. (−)-Epigallocatechin-3-gallate alleviates doxorubicin-induced cardiotoxicity in sarcoma 180 tumor-bearing mice. Life Sciences. Elsevier BV; 2017; 180:151-159 10.1016/j.lfs.2016.12.004
• Hyperalgesia and Persistent Pain after Breast Cancer Surgery: A Prospective Randomized Controlled Trial with Perioperative COX-2 Inhibition Cite
  van Helmond N, Steegers MA, Filippini-de Moor GP, Vissers KC, Wilder-Smith OH. Hyperalgesia and Persistent Pain after Breast Cancer Surgery: A Prospective Randomized Controlled Trial with Perioperative COX-2 Inhibition. PLOS ONE. Public Library of Science (PLoS); 2016; 11:e0166601 10.1371/journal.pone.0166601
• Scalp Cooling Alopecia Prevention trial (SCALP) for patients with early stage breast cancer. Cite
  Nangia JR, Wang T, Osborne CRC, Niravath PA, Otte K, Papish SW, et al. Scalp Cooling Alopecia Prevention trial (SCALP) for patients with early stage breast cancer.. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2017; 35:10088-10088 10.1200/jco.2017.35.15_suppl.10088
• Results of scalp cooling during anthracycline containing chemotherapy depend on scalp skin temperature Cite
  Komen M, Smorenburg C, Nortier J, van der Ploeg T, van den Hurk C, van der Hoeven J. Results of scalp cooling during anthracycline containing chemotherapy depend on scalp skin temperature. The Breast. Elsevier BV; 2016; 30:105-110 10.1016/j.breast.2016.09.007
• Multidisciplinary Approach to Novel Therapies in Cardio-Oncology Research (MANTICORE 101–Breast): A Randomized Trial for the Prevention of Trastuzumab-Associated Cardiotoxicity Cite
  Pituskin E, Mackey JR, Koshman S, Jassal D, Pitz M, Haykowsky MJ, et al. Multidisciplinary Approach to Novel Therapies in Cardio-Oncology Research (MANTICORE 101–Breast): A Randomized Trial for the Prevention of Trastuzumab-Associated Cardiotoxicity. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2016; 35:870-877 10.1200/jco.2016.68.7830
• Randomized, blinded trial of vitamin D3 for treating aromatase inhibitor-associated musculoskeletal symptoms (AIMSS) Cite
  Shapiro AC, Adlis SA, Robien K, Kirstein MN, Liang S, Richter SA, et al. Randomized, blinded trial of vitamin D3 for treating aromatase inhibitor-associated musculoskeletal symptoms (AIMSS). Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2016; 155:501-512 10.1007/s10549-016-3710-6
• Risk of Neutropenia-Related Hospitalization in Patients Who Received Colony-Stimulating Factors With Chemotherapy for Breast Cancer Cite
  Agiro A, Ma Q, Acheson AK, Wu S, Patt DA, Barron JJ, et al. Risk of Neutropenia-Related Hospitalization in Patients Who Received Colony-Stimulating Factors With Chemotherapy for Breast Cancer. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2016; 34:3872-3879 10.1200/jco.2016.67.2899
• Cancer-related fatigue in breast cancer survivors: more evidence for a physiological substrate Cite
  Ramos J, Cantos B, Maximiano C, Cebolla H, Fiuza-Luces C, Gutierrez L, et al. Cancer-related fatigue in breast cancer survivors: more evidence for a physiological substrate. Annals of Oncology. Elsevier BV; 2016; 27:vi518 10.1093/annonc/mdw390.64
• Protective Effects of Essential Oils as Natural Antioxidants against Hepatotoxicity Induced by Cyclophosphamide in Mice Cite
  Sheweita SA, El-Hosseiny LS, Nashashibi MA. Protective Effects of Essential Oils as Natural Antioxidants against Hepatotoxicity Induced by Cyclophosphamide in Mice. PLOS ONE. Public Library of Science (PLoS); 2016; 11:e0165667 10.1371/journal.pone.0165667
• BMI, Lifestyle Factors and Taxane-Induced Neuropathy in Breast Cancer Patients: The Pathways Study Cite
  Greenlee H, Hershman DL, Shi Z, Kwan ML, Ergas IJ, Roh JM, et al. BMI, Lifestyle Factors and Taxane-Induced Neuropathy in Breast Cancer Patients: The Pathways Study. Journal of the National Cancer Institute. Oxford University Press (OUP); 2016; 109:djw206 10.1093/jnci/djw206
• Impact of moderate intensity aerobic exercise on chemotherapy-induced anemia in elderly women with breast cancer: A randomized controlled clinical trial Cite
  Mohamady HM, Elsisi HF, Aneis YM. Impact of moderate intensity aerobic exercise on chemotherapy-induced anemia in elderly women with breast cancer: A randomized controlled clinical trial. Journal of Advanced Research. Elsevier BV; 2017; 8:7-12 10.1016/j.jare.2016.10.005
• Prevention of chemotherapy-induced alopecia in patients with breast or female genital tract cancer using sensor-controlled scalp-cooling Cite
  Kurbacher C, Herz S, Kolberg G, Kettelhoit N, Kurbacher A, Schweitzer C, et al. Prevention of chemotherapy-induced alopecia in patients with breast or female genital tract cancer using sensor-controlled scalp-cooling. Annals of Oncology. Elsevier BV; 2016; 27:vi516 10.1093/annonc/mdw390.60
• Medication-Related Osteonecrosis of the Jaws: Considerations on a New Antiresorptive Therapy (Denosumab) and Treatment Outcome after a 13-Year Experience Cite
  Favia G, Tempesta A, Limongelli L, Crincoli V, Maiorano E. Medication-Related Osteonecrosis of the Jaws: Considerations on a New Antiresorptive Therapy (Denosumab) and Treatment Outcome after a 13-Year Experience. International Journal of Dentistry. Hindawi Limited; 2016; 2016:1-9 10.1155/2016/1801676
• Aging, obesity, and post-therapy cognitive recovery in breast cancer survivors Cite
  Huang Z, Zheng Y, Bao P, Cai H, Hong Z, Ding D, et al. Aging, obesity, and post-therapy cognitive recovery in breast cancer survivors. Oncotarget. Impact Journals, LLC; 2016; 8:12364-12373 10.18632/oncotarget.12565
• Role of paroxetine in the management of hot flashes in gynecological cancer survivors: Results of the first randomized single-center controlled trial Cite
  Capriglione S, Plotti F, Montera R, Luvero D, Lopez S, Scaletta G, et al. Role of paroxetine in the management of hot flashes in gynecological cancer survivors: Results of the first randomized single-center controlled trial. Gynecologic Oncology. Elsevier BV; 2016; 143:584-588 10.1016/j.ygyno.2016.10.006
• Randomized trial of medroxyprogesterone acetate for the prevention of endometrial pathology from adjuvant tamoxifen for breast cancer: SWOG S9630 Cite
  Potkul RK, Unger JM, Livingston RB, Crew KD, Wilczynski SP, Salomon CG, et al. Randomized trial of medroxyprogesterone acetate for the prevention of endometrial pathology from adjuvant tamoxifen for breast cancer: SWOG S9630. npj Breast Cancer. Springer Science and Business Media LLC; 2016; 2 10.1038/npjbcancer.2016.24
• Memory and Spatial Cognition in Breast Cancer Patients Undergoing Adjuvant Endocrine Therapy Cite
  Berndt U, Leplow B, Schoenfeld R, Lantzsch T, Grosse R, Thomssen C. Memory and Spatial Cognition in Breast Cancer Patients Undergoing Adjuvant Endocrine Therapy. Breast Care. S. Karger AG; 2016; 11:240-246 10.1159/000446901
• Time-dependent risk and predictors of venous thromboembolism in breast cancer patients: A population-based cohort study Cite
  Brand JS, Hedayati E, Bhoo-Pathy N, Bergh J, Hall P, Humphreys K, et al. Time-dependent risk and predictors of venous thromboembolism in breast cancer patients: A population-based cohort study. Cancer. Wiley; 2016; 123:468-475 10.1002/cncr.30364
• Estrogens - the Saviors of Cognitive Function? Cite
  Pfeiler G. Estrogens - the Saviors of Cognitive Function?. Breast Care. S. Karger AG; 2016; 11:238-239 10.1159/000448636
• Efficacy of ginger for prophylaxis of chemotherapy-induced nausea and vomiting in breast cancer patients receiving adriamycin–cyclophosphamide regimen: a randomized, double-blind, placebo-controlled, crossover study Cite
  Thamlikitkul L, Srimuninnimit V, Akewanlop C, Ithimakin S, Techawathanawanna S, Korphaisarn K, et al. Efficacy of ginger for prophylaxis of chemotherapy-induced nausea and vomiting in breast cancer patients receiving adriamycin–cyclophosphamide regimen: a randomized, double-blind, placebo-controlled, crossover study. Supportive Care in Cancer. Springer Science and Business Media LLC; 2016; 25:459-464 10.1007/s00520-016-3423-8
• Cardioprotective Effect of Selenium Against Cyclophosphamide-Induced Cardiotoxicity in Rats Cite
  Gunes S, Sahinturk V, Karasati P, Sahin IK, Ayhanci A. Cardioprotective Effect of Selenium Against Cyclophosphamide-Induced Cardiotoxicity in Rats. Biological Trace Element Research. Springer Science and Business Media LLC; 2016; 177:107-114 10.1007/s12011-016-0858-1
• The Effect of Bone-Loading Exercise on Bone Mineral Density in Women Following Treatment for Breast Cancer Cite
  Zerzan S, Smoot B, Lee JQ, Lui A, Allen DD. The Effect of Bone-Loading Exercise on Bone Mineral Density in Women Following Treatment for Breast Cancer. Rehabilitation Oncology. Ovid Technologies (Wolters Kluwer Health); 2016; 34:144-155 10.1097/01.reo.0000000000000039
• The risk of myocardial infarction with aromatase inhibitors relative to tamoxifen in post-menopausal women with early stage breast cancer Cite
  Abdel-Qadir H, Amir E, Fischer HD, Fu L, Austin PC, Harvey PJ, et al. The risk of myocardial infarction with aromatase inhibitors relative to tamoxifen in post-menopausal women with early stage breast cancer. European Journal of Cancer. Elsevier BV; 2016; 68:11-21 10.1016/j.ejca.2016.08.022
• Treatment with aromatase inhibitors and markers of cardiovascular disease Cite
  Blondeaux E, Musio D, Bruzzi P, Lambertini M, Gazzola V, Poggio F, et al. Treatment with aromatase inhibitors and markers of cardiovascular disease. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2016; 160:261-267 10.1007/s10549-016-3985-7
• Prognostic value of endocrine treatment-related symptoms in patients with breast cancer: a meta-analysis Cite
  Zheng Q, Xia W, Lu Q, Hong R, Qin G, Xu F, et al. Prognostic value of endocrine treatment-related symptoms in patients with breast cancer: a meta-analysis. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2016; 160:197-209 10.1007/s10549-016-3995-5
• Factors associated with ovarian function recovery after chemotherapy for breast cancer: a systematic review and meta-analysis Cite
  Silva C, Caramelo O, Almeida-Santos T, Ribeiro Rama AC. Factors associated with ovarian function recovery after chemotherapy for breast cancer: a systematic review and meta-analysis. Human Reproduction. Oxford University Press (OUP); 2016; 31:2737-2749 10.1093/humrep/dew224
• Anthocyanin Attenuates Doxorubicin-Induced Cardiomyotoxicity via Estrogen Receptor-α/β and Stabilizes HSF1 to Inhibit the IGF-IIR Apoptotic Pathway Cite
  Huang P, Kuo W, Shen C, Chen Y, Lin Y, Ho T, et al. Anthocyanin Attenuates Doxorubicin-Induced Cardiomyotoxicity via Estrogen Receptor-α/β and Stabilizes HSF1 to Inhibit the IGF-IIR Apoptotic Pathway. International Journal of Molecular Sciences. MDPI AG; 2016; 17:1588 10.3390/ijms17091588
• Sleep disorders in breast cancer survivors Cite
  Otte JL, Davis L, Carpenter JS, Krier C, Skaar TC, Rand KL, et al. Sleep disorders in breast cancer survivors. Supportive Care in Cancer. Springer Science and Business Media LLC; 2016; 24:4197-4205 10.1007/s00520-016-3247-6
• Change in bone mineral density during adjuvant chemotherapy for early-stage breast cancer Cite
  Christensen CØ, Cronin-Fenton D, Frøslev T, Hermann AP, Ewertz M. Change in bone mineral density during adjuvant chemotherapy for early-stage breast cancer. Supportive Care in Cancer. Springer Science and Business Media LLC; 2016; 24:4229-4236 10.1007/s00520-016-3250-y
• Risk of second non-breast cancer among patients treated with and without postoperative radiotherapy for primary breast cancer: A systematic review and meta-analysis of population-based studies including 522,739 patients Cite
  Grantzau T, Overgaard J. Risk of second non-breast cancer among patients treated with and without postoperative radiotherapy for primary breast cancer: A systematic review and meta-analysis of population-based studies including 522,739 patients. Radiotherapy and Oncology. Elsevier BV; 2016; 121:402-413 10.1016/j.radonc.2016.08.017
• A randomised, placebo-controlled trial assessing the efficacy of an oral B group vitamin in preventing the development of chemotherapy-induced peripheral neuropathy (CIPN) Cite
  Schloss JM, Colosimo M, Airey C, Masci P, Linnane AW, Vitetta L. A randomised, placebo-controlled trial assessing the efficacy of an oral B group vitamin in preventing the development of chemotherapy-induced peripheral neuropathy (CIPN). Supportive Care in Cancer. Springer Science and Business Media LLC; 2016; 25:195-204 10.1007/s00520-016-3404-y
• Obesity As a Risk Factor for Anthracyclines and Trastuzumab Cardiotoxicity in Breast Cancer: A Systematic Review and Meta-Analysis Cite
  Guenancia C, Lefebvre A, Cardinale D, Yu AF, Ladoire S, Ghiringhelli F, et al. Obesity As a Risk Factor for Anthracyclines and Trastuzumab Cardiotoxicity in Breast Cancer: A Systematic Review and Meta-Analysis. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2016; 34:3157-3165 10.1200/jco.2016.67.4846
• Antihormonal treatment associated musculoskeletal pain in women with breast cancer in the adjuvant setting Cite
  Seber S, Solmaz D, Yetisyigit T. Antihormonal treatment associated musculoskeletal pain in women with breast cancer in the adjuvant setting. OncoTargets and Therapy. Informa UK Limited; 2016; Volume 9:4929-4935 10.2147/ott.s108968
• Rates of major complications during neoadjuvant and adjuvant chemotherapy for early breast cancer: An off study population Cite
  Redana S, Sharp A, Lote H, Mohammed K, Papadimitraki E, Capelan M, et al. Rates of major complications during neoadjuvant and adjuvant chemotherapy for early breast cancer: An off study population. The Breast. Elsevier BV; 2016; 30:13-18 10.1016/j.breast.2016.07.019
• Is it best to expect the worst? Influence of patients' side-effect expectations on endocrine treatment outcome in a 2-year prospective clinical cohort study Cite
  Nestoriuc Y, von Blanckenburg P, Schuricht F, Barsky A, Hadji P, Albert U, et al. Is it best to expect the worst? Influence of patients' side-effect expectations on endocrine treatment outcome in a 2-year prospective clinical cohort study. Annals of Oncology. Elsevier BV; 2016; 27:1909-1915 10.1093/annonc/mdw266
• Long-lasting impairments in adult neurogenesis, spatial learning and memory from a standard chemotherapy regimen used to treat breast cancer Cite
  Rendeiro C, Sheriff A, Bhattacharya TK, Gogola JV, Baxter JH, Chen H, et al. Long-lasting impairments in adult neurogenesis, spatial learning and memory from a standard chemotherapy regimen used to treat breast cancer. Behavioural Brain Research. Elsevier BV; 2016; 315:10-22 10.1016/j.bbr.2016.07.043
• Resting heart rate as a prognostic factor for mortality in patients with breast cancer Cite
  Lee DH, Park S, Lim SM, Lee MK, Giovannucci EL, Kim JH, et al. Resting heart rate as a prognostic factor for mortality in patients with breast cancer. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2016; 159:375-384 10.1007/s10549-016-3938-1
• Comprehensive Audiometric Analysis of Hearing Impairment and Tinnitus After Cisplatin-Based Chemotherapy in Survivors of Adult-Onset Cancer Cite
  Frisina RD, Wheeler HE, Fossa SD, Kerns SL, Fung C, Sesso HD, et al. Comprehensive Audiometric Analysis of Hearing Impairment and Tinnitus After Cisplatin-Based Chemotherapy in Survivors of Adult-Onset Cancer. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2016; 34:2712-2720 10.1200/jco.2016.66.8822
• Long-term chemotherapy-induced peripheral neuropathy among breast cancer survivors: prevalence, risk factors, and fall risk Cite
  Bao T, Basal C, Seluzicki C, Li SQ, Seidman AD, Mao JJ. Long-term chemotherapy-induced peripheral neuropathy among breast cancer survivors: prevalence, risk factors, and fall risk. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2016; 159:327-333 10.1007/s10549-016-3939-0
• Abstract 3413: Supplement use and chemotherapy-induced peripheral neuropathy in breast cancer patients treated on SWOG study S0221 Cite
  Zirpoli GR, McCann SE, Sucheston-Campbell LE, Hershman DL, Ciupak G, Davis W, et al. Abstract 3413: Supplement use and chemotherapy-induced peripheral neuropathy in breast cancer patients treated on SWOG study S0221. Epidemiology. American Association for Cancer Research; 2016; 10.1158/1538-7445.am2016-3413
• Taxane acute pain syndrome (TAPS) in patients receiving taxane-based chemotherapy for breast cancer—a systematic review Cite
  Fernandes R, Mazzarello S, Hutton B, Shorr R, Majeed H, Ibrahim MF, et al. Taxane acute pain syndrome (TAPS) in patients receiving taxane-based chemotherapy for breast cancer—a systematic review. Supportive Care in Cancer. Springer Science and Business Media LLC; 2016; 24:3633-3650 10.1007/s00520-016-3256-5
• Indole-3-carbinol protects against cisplatin-induced acute nephrotoxicity: role of calcitonin gene-related peptide and insulin-like growth factor-1 Cite
  El-Naga RN, Mahran YF. Indole-3-carbinol protects against cisplatin-induced acute nephrotoxicity: role of calcitonin gene-related peptide and insulin-like growth factor-1. Scientific Reports. Springer Science and Business Media LLC; 2016; 6 10.1038/srep29857
• The impact of tamoxifen brand switch on side effects and patient compliance in hormone receptor positive breast cancer patients Cite
  Zeidan B, Anderson K, Peiris L, Rainsbury D, Laws S. The impact of tamoxifen brand switch on side effects and patient compliance in hormone receptor positive breast cancer patients. The Breast. Elsevier BV; 2016; 29:62-67 10.1016/j.breast.2016.07.001
• Effect of ursolic acid in attenuating chronic constriction injury-induced neuropathic pain in rats Cite
  Bhat RA, Lingaraju MC, Pathak NN, Kalra J, Kumar D, Kumar D, et al. Effect of ursolic acid in attenuating chronic constriction injury-induced neuropathic pain in rats. Fundamental & Clinical Pharmacology. Wiley; 2016; 30:517-528 10.1111/fcp.12223
• Impact of resistance and aerobic exercise on sarcopenia and dynapenia in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial Cite
  Adams SC, Segal RJ, McKenzie DC, Vallerand JR, Morielli AR, Mackey JR, et al. Impact of resistance and aerobic exercise on sarcopenia and dynapenia in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2016; 158:497-507 10.1007/s10549-016-3900-2
• Chemotherapy-induced peripheral neuropathy: an update on the current understanding Cite
  Addington J, Freimer M. Chemotherapy-induced peripheral neuropathy: an update on the current understanding. F1000Research. F1000 Research Ltd; 2016; 5:1466 10.12688/f1000research.8053.1
• Predictors of persistent pain after breast cancer surgery: a systematic review and meta-analysis of observational studies Cite
  Wang L, Guyatt GH, Kennedy SA, Romerosa B, Kwon HY, Kaushal A, et al. Predictors of persistent pain after breast cancer surgery: a systematic review and meta-analysis of observational studies. Canadian Medical Association Journal. Joule Inc.; 2016; 188:E352-E361 10.1503/cmaj.151276
• Investigation of 2 Types of Self-administered Acupressure for Persistent Cancer-Related Fatigue in Breast Cancer Survivors Cite
  Zick SM, Sen A, Wyatt GK, Murphy SL, Arnedt JT, Harris RE. Investigation of 2 Types of Self-administered Acupressure for Persistent Cancer-Related Fatigue in Breast Cancer Survivors. JAMA Oncology. American Medical Association (AMA); 2016; 2:1470 10.1001/jamaoncol.2016.1867
• A prospective study on the neurological complications of breast cancer and its treatment: Updated analysis three years after cancer diagnosis Cite
  Fontes F, Pereira S, Castro-Lopes JM, Lunet N. A prospective study on the neurological complications of breast cancer and its treatment: Updated analysis three years after cancer diagnosis. The Breast. Elsevier BV; 2016; 29:31-38 10.1016/j.breast.2016.06.013
• Curcumin ameliorates neuropathic pain by down-regulating spinal IL-1β via suppressing astroglial NALP1 inflammasome and JAK2-STAT3 signalling Cite
  Liu S, Li Q, Zhang M, Mao-Ying Q, Hu L, Wu G, et al. Curcumin ameliorates neuropathic pain by down-regulating spinal IL-1β via suppressing astroglial NALP1 inflammasome and JAK2-STAT3 signalling. Scientific Reports. Springer Science and Business Media LLC; 2016; 6 10.1038/srep28956
• Aromatase inhibitors decrease radiation-induced lung fibrosis: Results of an experimental study Cite
  Altinok A, Yildirim S, Altug T, Sut N, Ober A, Ozsahin E, et al. Aromatase inhibitors decrease radiation-induced lung fibrosis: Results of an experimental study. The Breast. Elsevier BV; 2016; 28:174-177 10.1016/j.breast.2016.04.003
• Crocin treatment prevents doxorubicin-induced cardiotoxicity in rats Cite
  Razmaraii N, Babaei H, Mohajjel Nayebi A, Assadnassab G, Ashrafi Helan J, Azarmi Y. Crocin treatment prevents doxorubicin-induced cardiotoxicity in rats. Life Sciences. Elsevier BV; 2016; 157:145-151 10.1016/j.lfs.2016.06.012
• Mild Lung Restriction in Breast Cancer Patients After Hypofractionated and Conventional Radiation Therapy: A 3-Year Follow-Up Cite
  Verbanck S, Hanon S, Schuermans D, Van Parijs H, Vinh-Hung V, Miedema G, et al. Mild Lung Restriction in Breast Cancer Patients After Hypofractionated and Conventional Radiation Therapy: A 3-Year Follow-Up. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2016; 95:937-945 10.1016/j.ijrobp.2016.02.008
• Long-Term Effects of Radiotherapy on Arterial Stiffness in Breast Cancer Women Cite
  Vallerio P, Sarno L, Stucchi M, Musca F, Casadei F, Maloberti A, et al. Long-Term Effects of Radiotherapy on Arterial Stiffness in Breast Cancer Women. The American Journal of Cardiology. Elsevier BV; 2016; 118:771-776 10.1016/j.amjcard.2016.06.001
• Ocular Surface Disease in Breast Cancer Patients Using Aromatase Inhibitors Cite
  Chatziralli I, Sergentanis T, Zagouri F, Chrysikos D, Ladas I, Zografos GC, et al. Ocular Surface Disease in Breast Cancer Patients Using Aromatase Inhibitors. The Breast Journal. Wiley; 2016; 22:561-563 10.1111/tbj.12633
• Breast Cancer-Related Arm Lymphedema: Fluctuation over Six Months and the Effect of the Weather Cite
  Czerniec SA, Ward LC, Kilbreath SL. Breast Cancer-Related Arm Lymphedema: Fluctuation over Six Months and the Effect of the Weather. Lymphatic Research and Biology. Mary Ann Liebert Inc; 2016; 14:148-155 10.1089/lrb.2015.0030
• Clinical significance of fatty liver disease induced by tamoxifen and toremifene in breast cancer patients Cite
  Yang Y, Kim KM, An JH, Lee DB, Shim JH, Lim Y, et al. Clinical significance of fatty liver disease induced by tamoxifen and toremifene in breast cancer patients. The Breast. Elsevier BV; 2016; 28:67-72 10.1016/j.breast.2016.04.017
• Epigallocatechin-3-gallate ameliorates radiation-induced acute skin damage in breast cancer patients undergoing adjuvant radiotherapy Cite
  Zhu W, Jia L, Chen G, Zhao H, Sun X, Meng X, et al. Epigallocatechin-3-gallate ameliorates radiation-induced acute skin damage in breast cancer patients undergoing adjuvant radiotherapy. Oncotarget. Impact Journals, LLC; 2016; 7:48607-48613 10.18632/oncotarget.9495
• An observational study to examine changes in metabolic syndrome components in patients with breast cancer receiving neoadjuvant or adjuvant chemotherapy Cite
  Dieli‐Conwright CM, Wong L, Waliany S, Bernstein L, Salehian B, Mortimer JE. An observational study to examine changes in metabolic syndrome components in patients with breast cancer receiving neoadjuvant or adjuvant chemotherapy. Cancer. Wiley; 2016; 122:2646-2653 10.1002/cncr.30104
• Effects of vitamin D and calcium supplementation on side effects profile in patients of breast cancer treated with letrozole Cite
  Arul Vijaya Vani S, Ananthanarayanan P, Kadambari D, Harichandrakumar K, Niranjjan R, Nandeesha H. Effects of vitamin D and calcium supplementation on side effects profile in patients of breast cancer treated with letrozole. Clinica Chimica Acta. Elsevier BV; 2016; 459:53-56 10.1016/j.cca.2016.05.020
• A population-based analysis of secondary malignancies in breast cancer patients receiving breast reconstruction Cite
  Warschkow R, Cerny T, Schmied BM, Güller U, Thuerlimann B, Joerger M. A population-based analysis of secondary malignancies in breast cancer patients receiving breast reconstruction. British Journal of Cancer. Springer Science and Business Media LLC; 2016; 115:80-84 10.1038/bjc.2016.108
• Clinical and neurophysiological evaluation of persistent sensory disturbances in breast cancer women after mastectomy with or without radiotherapy Cite
  Hojan K, Wojtysiak M, Huber J, Molińska-Glura M, Wiertel-Krawczuk A, Milecki P. Clinical and neurophysiological evaluation of persistent sensory disturbances in breast cancer women after mastectomy with or without radiotherapy. European Journal of Oncology Nursing. Elsevier BV; 2016; 23:8-14 10.1016/j.ejon.2016.03.007
• The effectiveness of inhaled ginger essential oil in improving dietary intake in breast-cancer patients experiencing chemotherapy-induced nausea and vomiting Cite
  Salihah N, Mazlan N, Lua PL. The effectiveness of inhaled ginger essential oil in improving dietary intake in breast-cancer patients experiencing chemotherapy-induced nausea and vomiting. Focus on Alternative and Complementary Therapies. Wiley; 2016; 21:8-16 10.1111/fct.12236
• Osteoporosis and pain severity in reproductive age patients with breast cancer Cite
  Tretyakova NY, Chizhikov AV. Osteoporosis and pain severity in reproductive age patients with breast cancer. Kazan medical journal. ECO-Vector LLC; 2016; 97:207-212 10.17750/kmj2016-207
• Cognitive function in cancer survivors: analysis of the 1999–2002 National Health and Nutrition Examination Survey Cite
  Williams AM, Janelsins MC, van Wijngaarden E. Cognitive function in cancer survivors: analysis of the 1999–2002 National Health and Nutrition Examination Survey. Supportive Care in Cancer. Springer Science and Business Media LLC; 2015; 24:2155-2162 10.1007/s00520-015-2992-2
• Comparison of Neurocognitive Function After Anthracycline-Based Chemotherapy vs Nonanthracycline-Based Chemotherapy Cite
  Van Dyk K, Petersen L, Ganz PA. Comparison of Neurocognitive Function After Anthracycline-Based Chemotherapy vs Nonanthracycline-Based Chemotherapy. JAMA Oncology. American Medical Association (AMA); 2016; 2:964 10.1001/jamaoncol.2016.0350
• Breast Cancer Therapy–Related Cardiac Dysfunction in Adult Women Treated in Routine Clinical Practice: A Population-Based Cohort Study Cite
  Thavendiranathan P, Abdel-Qadir H, Fischer HD, Camacho X, Amir E, Austin PC, et al. Breast Cancer Therapy–Related Cardiac Dysfunction in Adult Women Treated in Routine Clinical Practice: A Population-Based Cohort Study. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2016; 34:2239-2246 10.1200/jco.2015.65.1505
• Protective effect of Co-enzyme Q10 On doxorubicin-induced cardiomyopathy of rat hearts Cite
  Chen P, Hou C, Shibu MA, Day CH, Pai P, Liu Z, et al. Protective effect of Co-enzyme Q10 On doxorubicin-induced cardiomyopathy of rat hearts. Environmental Toxicology. Wiley; 2016; 32:679-689 10.1002/tox.22270
• Prognostic Effects of Adjuvant Chemotherapy-Induced Amenorrhea and Subsequent Resumption of Menstruation for Premenopausal Breast Cancer Patients Cite
  Jeon SJ, Lee JI, Jeon MJ, Lee M. Prognostic Effects of Adjuvant Chemotherapy-Induced Amenorrhea and Subsequent Resumption of Menstruation for Premenopausal Breast Cancer Patients. Medicine. Ovid Technologies (Wolters Kluwer Health); 2016; 95:e3301 10.1097/md.0000000000003301
• Cardiotoxicity of breast cancer treatment: no easy solution for an important long-term problem Cite
  van der Meer P, Gietema JA, Suter TM, van Veldhuisen DJ. Cardiotoxicity of breast cancer treatment: no easy solution for an important long-term problem. European Heart Journal. Oxford University Press (OUP); 2016; 37:1681-1683 10.1093/eurheartj/ehw133
• Periodontal health in breast cancer patients on aromatase inhibitors versus postmenopausal controls: a longitudinal analysis Cite
  Eagle I, Benavides E, Eber R, Kolenic G, Jung Y, Van Poznak C, et al. Periodontal health in breast cancer patients on aromatase inhibitors versus postmenopausal controls: a longitudinal analysis. Journal of Clinical Periodontology. Wiley; 2016; 43:659-667 10.1111/jcpe.12562
• Hot flashes in breast cancer survivors: Frequency, severity and impact Cite
  Chang H, Jotwani AC, Lai Y, Jensen MP, Syrjala KL, Fann JR, et al. Hot flashes in breast cancer survivors: Frequency, severity and impact. The Breast. Elsevier BV; 2016; 27:116-121 10.1016/j.breast.2016.02.013
• The Impact of Axillary Lymph Node Surgery on Breast Skin Thickening During and After Radiation Therapy for Breast Cancer Cite
  Torres MA, Yang X, Noreen S, Chen H, Han T, Henry S, et al. The Impact of Axillary Lymph Node Surgery on Breast Skin Thickening During and After Radiation Therapy for Breast Cancer. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2016; 95:590-596 10.1016/j.ijrobp.2016.01.030
• Use of Calcium Channel Blockers and Risk of Breast Cancer Cite
  Azoulay L, Soldera S, Yin H, Bouganim N. Use of Calcium Channel Blockers and Risk of Breast Cancer. Epidemiology. Ovid Technologies (Wolters Kluwer Health); 2016; 27:594-601 10.1097/ede.0000000000000483
• Persistent Breast Pain Among Women With Histories of Breast-conserving Surgery for Breast Cancer Compared With Women Without Histories of Breast Surgery or Cancer Cite
  Edmond SN, Shelby RA, Keefe FJ, Fisher HM, Schmidt JE, Soo MS, et al. Persistent Breast Pain Among Women With Histories of Breast-conserving Surgery for Breast Cancer Compared With Women Without Histories of Breast Surgery or Cancer. The Clinical Journal of Pain. Ovid Technologies (Wolters Kluwer Health); 2017; 33:51-56 10.1097/ajp.0000000000000377
• Acupuncture As an Integrative Approach for the Treatment of Hot Flashes in Women With Breast Cancer: A Prospective Multicenter Randomized Controlled Trial (AcCliMaT) Cite
  Lesi G, Razzini G, Musti MA, Stivanello E, Petrucci C, Benedetti B, et al. Acupuncture As an Integrative Approach for the Treatment of Hot Flashes in Women With Breast Cancer: A Prospective Multicenter Randomized Controlled Trial (AcCliMaT). Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2016; 34:1795-1802 10.1200/jco.2015.63.2893
• Risedronate may preserve bone microarchitecture in breast cancer survivors on aromatase inhibitors: A randomized, controlled clinical trial Cite
  Prasad C, Greenspan SL, Vujevich KT, Brufsky A, Lembersky BC, van Londen G, et al. Risedronate may preserve bone microarchitecture in breast cancer survivors on aromatase inhibitors: A randomized, controlled clinical trial. Bone. Elsevier BV; 2016; 90:123-126 10.1016/j.bone.2016.03.010
• Informing hot flash treatment decisions for breast cancer survivors: a systematic review of randomized trials comparing active interventions Cite
  Johns C, Seav SM, Dominick SA, Gorman JR, Li H, Natarajan L, et al. Informing hot flash treatment decisions for breast cancer survivors: a systematic review of randomized trials comparing active interventions. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2016; 156:415-426 10.1007/s10549-016-3765-4
• Lymphocyte depletion and repopulation after chemotherapy for primary breast cancer Cite
  Verma R, Foster RE, Horgan K, Mounsey K, Nixon H, Smalle N, et al. Lymphocyte depletion and repopulation after chemotherapy for primary breast cancer. Breast Cancer Research. Springer Science and Business Media LLC; 2016; 18 10.1186/s13058-015-0669-x
• Impact of chemotherapy followed by aromatase inhibitors on bone health of women with ER-positive early breast cancer in real world clinical settings in Greece: Results of the POCHARBI trial conducted by the Hellenic Society of Breast Surgeons Cite
  Markopoulos C, Koukouras D, Venizelos V, Karyda I, Xepapadakis G, Misitzis J, et al. Impact of chemotherapy followed by aromatase inhibitors on bone health of women with ER-positive early breast cancer in real world clinical settings in Greece: Results of the POCHARBI trial conducted by the Hellenic Society of Breast Surgeons. The Breast. Elsevier BV; 2016; 27:27-34 10.1016/j.breast.2016.02.007
• The impact of early detection and intervention of breast cancer‐related lymphedema: a systematic review Cite
  Shah C, Arthur DW, Wazer D, Khan A, Ridner S, Vicini F. The impact of early detection and intervention of breast cancer‐related lymphedema: a systematic review. Cancer Medicine. Wiley; 2016; 5:1154-1162 10.1002/cam4.691
• Incidence of chemotherapy-induced nausea and vomiting associated with docetaxel and cyclophosphamide in early breast cancer patients and aprepitant efficacy as salvage therapy. Results from the Spanish Breast Cancer Group/2009-02 study Cite
  Llombart-Cussac A, Ramos M, Dalmau E, García-Saenz JA, González-Farré X, Murillo L, et al. Incidence of chemotherapy-induced nausea and vomiting associated with docetaxel and cyclophosphamide in early breast cancer patients and aprepitant efficacy as salvage therapy. Results from the Spanish Breast Cancer Group/2009-02 study. European Journal of Cancer. Elsevier BV; 2016; 58:122-129 10.1016/j.ejca.2016.01.015
• Respiratory Factors Contributing to Exercise Intolerance in Breast Cancer Survivors: A Case-Control Study Cite
  O'Donnell DE, Webb KA, Langer D, Elbehairy AF, Neder JA, Dudgeon DJ. Respiratory Factors Contributing to Exercise Intolerance in Breast Cancer Survivors: A Case-Control Study. Journal of Pain and Symptom Management. Elsevier BV; 2016; 52:54-63 10.1016/j.jpainsymman.2016.01.004
• Clinically assessed posttraumatic stress in patients with breast cancer during the first year after diagnosis in the prospective, longitudinal, controlled COGNICARES study Cite
  Voigt V, Neufeld F, Kaste J, Bühner M, Sckopke P, Wuerstlein R, et al. Clinically assessed posttraumatic stress in patients with breast cancer during the first year after diagnosis in the prospective, longitudinal, controlled COGNICARES study. Psycho-Oncology. Wiley; 2016; 26:74-80 10.1002/pon.4102
• Risk factors, prevalence, and course of severe fatigue after breast cancer treatment: a meta-analysis involving 12 327 breast cancer survivors Cite
  Abrahams H, Gielissen M, Schmits I, Verhagen C, Rovers M, Knoop H. Risk factors, prevalence, and course of severe fatigue after breast cancer treatment: a meta-analysis involving 12 327 breast cancer survivors. Annals of Oncology. Elsevier BV; 2016; 27:965-974 10.1093/annonc/mdw099
• Abstract P4-10-05: Changes in metabolic syndrome components in breast cancer patients receiving neoadjuvant or adjuvant chemotherapy Cite
  Dieli-Conwright C, Wong L, Waliany S, Bernstein L, Salehian B, Mortimer J. Abstract P4-10-05: Changes in metabolic syndrome components in breast cancer patients receiving neoadjuvant or adjuvant chemotherapy. Poster Session Abstracts. American Association for Cancer Research; 2016; 10.1158/1538-7445.sabcs15-p4-10-05
• Abstract S5-08: Late side-effects of breast cancer radiotherapy: Second cancer incidence and non-breast-cancer mortality among 40,000 women in 75 trials Cite
  Taylor C, Correa C, Anderson S, Duane F, Ewertz M, Jagsi R, et al. Abstract S5-08: Late side-effects of breast cancer radiotherapy: Second cancer incidence and non-breast-cancer mortality among 40,000 women in 75 trials. General Session Abstracts. American Association for Cancer Research; 2016; 10.1158/1538-7445.sabcs15-s5-08
• Cardiomyopathy Associated With Targeted Therapy for Breast Cancer Cite
  Sivagnanam K, Rahman ZU, Paul T. Cardiomyopathy Associated With Targeted Therapy for Breast Cancer. The American Journal of the Medical Sciences. Elsevier BV; 2016; 351:194-199 10.1016/j.amjms.2015.11.014
• Understanding the impact of taste changes in oncology care Cite
  Epstein JB, Smutzer G, Doty RL. Understanding the impact of taste changes in oncology care. Supportive Care in Cancer. Springer Science and Business Media LLC; 2016; 24:1917-1931 10.1007/s00520-016-3083-8
• Quality of life in elderly patients with localized breast cancer treated with radiotherapy. A prospective study Cite
  Arraras JI, Manterola A, Asin G, Illarramendi JJ, Cruz Sdl, Ibañez B, et al. Quality of life in elderly patients with localized breast cancer treated with radiotherapy. A prospective study. The Breast. Elsevier BV; 2016; 26:46-53 10.1016/j.breast.2015.12.008
• Efficacy, tolerability, and safety of cannabinoids for chemotherapy-induced nausea and vomiting—a systematic review of systematic reviews Cite
  Tafelski S, Häuser W, Schäfer M. Efficacy, tolerability, and safety of cannabinoids for chemotherapy-induced nausea and vomiting—a systematic review of systematic reviews. Der Schmerz. Springer Science and Business Media LLC; 2016; 30:14-24 10.1007/s00482-015-0092-3
• Cardiac Outcomes of Patients Receiving Adjuvant Weekly Paclitaxel and Trastuzumab for Node-Negative, ERBB2-Positive Breast Cancer Cite
  Dang C, Guo H, Najita J, Yardley D, Marcom K, Albain K, et al. Cardiac Outcomes of Patients Receiving Adjuvant Weekly Paclitaxel and Trastuzumab for Node-Negative, ERBB2-Positive Breast Cancer. JAMA Oncology. American Medical Association (AMA); 2016; 2:29 10.1001/jamaoncol.2015.3709
• Assessing the prevalence of compromised bone health among overweight and obese African-American breast cancer survivors: a case–control study Cite
  Sheean P, Liang H, Schiffer L, Arroyo C, Troy K, Stolley M. Assessing the prevalence of compromised bone health among overweight and obese African-American breast cancer survivors: a case–control study. Journal of Cancer Survivorship. Springer Science and Business Media LLC; 2015; 10:21-30 10.1007/s11764-015-0448-9
• Effects of surgery on the cancer stem cell niche Cite
  O'Leary D, O'Leary E, Foley N, Cotter T, Wang J, Redmond H. Effects of surgery on the cancer stem cell niche. European Journal of Surgical Oncology (EJSO). Elsevier BV; 2016; 42:319-325 10.1016/j.ejso.2015.12.008
• Reduced prefrontal activation during working and long-term memory tasks and impaired patient-reported cognition among cancer survivors postchemotherapy compared with healthy controls Cite
  Wang L, Apple AC, Schroeder MP, Ryals AJ, Voss JL, Gitelman D, et al. Reduced prefrontal activation during working and long-term memory tasks and impaired patient-reported cognition among cancer survivors postchemotherapy compared with healthy controls. Cancer. Wiley; 2015; 122:258-268 10.1002/cncr.29737
• Wheat bran arabinoxylan supplementation alleviates 5-fluorouracil induced mucositis and myelosuppression in BALB/c mice Cite
  Song M, Baik HW, Hong S, Sung M. Wheat bran arabinoxylan supplementation alleviates 5-fluorouracil induced mucositis and myelosuppression in BALB/c mice. Journal of Functional Foods. Elsevier BV; 2016; 21:312-320 10.1016/j.jff.2015.12.001
• Effects of physical exercise during adjuvant breast cancer treatment on physical and psychosocial dimensions of cancer-related fatigue: A meta-analysis Cite
  van Vulpen JK, Peeters PH, Velthuis MJ, van der Wall E, May AM. Effects of physical exercise during adjuvant breast cancer treatment on physical and psychosocial dimensions of cancer-related fatigue: A meta-analysis. Maturitas. Elsevier BV; 2016; 85:104-111 10.1016/j.maturitas.2015.12.007
• Neurotoxic Effects of Anthracycline- vs Nonanthracycline-Based Chemotherapy on Cognition in Breast Cancer Survivors Cite
  Kesler SR, Blayney DW. Neurotoxic Effects of Anthracycline- vs Nonanthracycline-Based Chemotherapy on Cognition in Breast Cancer Survivors. JAMA Oncology. American Medical Association (AMA); 2016; 2:185 10.1001/jamaoncol.2015.4333
• Dietary intake variability in the cycle of cytotoxic chemotherapy Cite
  Mardas M, Mądry R, Stelmach-Mardas M. Dietary intake variability in the cycle of cytotoxic chemotherapy. Supportive Care in Cancer. Springer Science and Business Media LLC; 2016; 24:2619-2625 10.1007/s00520-015-3072-3
• Contemporary Toxicity Profile of Breast Brachytherapy Versus External Beam Radiation After Lumpectomy for Breast Cancer Cite
  Huo J, Giordano SH, Smith BD, Shaitelman SF, Smith GL. Contemporary Toxicity Profile of Breast Brachytherapy Versus External Beam Radiation After Lumpectomy for Breast Cancer. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2016; 94:709-718 10.1016/j.ijrobp.2015.12.013
• Cardiovascular Disease Risk in a Large, Population-Based Cohort of Breast Cancer Survivors Cite
  Boekel NB, Schaapveld M, Gietema JA, Russell NS, Poortmans P, Theuws JC, et al. Cardiovascular Disease Risk in a Large, Population-Based Cohort of Breast Cancer Survivors. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2016; 94:1061-1072 10.1016/j.ijrobp.2015.11.040
• Anastrozole-Induced Carpal Tunnel Syndrome: Results From the International Breast Cancer Intervention Study II Prevention Trial Cite
  Spagnolo F, Sestak I, Howell A, Forbes JF, Cuzick J. Anastrozole-Induced Carpal Tunnel Syndrome: Results From the International Breast Cancer Intervention Study II Prevention Trial. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2016; 34:139-143 10.1200/jco.2015.63.4972
• Curcuminoids from Curcuma longa L. reduced intestinal mucositis induced by 5-fluorouracil in mice: Bioadhesive, proliferative, anti-inflammatory and antioxidant effects Cite
  dos Santos Filho EX, Ávila PHM, Bastos CCC, Batista AC, Naves LN, Marreto RN, et al. Curcuminoids from Curcuma longa L. reduced intestinal mucositis induced by 5-fluorouracil in mice: Bioadhesive, proliferative, anti-inflammatory and antioxidant effects. Toxicology Reports. Elsevier BV; 2016; 3:55-62 10.1016/j.toxrep.2015.10.010
• The Temporal Risk of Heart Failure Associated With Adjuvant Trastuzumab in Breast Cancer Patients: A Population Study Cite
  Goldhar HA, Yan AT, Ko DT, Earle CC, Tomlinson GA, Trudeau ME, et al. The Temporal Risk of Heart Failure Associated With Adjuvant Trastuzumab in Breast Cancer Patients: A Population Study. Journal of the National Cancer Institute. Oxford University Press (OUP); 2015; 108:djv301 10.1093/jnci/djv301
• Early cardiac toxicity following adjuvant radiotherapy of left-sided breast cancer with or without concurrent trastuzumab Cite
  Cao L, Cai G, Chang C, Yang Z, Feng Y, Yu X, et al. Early cardiac toxicity following adjuvant radiotherapy of left-sided breast cancer with or without concurrent trastuzumab. Oncotarget. Impact Journals, LLC; 2015; 7:1042-1054 10.18632/oncotarget.6053
• Cancer-related fatigue shows a stable association with diurnal cortisol dysregulation in breast cancer patients Cite
  Schmidt ME, Semik J, Habermann N, Wiskemann J, Ulrich CM, Steindorf K. Cancer-related fatigue shows a stable association with diurnal cortisol dysregulation in breast cancer patients. Brain, Behavior, and Immunity. Elsevier BV; 2016; 52:98-105 10.1016/j.bbi.2015.10.005
• Cancer Recurrence and Regional Anesthesia: The Theories, the Data, and the Future in Outcomes Cite
  Le-Wendling L, Nin O, Capdevila X. Cancer Recurrence and Regional Anesthesia: The Theories, the Data, and the Future in Outcomes. Pain Medicine. Oxford University Press (OUP); 2016;:pme12893 10.1111/pme.12893
• The effects of short-term fasting on tolerance to (neo) adjuvant chemotherapy in HER2-negative breast cancer patients: a randomized pilot study Cite
  de Groot S, Vreeswijk MP, Welters MJ, Gravesteijn G, Boei JJ, Jochems A, et al. The effects of short-term fasting on tolerance to (neo) adjuvant chemotherapy in HER2-negative breast cancer patients: a randomized pilot study. BMC Cancer. Springer Science and Business Media LLC; 2015; 15 10.1186/s12885-015-1663-5
• Metabolic and anthropometric changes in early breast cancer patients receiving adjuvant therapy Cite
  Arpino G, De Angelis C, Buono G, Colao A, Giuliano M, Malgieri S, et al. Metabolic and anthropometric changes in early breast cancer patients receiving adjuvant therapy. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2015; 154:127-132 10.1007/s10549-015-3586-x
• Late cardiac morbidity of adjuvant radiotherapy for early breast cancer – A population-based study Cite
  Leung HW, Chan AL, Muo C. Late cardiac morbidity of adjuvant radiotherapy for early breast cancer – A population-based study. Journal of Cardiology. Elsevier BV; 2016; 67:567-571 10.1016/j.jjcc.2015.07.009
• Electroacupuncture Versus Gabapentin for Hot Flashes Among Breast Cancer Survivors: A Randomized Placebo-Controlled Trial Cite
  Mao JJ, Bowman MA, Xie SX, Bruner D, DeMichele A, Farrar JT. Electroacupuncture Versus Gabapentin for Hot Flashes Among Breast Cancer Survivors: A Randomized Placebo-Controlled Trial. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2015; 33:3615-3620 10.1200/jco.2015.60.9412
• Cardiac assessment of early breast cancer patients 18years after treatment with cyclophosphamide-, methotrexate-, fluorouracil- or epirubicin-based chemotherapy Cite
  de Azambuja E, Ameye L, Diaz M, Vandenbossche S, Aftimos P, Hernández SB, et al. Cardiac assessment of early breast cancer patients 18years after treatment with cyclophosphamide-, methotrexate-, fluorouracil- or epirubicin-based chemotherapy. European Journal of Cancer. Elsevier BV; 2015; 51:2517-2524 10.1016/j.ejca.2015.08.011
• Skeletal adverse effects with aromatase inhibitors in early breast cancer: evidence to date and clinical guidance Cite
  Servitja S, Martos T, Rodriguez Sanz M, Garcia-Giralt N, Prieto-Alhambra D, Garrigos L, et al. Skeletal adverse effects with aromatase inhibitors in early breast cancer: evidence to date and clinical guidance. Therapeutic Advances in Medical Oncology. SAGE Publications; 2015; 7:291-296 10.1177/1758834015598536
• Tamoxifen-induced ovarian hyperstimulation during premenopausal hormonal therapy for breast cancer in Japanese women Cite
  Yamazaki R, Inokuchi M, Ishikawa S, Myojo S, Iwadare J, Bono Y, et al. Tamoxifen-induced ovarian hyperstimulation during premenopausal hormonal therapy for breast cancer in Japanese women. SpringerPlus. Springer Science and Business Media LLC; 2015; 4 10.1186/s40064-015-1223-0
• The Role of Grape Seed Extract in the Treatment of Chemo/Radiotherapy Induced Toxicity: A Systematic Review of Preclinical Studies Cite
  Olaku OO, Ojukwu MO, Zia FZ, White JD. The Role of Grape Seed Extract in the Treatment of Chemo/Radiotherapy Induced Toxicity: A Systematic Review of Preclinical Studies. Nutrition and Cancer. Informa UK Limited; 2015; 67:730-740 10.1080/01635581.2015.1029639
• Depressive-like behaviours and decreased dendritic branching in the medial prefrontal cortex of mice with tumors: A novel validated model of cancer-induced depression Cite
  Nashed MG, Seidlitz EP, Frey BN, Singh G. Depressive-like behaviours and decreased dendritic branching in the medial prefrontal cortex of mice with tumors: A novel validated model of cancer-induced depression. Behavioural Brain Research. Elsevier BV; 2015; 294:25-35 10.1016/j.bbr.2015.07.040
• Weight Change in Breast Cancer Survivors Compared to Cancer-Free Women: A Prospective Study in Women at Familial Risk of Breast Cancer Cite
  Gross AL, May BJ, Axilbund JE, Armstrong DK, Roden RB, Visvanathan K. Weight Change in Breast Cancer Survivors Compared to Cancer-Free Women: A Prospective Study in Women at Familial Risk of Breast Cancer. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2015; 24:1262-1269 10.1158/1055-9965.epi-15-0212
• Resveratrol, a polyphenol phytoalexin, protects against doxorubicin‐induced cardiotoxicity Cite
  Gu J, Hu W, Zhang D. Resveratrol, a polyphenol phytoalexin, protects against doxorubicin‐induced cardiotoxicity. Journal of Cellular and Molecular Medicine. Wiley; 2015; 19:2324-2328 10.1111/jcmm.12633
• Arthralgia among women taking aromatase inhibitors: is there a shared inflammatory mechanism with co-morbid fatigue and insomnia? Cite
  Bauml J, Chen L, Chen J, Boyer J, Kalos M, Li SQ, et al. Arthralgia among women taking aromatase inhibitors: is there a shared inflammatory mechanism with co-morbid fatigue and insomnia?. Breast Cancer Research. Springer Science and Business Media LLC; 2015; 17 10.1186/s13058-015-0599-7
• Fracture Risk and Adjuvant Therapies in Young Breast Cancer Patients: A Population-Based Study Cite
  Chang C, Chen S, Liu C. Fracture Risk and Adjuvant Therapies in Young Breast Cancer Patients: A Population-Based Study. PLOS ONE. Public Library of Science (PLoS); 2015; 10:e0130725 10.1371/journal.pone.0130725
• Association between tamoxifen treatment and the development of different stages of nonalcoholic fatty liver disease among breast cancer patients Cite
  Pan H, Chang H, Lee C. Association between tamoxifen treatment and the development of different stages of nonalcoholic fatty liver disease among breast cancer patients. Journal of the Formosan Medical Association. Elsevier BV; 2016; 115:411-417 10.1016/j.jfma.2015.05.006
• Doxorubicin and cyclophosphamide treatment produces anxiety-like behavior and spatial cognition impairment in rats: Possible involvement of hippocampal neurogenesis via brain-derived neurotrophic factor and cyclin D1 regulation Cite
  Kitamura Y, Hattori S, Yoneda S, Watanabe S, Kanemoto E, Sugimoto M, et al. Doxorubicin and cyclophosphamide treatment produces anxiety-like behavior and spatial cognition impairment in rats: Possible involvement of hippocampal neurogenesis via brain-derived neurotrophic factor and cyclin D1 regulation. Behavioural Brain Research. Elsevier BV; 2015; 292:184-193 10.1016/j.bbr.2015.06.007
• Objectively measured physical activity and cognitive functioning in breast cancer survivors Cite
  Marinac CR, Godbole S, Kerr J, Natarajan L, Patterson RE, Hartman SJ. Objectively measured physical activity and cognitive functioning in breast cancer survivors. Journal of Cancer Survivorship. Springer Science and Business Media LLC; 2014; 9:230-238 10.1007/s11764-014-0404-0
• Taxane induced neuropathy in patients affected by breast cancer: Literature review Cite
  De Iuliis F, Taglieri L, Salerno G, Lanza R, Scarpa S. Taxane induced neuropathy in patients affected by breast cancer: Literature review. Critical Reviews in Oncology/Hematology. Elsevier BV; 2015; 96:34-45 10.1016/j.critrevonc.2015.04.011
• Effect of Low-Intensity Physical Activity and Moderate- to High-Intensity Physical Exercise During Adjuvant Chemotherapy on Physical Fitness, Fatigue, and Chemotherapy Completion Rates: Results of the PACES Randomized Clinical Trial Cite
  van Waart H, Stuiver MM, van Harten WH, Geleijn E, Kieffer JM, Buffart LM, et al. Effect of Low-Intensity Physical Activity and Moderate- to High-Intensity Physical Exercise During Adjuvant Chemotherapy on Physical Fitness, Fatigue, and Chemotherapy Completion Rates: Results of the PACES Randomized Clinical Trial. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2015; 33:1918-1927 10.1200/jco.2014.59.1081
• Saffron extracts alleviate cardiomyocytes injury induced by doxorubicin and ischemia-reperfusionin vitro Cite
  Chahine N, Nader M, Duca L, Martiny L, Chahine R. Saffron extracts alleviate cardiomyocytes injury induced by doxorubicin and ischemia-reperfusionin vitro. Drug and Chemical Toxicology. Informa UK Limited; 2015; 39:87-96 10.3109/01480545.2015.1036281
• Long-term use of tamoxifen reduces the risk of dementia: a nationwide population-based cohort study Cite
  Sun L, Chen H, Liang J, Kao C. Long-term use of tamoxifen reduces the risk of dementia: a nationwide population-based cohort study. QJM. Oxford University Press (OUP); 2015; 109:103-109 10.1093/qjmed/hcv072
• Second Malignancies After Adjuvant Radiation Therapy for Early Stage Breast Cancer: Is There Increased Risk With Addition of Regional Radiation to Local Radiation? Cite
  Hamilton SN, Tyldesley S, Li D, Olson R, McBride M. Second Malignancies After Adjuvant Radiation Therapy for Early Stage Breast Cancer: Is There Increased Risk With Addition of Regional Radiation to Local Radiation?. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2015; 91:977-985 10.1016/j.ijrobp.2014.12.051
• Fracture incidence in pre- and postmenopausal women after completion of adjuvant hormonal therapy for breast cancer Cite
  Koopal C, Janssen-Heijnen M, van de Wouw A, van den Bergh J. Fracture incidence in pre- and postmenopausal women after completion of adjuvant hormonal therapy for breast cancer. The Breast. Elsevier BV; 2015; 24:153-158 10.1016/j.breast.2014.12.008
• Symptomatic Toxicities Experienced During Anticancer Treatment: Agreement Between Patient and Physician Reporting in Three Randomized Trials Cite
  Di Maio M, Gallo C, Leighl NB, Piccirillo MC, Daniele G, Nuzzo F, et al. Symptomatic Toxicities Experienced During Anticancer Treatment: Agreement Between Patient and Physician Reporting in Three Randomized Trials. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2015; 33:910-915 10.1200/jco.2014.57.9334
• Circadian disruption and biomarkers of tumor progression in breast cancer patients awaiting surgery Cite
  Cash E, Sephton S, Chagpar A, Spiegel D, Rebholz W, Zimmaro L, et al. Circadian disruption and biomarkers of tumor progression in breast cancer patients awaiting surgery. Brain, Behavior, and Immunity. Elsevier BV; 2015; 48:102-114 10.1016/j.bbi.2015.02.017
• Cognitive Impairment after Chemotherapy Related to Atypical Network Architecture for Executive Control Cite
  Piccirillo JF, Hardin FM, Nicklaus J, Kallogjeri D, Wilson M, Ma CX, et al. Cognitive Impairment after Chemotherapy Related to Atypical Network Architecture for Executive Control. Oncology. S. Karger AG; 2015; 88:360-368 10.1159/000370117
• Treatment-Associated Musculoskeletal and Vasomotor Symptoms and Relapse-Free Survival in the NCIC CTG MA.27 Adjuvant Breast Cancer Aromatase Inhibitor Trial Cite
  Stearns V, Chapman JW, Ma CX, Ellis MJ, Ingle JN, Pritchard KI, et al. Treatment-Associated Musculoskeletal and Vasomotor Symptoms and Relapse-Free Survival in the NCIC CTG MA.27 Adjuvant Breast Cancer Aromatase Inhibitor Trial. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2015; 33:265-271 10.1200/jco.2014.57.6926
• Prevalence of Cerebral Small-Vessel Disease in Long-Term Breast Cancer Survivors Exposed to Both Adjuvant Radiotherapy and Chemotherapy Cite
  Koppelmans V, Vernooij MW, Boogerd W, Seynaeve C, Ikram MA, Breteler MM, et al. Prevalence of Cerebral Small-Vessel Disease in Long-Term Breast Cancer Survivors Exposed to Both Adjuvant Radiotherapy and Chemotherapy. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2015; 33:588-593 10.1200/jco.2014.56.8345
• Habitual sleep–wake behaviors and lifestyle as predictors of diurnal cortisol patterns in young breast cancer survivors: A longitudinal study Cite
  Hsiao F, Kuo W, Jow G, Chang K, Yang P, Lam H, et al. Habitual sleep–wake behaviors and lifestyle as predictors of diurnal cortisol patterns in young breast cancer survivors: A longitudinal study. Psychoneuroendocrinology. Elsevier BV; 2015; 53:60-68 10.1016/j.psyneuen.2014.12.014
• Active Breathing Coordinator reduces radiation dose to the heart and preserves local control in patients with left breast cancer: Report of a prospective trial Cite
  Eldredge-Hindy H, Lockamy V, Crawford A, Nettleton V, Werner-Wasik M, Siglin J, et al. Active Breathing Coordinator reduces radiation dose to the heart and preserves local control in patients with left breast cancer: Report of a prospective trial. Practical Radiation Oncology. Elsevier BV; 2015; 5:4-10 10.1016/j.prro.2014.06.004
• Three-Arm Randomized Phase III Trial: Quality Aloe and Placebo Cream Versus Powder as Skin Treatment During Breast Cancer Radiation Therapy Cite
  Hoopfer D, Holloway C, Gabos Z, Alidrisi M, Chafe S, Krause B, et al. Three-Arm Randomized Phase III Trial: Quality Aloe and Placebo Cream Versus Powder as Skin Treatment During Breast Cancer Radiation Therapy. Clinical Breast Cancer. Elsevier BV; 2015; 15:181-190.e4 10.1016/j.clbc.2014.12.006
• Safety and efficacy outcomes with erythropoiesis-stimulating agents in patients with breast cancer: a meta-analysis Cite
  Aapro M, Moebus V, Nitz U, O'Shaughnessy J, Pronzato P, Untch M, et al. Safety and efficacy outcomes with erythropoiesis-stimulating agents in patients with breast cancer: a meta-analysis. Annals of Oncology. Elsevier BV; 2015; 26:688-695 10.1093/annonc/mdu579
• Risk of Marrow Neoplasms After Adjuvant Breast Cancer Therapy: The National Comprehensive Cancer Network Experience Cite
  Wolff AC, Blackford AL, Visvanathan K, Rugo HS, Moy B, Goldstein LJ, et al. Risk of Marrow Neoplasms After Adjuvant Breast Cancer Therapy: The National Comprehensive Cancer Network Experience. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2015; 33:340-348 10.1200/jco.2013.54.6119
• Randomized Exercise Trial of Aromatase Inhibitor–Induced Arthralgia in Breast Cancer Survivors Cite
  Irwin ML, Cartmel B, Gross CP, Ercolano E, Li F, Yao X, et al. Randomized Exercise Trial of Aromatase Inhibitor–Induced Arthralgia in Breast Cancer Survivors. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2015; 33:1104-1111 10.1200/jco.2014.57.1547
• Risk of second non-breast cancer after radiotherapy for breast cancer: A systematic review and meta-analysis of 762,468 patients Cite
  Grantzau T, Overgaard J. Risk of second non-breast cancer after radiotherapy for breast cancer: A systematic review and meta-analysis of 762,468 patients. Radiotherapy and Oncology. Elsevier BV; 2015; 114:56-65 10.1016/j.radonc.2014.10.004
• Bisphosphonates May Protect against Bone Loss in Postmenopausal Women with Early Breast Cancer Receiving Adjuvant Aromatase Inhibitor Therapy: Results from a Meta-analysis Cite
  Su G, Xiang Y, He G, Jiang C, Li C, Yan Z, et al. Bisphosphonates May Protect against Bone Loss in Postmenopausal Women with Early Breast Cancer Receiving Adjuvant Aromatase Inhibitor Therapy: Results from a Meta-analysis. Archives of Medical Research. Elsevier BV; 2014; 45:570-579 10.1016/j.arcmed.2014.10.007
• The flavonoid quercetin: Possible solution for anthracycline-induced cardiotoxicity and multidrug resistance Cite
  Czepas J, Gwoździński K. The flavonoid quercetin: Possible solution for anthracycline-induced cardiotoxicity and multidrug resistance. Biomedicine & Pharmacotherapy. Elsevier BV; 2014; 68:1149-1159 10.1016/j.biopha.2014.10.013
• Chronic heart damage following doxorubicin treatment is alleviated by lovastatin Cite
  Henninger C, Huelsenbeck S, Wenzel P, Brand M, Huelsenbeck J, Schad A, et al. Chronic heart damage following doxorubicin treatment is alleviated by lovastatin. Pharmacological Research. Elsevier BV; 2015; 91:47-56 10.1016/j.phrs.2014.11.003
• A Longitudinal Study of Depression, Fatigue, and Sleep Disturbances as a Symptom Cluster in Women With Breast Cancer Cite
  Ho S, Rohan KJ, Parent J, Tager FA, McKinley PS. A Longitudinal Study of Depression, Fatigue, and Sleep Disturbances as a Symptom Cluster in Women With Breast Cancer. Journal of Pain and Symptom Management. Elsevier BV; 2015; 49:707-715 10.1016/j.jpainsymman.2014.09.009
• Clinical Practice Guidelines on the Use of Integrative Therapies as Supportive Care in Patients Treated for Breast Cancer Cite
  Greenlee H, Balneaves LG, Carlson LE, Cohen M, Deng G, Hershman D, et al. Clinical Practice Guidelines on the Use of Integrative Therapies as Supportive Care in Patients Treated for Breast Cancer. JNCI Monographs. Oxford University Press (OUP); 2014; 2014:346-358 10.1093/jncimonographs/lgu041
• Breast Cancer Laterality Does Not Influence Survival in a Large Modern Cohort: Implications for Radiation-Related Cardiac Mortality Cite
  Rutter CE, Chagpar AB, Evans SB. Breast Cancer Laterality Does Not Influence Survival in a Large Modern Cohort: Implications for Radiation-Related Cardiac Mortality. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2014; 90:329-334 10.1016/j.ijrobp.2014.06.030
• Successful reduction of alopecia induced by anthracycline and taxane containing adjuvant chemotherapy in breast cancer – clinical evaluation of sensor-controlled scalp cooling Cite
  Friedrichs K, Carstensen MH. Successful reduction of alopecia induced by anthracycline and taxane containing adjuvant chemotherapy in breast cancer – clinical evaluation of sensor-controlled scalp cooling. SpringerPlus. Springer Science and Business Media LLC; 2014; 3 10.1186/2193-1801-3-500
• Can short-term fasting protect against doxorubicin-induced cardiotoxicity? Cite
  Dirks-Naylor AJ. Can short-term fasting protect against doxorubicin-induced cardiotoxicity?. World Journal of Biological Chemistry. Baishideng Publishing Group Inc.; 2014; 5:269 10.4331/wjbc.v5.i3.269
• Cardiovascular Morbidity and Mortality After Treatment for Ductal Carcinoma In Situ of the Breast Cite
  Boekel NB, Schaapveld M, Gietema JA, Rutgers EJT, Versteegh MIM, Visser O, et al. Cardiovascular Morbidity and Mortality After Treatment for Ductal Carcinoma In Situ of the Breast. JNCI: Journal of the National Cancer Institute. Oxford University Press (OUP); 2014; 106 10.1093/jnci/dju156
• Ototoxicity of paclitaxel in rat cochlear organotypic cultures Cite
  Dong Y, Ding D, Jiang H, Shi J, Salvi R, Roth JA. Ototoxicity of paclitaxel in rat cochlear organotypic cultures. Toxicology and Applied Pharmacology. Elsevier BV; 2014; 280:526-533 10.1016/j.taap.2014.08.022
• Decision-making impairments in breast cancer patients treated with tamoxifen Cite
  Chen X, Li J, Chen J, Li D, Ye R, Zhang J, et al. Decision-making impairments in breast cancer patients treated with tamoxifen. Hormones and Behavior. Elsevier BV; 2014; 66:449-456 10.1016/j.yhbeh.2014.07.005
• Clinical Predictive Models for Chemotherapy-Induced Febrile Neutropenia in Breast Cancer Patients: A Validation Study Cite
  Chen K, Zhang X, Deng H, Zhu L, Su F, Jia W, et al. Clinical Predictive Models for Chemotherapy-Induced Febrile Neutropenia in Breast Cancer Patients: A Validation Study. PLoS ONE. Public Library of Science (PLoS); 2014; 9:e96413 10.1371/journal.pone.0096413
• Risk of second primary lung cancer in women after radiotherapy for breast cancer Cite
  Grantzau T, Thomsen MS, Væth M, Overgaard J. Risk of second primary lung cancer in women after radiotherapy for breast cancer. Radiotherapy and Oncology. Elsevier BV; 2014; 111:366-373 10.1016/j.radonc.2014.05.004
• Risk of Hospitalization According to Chemotherapy Regimen in Early-Stage Breast Cancer Cite
  Barcenas CH, Niu J, Zhang N, Zhang Y, Buchholz TA, Elting LS, et al. Risk of Hospitalization According to Chemotherapy Regimen in Early-Stage Breast Cancer. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2014; 32:2010-2017 10.1200/jco.2013.49.3676
• Retrospective study of radiotherapy-induced skin reactions in breast cancer patients: Reduced incidence of moist desquamation with a hydroactive colloid gel versus dexpanthenol Cite
  Censabella S, Claes S, Orlandini M, Braekers R, Thijs H, Bulens P. Retrospective study of radiotherapy-induced skin reactions in breast cancer patients: Reduced incidence of moist desquamation with a hydroactive colloid gel versus dexpanthenol. European Journal of Oncology Nursing. Elsevier BV; 2014; 18:499-504 10.1016/j.ejon.2014.04.009
• Febrile Neutropaenia and Chemotherapy Discontinuation in Women Aged 70 Years or Older Receiving Adjuvant Chemotherapy for Early Breast Cancer Cite
  Adjogatse D, Thanopoulou E, Okines A, Thillai K, Tasker F, Johnston S, et al. Febrile Neutropaenia and Chemotherapy Discontinuation in Women Aged 70 Years or Older Receiving Adjuvant Chemotherapy for Early Breast Cancer. Clinical Oncology. Elsevier BV; 2014; 26:692-696 10.1016/j.clon.2014.05.002
• Modification of Abdominal Fat Distribution After Aromatase Inhibitor Therapy in Breast Cancer Patients Visualized Using 3-D Computed Tomography Volumetry Cite
  Battisti S, Guida FM, Coppa F, Vaccaro DM, Santini D, Tonini G, et al. Modification of Abdominal Fat Distribution After Aromatase Inhibitor Therapy in Breast Cancer Patients Visualized Using 3-D Computed Tomography Volumetry. Clinical Breast Cancer. Elsevier BV; 2014; 14:365-370 10.1016/j.clbc.2014.02.003
• Adjuvant Tamoxifen Influences the Lipid Profile in Breast Cancer Patients Cite
  Lin C, Chen L, Kuo S, Chen D. Adjuvant Tamoxifen Influences the Lipid Profile in Breast Cancer Patients. Breast Care. S. Karger AG; 2014; 9:1-1 10.1159/000358752
• Identification of patient subgroups and risk factors for persistent arm/shoulder pain following breast cancer surgery Cite
  Miaskowski C, Paul SM, Cooper B, West C, Levine JD, Elboim C, et al. Identification of patient subgroups and risk factors for persistent arm/shoulder pain following breast cancer surgery. European Journal of Oncology Nursing. Elsevier BV; 2014; 18:242-253 10.1016/j.ejon.2013.12.002
• Endometrial Cancer Incidence in Breast Cancer Patients Correlating with Age and Duration of Tamoxifen Use: a Population Based Study Cite
  Chen J, Kuo S, Liaw Y, Avital I, Stojadinovic A, Man Y, et al. Endometrial Cancer Incidence in Breast Cancer Patients Correlating with Age and Duration of Tamoxifen Use: a Population Based Study. Journal of Cancer. Ivyspring International Publisher; 2014; 5:151-155 10.7150/jca.8412
• Upper Limb Physical Function and Adverse Effects After Breast Cancer Surgery: A Prospective 2.5-Year Follow-Up Study and Preoperative Measures Cite
  Sagen A, Kaaresen R, Sandvik L, Thune I, Risberg MA. Upper Limb Physical Function and Adverse Effects After Breast Cancer Surgery: A Prospective 2.5-Year Follow-Up Study and Preoperative Measures. Archives of Physical Medicine and Rehabilitation. Elsevier BV; 2014; 95:875-881 10.1016/j.apmr.2013.12.015
• Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation Cite
  Ichikawa Y, Ghanefar M, Bayeva M, Wu R, Khechaduri A, Prasad SVN, et al. Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation. Journal of Clinical Investigation. American Society for Clinical Investigation; 2014; 124:617-630 10.1172/jci72931
• The Influence ofBRCA1/BRCA2Mutations on Toxicity Related to Chemotherapy and Radiotherapy in Early Breast Cancer Patients Cite
  Huszno J, Budryk M, Kolosza Z, Nowara E. The Influence ofBRCA1/BRCA2Mutations on Toxicity Related to Chemotherapy and Radiotherapy in Early Breast Cancer Patients. Oncology. S. Karger AG; 2013; 85:278-282 10.1159/000354834
• Changes in body weight during various types of chemotherapy in breast cancer patients Cite
  Winkels RM, Beijer S, van Lieshout R, van Barneveld D, Hofstede J, Kuiper J, et al. Changes in body weight during various types of chemotherapy in breast cancer patients. e-SPEN Journal. Elsevier BV; 2014; 9:e39-e44 10.1016/j.clnme.2013.10.004
• A Survey of Joint and Muscle Aches, Pain, and Stiffness Comparing Women With and Without Breast Cancer Cite
  Fenlon D, Addington-Hall JM, O’Callaghan AC, Clough J, Nicholls P, Simmonds P. A Survey of Joint and Muscle Aches, Pain, and Stiffness Comparing Women With and Without Breast Cancer. Journal of Pain and Symptom Management. Elsevier BV; 2013; 46:523-535 10.1016/j.jpainsymman.2012.10.282
• Menopausal Symptoms among Breast Cancer Patients: A Potential Indicator of Favorable Prognosis Cite
  Chen Y, Dorjgochoo T, Bao P, Zheng Y, Cai H, Lu W, et al. Menopausal Symptoms among Breast Cancer Patients: A Potential Indicator of Favorable Prognosis. PLoS ONE. Public Library of Science (PLoS); 2013; 8:e75926 10.1371/journal.pone.0075926
• Review and Meta-Analysis of Incidence and Clinical Predictors of Anthracycline Cardiotoxicity Cite
  Lotrionte M, Biondi-Zoccai G, Abbate A, Lanzetta G, D'Ascenzo F, Malavasi V, et al. Review and Meta-Analysis of Incidence and Clinical Predictors of Anthracycline Cardiotoxicity. The American Journal of Cardiology. Elsevier BV; 2013; 112:1980-1984 10.1016/j.amjcard.2013.08.026
• Dietary Trans Fats Enhance Doxorubicin-Induced Cardiotoxicity in Mice Cite
  Mong M, Hsia T, Yin M. Dietary Trans Fats Enhance Doxorubicin-Induced Cardiotoxicity in Mice. Journal of Food Science. Wiley; 2013; 78:H1621-H1628 10.1111/1750-3841.12257
• Scalp cooling to prevent alopecia after chemotherapy can be considered safe in patients with breast cancer Cite
  van den Hurk C, van de Poll-Franse L, Breed W, Coebergh J, Nortier J. Scalp cooling to prevent alopecia after chemotherapy can be considered safe in patients with breast cancer. The Breast. Elsevier BV; 2013; 22:1001-1004 10.1016/j.breast.2013.07.039
• Dissociation of decision making under ambiguity and decision making under risk in breast cancer patients receiving adjuvant chemotherapy: A neuropsychological study Cite
  Chen X, Zhu C, Li J, Qiu L, Zhang L, Yu F, et al. Dissociation of decision making under ambiguity and decision making under risk in breast cancer patients receiving adjuvant chemotherapy: A neuropsychological study. Brain Research. Elsevier BV; 2013; 1533:63-72 10.1016/j.brainres.2013.08.015
• Chemotherapy altered brain functional connectivity in women with breast cancer: a pilot study Cite
  Dumas JA, Makarewicz J, Schaubhut GJ, Devins R, Albert K, Dittus K, et al. Chemotherapy altered brain functional connectivity in women with breast cancer: a pilot study. Brain Imaging and Behavior. Springer Science and Business Media LLC; 2013; 7:524-532 10.1007/s11682-013-9244-1
• Protective effect of melatonin against Adriamycin-induced cardiotoxicity Cite
  ZHANG Y, LI L, XIANG C, MA Z, MA T, ZHU S. Protective effect of melatonin against Adriamycin-induced cardiotoxicity. Experimental and Therapeutic Medicine. Spandidos Publications; 2013; 5:1496-1500 10.3892/etm.2013.989
• Proteomic Profiling Reveals That Resveratrol Inhibits HSP27 Expression and Sensitizes Breast Cancer Cells to Doxorubicin Therapy Cite
  Díaz-Chávez J, Fonseca-Sánchez MA, Arechaga-Ocampo E, Flores-Pérez A, Palacios-Rodríguez Y, Domínguez-Gómez G, et al. Proteomic Profiling Reveals That Resveratrol Inhibits HSP27 Expression and Sensitizes Breast Cancer Cells to Doxorubicin Therapy. PLoS ONE. Public Library of Science (PLoS); 2013; 8:e64378 10.1371/journal.pone.0064378
• Both aerobic exercise and resveratrol supplementation attenuate doxorubicin-induced cardiac injury in mice Cite
  Dolinsky VW, Rogan KJ, Sung MM, Zordoky BN, Haykowsky MJ, Young ME, et al. Both aerobic exercise and resveratrol supplementation attenuate doxorubicin-induced cardiac injury in mice. American Journal of Physiology-Endocrinology and Metabolism. American Physiological Society; 2013; 305:E243-E253 10.1152/ajpendo.00044.2013
• Cognitive Training for Improving Executive Function in Chemotherapy-Treated Breast Cancer Survivors Cite
  Kesler S, Hadi Hosseini S, Heckler C, Janelsins M, Palesh O, Mustian K, et al. Cognitive Training for Improving Executive Function in Chemotherapy-Treated Breast Cancer Survivors. Clinical Breast Cancer. Elsevier BV; 2013; 13:299-306 10.1016/j.clbc.2013.02.004
• Pharmacological and non-hormonal treatment of hot flashes in breast cancer survivors: CEPO review and recommendations Cite
  L’Espérance S, Frenette S, Dionne A, Dionne J. Pharmacological and non-hormonal treatment of hot flashes in breast cancer survivors: CEPO review and recommendations. Supportive Care in Cancer. Springer Science and Business Media LLC; 2013; 21:1461-1474 10.1007/s00520-013-1732-8
• Specific Adverse Events Predict Survival Benefit in Patients Treated With Tamoxifen or Aromatase Inhibitors: An International Tamoxifen Exemestane Adjuvant Multinational Trial Analysis Cite
  Fontein DB, Seynaeve C, Hadji P, Hille ET, van de Water W, Putter H, et al. Specific Adverse Events Predict Survival Benefit in Patients Treated With Tamoxifen or Aromatase Inhibitors: An International Tamoxifen Exemestane Adjuvant Multinational Trial Analysis. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2013; 31:2257-2264 10.1200/jco.2012.45.3068
• Cognitive Complaints After Breast Cancer Treatments: Examining the Relationship With Neuropsychological Test Performance Cite
  Ganz PA, Kwan L, Castellon SA, Oppenheim A, Bower JE, Silverman DHS, et al. Cognitive Complaints After Breast Cancer Treatments: Examining the Relationship With Neuropsychological Test Performance. JNCI: Journal of the National Cancer Institute. Oxford University Press (OUP); 2013; 105:791-801 10.1093/jnci/djt073
• Impact of scalp cooling on chemotherapy-induced alopecia, wig use and hair growth of patients with cancer Cite
  van den Hurk C, van den Akker-van Marle M, Breed W, van de Poll-Franse L, Nortier J, Coebergh J. Impact of scalp cooling on chemotherapy-induced alopecia, wig use and hair growth of patients with cancer. European Journal of Oncology Nursing. Elsevier BV; 2013; 17:536-540 10.1016/j.ejon.2013.02.004
• Oral Antibiotics for Fever in Low-Risk Neutropenic Patients With Cancer: A Double-Blind, Randomized, Multicenter Trial Comparing Single Daily Moxifloxacin With Twice Daily Ciprofloxacin Plus Amoxicillin/Clavulanic Acid Combination Therapy—EORTC Infectious Diseases Group Trial XV Cite
  Kern WV, Marchetti O, Drgona L, Akan H, Aoun M, Akova M, et al. Oral Antibiotics for Fever in Low-Risk Neutropenic Patients With Cancer: A Double-Blind, Randomized, Multicenter Trial Comparing Single Daily Moxifloxacin With Twice Daily Ciprofloxacin Plus Amoxicillin/Clavulanic Acid Combination Therapy—EORTC Infectious Diseases Group Trial XV. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2013; 31:1149-1156 10.1200/jco.2012.45.8109
• AFRICAN AMERICAN RACE IS A CORRELATE OF HEART FAILURE IN BREAST CANCER SURVIVORS: A STUDY OF 26,347 WOMEN IDENTIFIED WITH BREAST CANCER FROM 1973-2007 Cite
  Valina-Toth AL, Zavodnik T, Seicean S, Plana J, Marwick T. AFRICAN AMERICAN RACE IS A CORRELATE OF HEART FAILURE IN BREAST CANCER SURVIVORS: A STUDY OF 26,347 WOMEN IDENTIFIED WITH BREAST CANCER FROM 1973-2007. Journal of the American College of Cardiology. Elsevier BV; 2013; 61:E580 10.1016/s0735-1097(13)60580-x
• Short-term calorie and protein restriction provide partial protection from chemotoxicity but do not delay glioma progression Cite
  Brandhorst S, Wei M, Hwang S, Morgan TE, Longo VD. Short-term calorie and protein restriction provide partial protection from chemotoxicity but do not delay glioma progression. Experimental Gerontology. Elsevier BV; 2013; 48:1120-1128 10.1016/j.exger.2013.02.016
• Meta-analysis of breast cancer outcome and toxicity in adjuvant trials of aromatase inhibitors in postmenopausal women Cite
  Aydiner A. Meta-analysis of breast cancer outcome and toxicity in adjuvant trials of aromatase inhibitors in postmenopausal women. The Breast. Elsevier BV; 2013; 22:121-129 10.1016/j.breast.2013.01.014
• 3,3′-Diindolymethane ameliorates adriamycin-induced cardiac fibrosis via activation of a BRCA1-dependent anti-oxidant pathway Cite
  Yao Z, Hu W, Yin S, Huang Z, Zhu Q, Chen J, et al. 3,3′-Diindolymethane ameliorates adriamycin-induced cardiac fibrosis via activation of a BRCA1-dependent anti-oxidant pathway. Pharmacological Research. Elsevier BV; 2013; 70:139-146 10.1016/j.phrs.2013.01.006
• Is basic research providing answers if adjuvant anti-estrogen treatment of breast cancer can induce cognitive impairment? Cite
  Buwalda B, Schagen SB. Is basic research providing answers if adjuvant anti-estrogen treatment of breast cancer can induce cognitive impairment?. Life Sciences. Elsevier BV; 2013; 93:581-588 10.1016/j.lfs.2012.12.012
• Seroma Formation after Breast Cancer Surgery: What We Have Learned in the Last Two Decades Cite
  Srivastava V, Basu S, Shukla VK. Seroma Formation after Breast Cancer Surgery: What We Have Learned in the Last Two Decades. Journal of Breast Cancer. Korean Breast Cancer Society; 2012; 15:373 10.4048/jbc.2012.15.4.373
• Factors of influence on acute skin toxicity of breast cancer patients treated with standard three-dimensional conformal radiotherapy (3D-CRT) after breast conserving surgery (BCS) Cite
  Kraus-Tiefenbacher U, Sfintizky A, Welzel G, Simeonova A, Sperk E, Siebenlist K, et al. Factors of influence on acute skin toxicity of breast cancer patients treated with standard three-dimensional conformal radiotherapy (3D-CRT) after breast conserving surgery (BCS). Radiation Oncology. Springer Science and Business Media LLC; 2012; 7 10.1186/1748-717x-7-217
• Incidence of Heart Failure or Cardiomyopathy After Adjuvant Trastuzumab Therapy for Breast Cancer Cite
  Chen J, Long JB, Hurria A, Owusu C, Steingart RM, Gross CP. Incidence of Heart Failure or Cardiomyopathy After Adjuvant Trastuzumab Therapy for Breast Cancer. Journal of the American College of Cardiology. Elsevier BV; 2012; 60:2504-2512 10.1016/j.jacc.2012.07.068
• Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and prevention Cite
  Grisold W, Cavaletti G, Windebank AJ. Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and prevention. Neuro-Oncology. Oxford University Press (OUP); 2012; 14:iv45-iv54 10.1093/neuonc/nos203
• Management of dermatological toxicities in patients receiving EGFR inhibitors Cite
  Lynch K. Management of dermatological toxicities in patients receiving EGFR inhibitors. Community Oncology. Elsevier BV; 2012; 9:315-323 10.1016/j.cmonc.2012.09.008
• Effects of 5-fluorouracil chemotherapy on fatigue: Role of MCP-1 Cite
  Mahoney S, Davis J, Murphy E, McClellan J, Gordon B, Pena M. Effects of 5-fluorouracil chemotherapy on fatigue: Role of MCP-1. Brain, Behavior, and Immunity. Elsevier BV; 2013; 27:155-161 10.1016/j.bbi.2012.10.012
• Chemotherapy disrupts learning, neurogenesis and theta activity in the adult brain Cite
  Nokia MS, Anderson ML, Shors TJ. Chemotherapy disrupts learning, neurogenesis and theta activity in the adult brain. European Journal of Neuroscience. Wiley; 2012; 36:3521-3530 10.1111/ejn.12007
• Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month results Cite
  Coleman R, de Boer R, Eidtmann H, Llombart A, Davidson N, Neven P, et al. Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month results. Annals of Oncology. Elsevier BV; 2013; 24:398-405 10.1093/annonc/mds277
• Protective effects of resveratrol on cisplatin-dependent inner-ear damage in rats Cite
  Şimşek G, Tokgoz SA, Vuralkan E, Caliskan M, Besalti O, Akin I. Protective effects of resveratrol on cisplatin-dependent inner-ear damage in rats. European Archives of Oto-Rhino-Laryngology. Springer Science and Business Media LLC; 2012; 270:1789-1793 10.1007/s00405-012-2183-4
• Cardiorespiratory and neuromuscular deconditioning in fatigued and non-fatigued breast cancer survivors Cite
  Neil SE, Klika RJ, Garland SJ, McKenzie DC, Campbell KL. Cardiorespiratory and neuromuscular deconditioning in fatigued and non-fatigued breast cancer survivors. Supportive Care in Cancer. Springer Science and Business Media LLC; 2012; 21:873-881 10.1007/s00520-012-1600-y
• Risk of Heart Failure in Breast Cancer Patients After Anthracycline and Trastuzumab Treatment: A Retrospective Cohort Study Cite
  Bowles EJA, Wellman R, Feigelson HS, Onitilo AA, Freedman AN, Delate T, et al. Risk of Heart Failure in Breast Cancer Patients After Anthracycline and Trastuzumab Treatment: A Retrospective Cohort Study. JNCI Journal of the National Cancer Institute. Oxford University Press (OUP); 2012; 104:1293-1305 10.1093/jnci/djs317
• Relationship between specific adverse events and efficacy of exemestane therapy in early postmenopausal breast cancer patients Cite
  Fontein D, Houtsma D, Hille E, Seynaeve C, Putter H, Meershoek-Klein Kranenbarg E, et al. Relationship between specific adverse events and efficacy of exemestane therapy in early postmenopausal breast cancer patients. Annals of Oncology. Elsevier BV; 2012; 23:3091-3097 10.1093/annonc/mds204
• Reduced hippocampal volume and verbal memory performance associated with interleukin-6 and tumor necrosis factor-alpha levels in chemotherapy-treated breast cancer survivors Cite
  Kesler S, Janelsins M, Koovakkattu D, Palesh O, Mustian K, Morrow G, et al. Reduced hippocampal volume and verbal memory performance associated with interleukin-6 and tumor necrosis factor-alpha levels in chemotherapy-treated breast cancer survivors. Brain, Behavior, and Immunity. Elsevier BV; 2013; 30:S109-S116 10.1016/j.bbi.2012.05.017
• A Randomized, Double-Blind, Placebo-Controlled Study of Oral Coenzyme Q10 to Relieve Self-Reported Treatment-Related Fatigue in Newly Diagnosed Patients with Breast Cancer Cite
  Lesser GJ, Case D, Stark N, Williford S, Giguere J, Garino LA, et al. A Randomized, Double-Blind, Placebo-Controlled Study of Oral Coenzyme Q10 to Relieve Self-Reported Treatment-Related Fatigue in Newly Diagnosed Patients with Breast Cancer. The Journal of Supportive Oncology. Elsevier BV; 2012; 10.1016/j.suponc.2012.03.003
• Frontal gray matter reduction after breast cancer chemotherapy and association with executive symptoms: A replication and extension study Cite
  McDonald BC, Conroy SK, Smith DJ, West JD, Saykin AJ. Frontal gray matter reduction after breast cancer chemotherapy and association with executive symptoms: A replication and extension study. Brain, Behavior, and Immunity. Elsevier BV; 2013; 30:S117-S125 10.1016/j.bbi.2012.05.007
• Weight change associated with anastrozole and tamoxifen treatment in postmenopausal women with or at high risk of developing breast cancer Cite
  Sestak I, Harvie M, Howell A, Forbes JF, Dowsett M, Cuzick J. Weight change associated with anastrozole and tamoxifen treatment in postmenopausal women with or at high risk of developing breast cancer. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2012; 134:727-734 10.1007/s10549-012-2085-6
• A Multicenter Investigation of Late Adverse Events in Japanese Women Treated with Breast-conserving Surgery plus Conventional Fractionated Whole-breast Radiation Therapy Cite
  Nozaki M, Kagami Y, Mitsumori M, Hiraoka M. A Multicenter Investigation of Late Adverse Events in Japanese Women Treated with Breast-conserving Surgery plus Conventional Fractionated Whole-breast Radiation Therapy. Japanese Journal of Clinical Oncology. Oxford University Press (OUP); 2012; 42:522-527 10.1093/jjco/hys050
• Reproductive Status at First Diagnosis Influences Risk of Radiation-Induced Second Primary Contralateral Breast Cancer in the WECARE Study Cite
  Brooks JD, Boice JD, Stovall M, Reiner AS, Bernstein L, John EM, et al. Reproductive Status at First Diagnosis Influences Risk of Radiation-Induced Second Primary Contralateral Breast Cancer in the WECARE Study. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2012; 84:917-924 10.1016/j.ijrobp.2012.01.047
• Clinician awareness and knowledge of breast cancer-related lymphedema in a large, integrated health care delivery setting Cite
  Tam EK, Shen L, Munneke JR, Ackerson LM, Partee PN, Somkin CP, et al. Clinician awareness and knowledge of breast cancer-related lymphedema in a large, integrated health care delivery setting. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2011; 131:1029-1038 10.1007/s10549-011-1829-z
• Fatigue and sleep quality are associated with changes in inflammatory markers in breast cancer patients undergoing chemotherapy Cite
  Liu L, Mills PJ, Rissling M, Fiorentino L, Natarajan L, Dimsdale JE, et al. Fatigue and sleep quality are associated with changes in inflammatory markers in breast cancer patients undergoing chemotherapy. Brain, Behavior, and Immunity. Elsevier BV; 2012; 26:706-713 10.1016/j.bbi.2012.02.001
• Fatigue, Inflammation, and ω-3 and ω-6 Fatty Acid Intake Among Breast Cancer Survivors Cite
  Alfano CM, Imayama I, Neuhouser ML, Kiecolt-Glaser JK, Smith AW, Meeske K, et al. Fatigue, Inflammation, and ω-3 and ω-6 Fatty Acid Intake Among Breast Cancer Survivors. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2012; 30:1280-1287 10.1200/jco.2011.36.4109
• Incidence and Prognostic Impact of Amenorrhea During Adjuvant Therapy in High-Risk Premenopausal Breast Cancer: Analysis of a National Cancer Institute of Canada Clinical Trials Group Study—NCIC CTG MA.5 Cite
  Parulekar WR, Day AG, Ottaway JA, Shepherd LE, Trudeau ME, Bramwell V, et al. Incidence and Prognostic Impact of Amenorrhea During Adjuvant Therapy in High-Risk Premenopausal Breast Cancer: Analysis of a National Cancer Institute of Canada Clinical Trials Group Study—NCIC CTG MA.5. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2005; 23:6002-6008 10.1200/jco.2005.07.096
• Incidence of reversible amenorrhea in women with breast cancer undergoing adjuvant anthracycline-based chemotherapy with or without docetaxel Cite
  Berliere M, Dalenc F, Malingret N, Vindevogel A, Piette P, Roche H, et al. Incidence of reversible amenorrhea in women with breast cancer undergoing adjuvant anthracycline-based chemotherapy with or without docetaxel. BMC Cancer. Springer Science and Business Media LLC; 2008; 8 10.1186/1471-2407-8-56
• Relationship between reproductive history, anthropometrics, lifestyle factors, and the likelihood of persistent chemotherapy-related amenorrhea in women with premenopausal breast cancer Cite
  Abusief ME, Missmer SA, Ginsburg ES, Weeks JC, Partridge AH. Relationship between reproductive history, anthropometrics, lifestyle factors, and the likelihood of persistent chemotherapy-related amenorrhea in women with premenopausal breast cancer. Fertility and Sterility. Elsevier BV; 2012; 97:154-159 10.1016/j.fertnstert.2011.10.005
• Incidence of chemotherapy-induced amenorrhea in hormone-sensitive breast cancer patients: the impact of addition of taxanes to anthracycline-based regimens Cite
  Pérez-Fidalgo JA, Roselló S, García-Garré E, Jordá E, Martín-Martorell P, Bermejo B, et al. Incidence of chemotherapy-induced amenorrhea in hormone-sensitive breast cancer patients: the impact of addition of taxanes to anthracycline-based regimens. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2009; 120:245-251 10.1007/s10549-009-0426-x
• Longer Therapy, Iatrogenic Amenorrhea, and Survival in Early Breast Cancer Cite
  Swain SM, Jeong J, Geyer CE, Costantino JP, Pajon ER, Fehrenbacher L, et al. Longer Therapy, Iatrogenic Amenorrhea, and Survival in Early Breast Cancer. New England Journal of Medicine. Massachusetts Medical Society; 2010; 362:2053-2065 10.1056/nejmoa0909638
• Long-term toxic effects of adjuvant chemotherapy in breast cancer Cite
  Azim H, de Azambuja E, Colozza M, Bines J, Piccart M. Long-term toxic effects of adjuvant chemotherapy in breast cancer. Annals of Oncology. Elsevier BV; 2011; 22:1939-1947 10.1093/annonc/mdq683
• Neuropsychological Performance in Survivors of Breast Cancer More Than 20 Years After Adjuvant Chemotherapy Cite
  Koppelmans V, Breteler MM, Boogerd W, Seynaeve C, Gundy C, Schagen SB. Neuropsychological Performance in Survivors of Breast Cancer More Than 20 Years After Adjuvant Chemotherapy. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2012; 30:1080-1086 10.1200/jco.2011.37.0189
• Predictors of Aromatase Inhibitor Discontinuation as a Result of Treatment-Emergent Symptoms in Early-Stage Breast Cancer Cite
  Henry NL, Azzouz F, Desta Z, Li L, Nguyen AT, Lemler S, et al. Predictors of Aromatase Inhibitor Discontinuation as a Result of Treatment-Emergent Symptoms in Early-Stage Breast Cancer. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2012; 30:936-942 10.1200/jco.2011.38.0261
• Accelerated partial breast irradiation using once-daily fractionation: analysis of 312 cases with four years median follow-up Cite
  Shaikh AY, LaCombe MA, Du H, Raghavan VT, Nanda RK, Bloomer WD. Accelerated partial breast irradiation using once-daily fractionation: analysis of 312 cases with four years median follow-up. Radiation Oncology. Springer Science and Business Media LLC; 2012; 7 10.1186/1748-717x-7-17
• Fasting Cycles Retard Growth of Tumors and Sensitize a Range of Cancer Cell Types to Chemotherapy Cite
  Lee C, Raffaghello L, Brandhorst S, Safdie FM, Bianchi G, Martin-Montalvo A, et al. Fasting Cycles Retard Growth of Tumors and Sensitize a Range of Cancer Cell Types to Chemotherapy. Science Translational Medicine. American Association for the Advancement of Science (AAAS); 2012; 4:124ra27-124ra27 10.1126/scitranslmed.3003293
• The Longitudinal Relationship between Fatigue and Sleep in Breast Cancer Patients Undergoing Chemotherapy Cite
  Liu L, Rissling M, Natarajan L, Fiorentino L, Mills PJ, Dimsdale JE, et al. The Longitudinal Relationship between Fatigue and Sleep in Breast Cancer Patients Undergoing Chemotherapy. Sleep. Oxford University Press (OUP); 2012; 35:237-245 10.5665/sleep.1630
• Grape Seed and Skin Extract Protects Against Acute Chemotherapy Toxicity induced by Doxorubicin in Rat Heart Cite
  Mokni M, Hamlaoui-Guesmi S, Amri M, Marzouki L, Limam F, Aouani E. Grape Seed and Skin Extract Protects Against Acute Chemotherapy Toxicity induced by Doxorubicin in Rat Heart. Cardiovascular Toxicology. Springer Science and Business Media LLC; 2012; 12:158-165 10.1007/s12012-012-9155-1
• Effects of herbal and dietary supplements on cognition in menopause: A systematic review Cite
  Clement YN, Onakpoya I, Hung SK, Ernst E. Effects of herbal and dietary supplements on cognition in menopause: A systematic review. Maturitas. Elsevier BV; 2011; 68:256-263 10.1016/j.maturitas.2010.12.005
• Fat necrosis in women with early-stage breast cancer treated with accelerated partial breast irradiation (APBI) using interstitial brachytherapy Cite
  Budrukkar A, Jagtap V, Kembhavi S, Munshi A, Jalali R, Seth T, et al. Fat necrosis in women with early-stage breast cancer treated with accelerated partial breast irradiation (APBI) using interstitial brachytherapy. Radiotherapy and Oncology. Elsevier BV; 2012; 103:161-165 10.1016/j.radonc.2011.12.012
• Cardioprotective effect of curcumin against doxorubicin-induced myocardial toxicity in albino rats Cite
  Swamy A, Gulliaya S, Thippeswamy A, Koti B, Manjula D. Cardioprotective effect of curcumin against doxorubicin-induced myocardial toxicity in albino rats. Indian Journal of Pharmacology. Medknow; 2012; 44:73 10.4103/0253-7613.91871
• Suspected black cohosh hepatotoxicity Cite
  Naser B, Schnitker J, Minkin MJ, de Arriba SG, Nolte K, Osmers R. Suspected black cohosh hepatotoxicity. Menopause. Ovid Technologies (Wolters Kluwer Health); 2011; 18:366-375 10.1097/gme.0b013e3181fcb2a6
• Black cohosh (Cimicifuga racemosa) in tamoxifen-treated breast cancer patients with climacteric complaints – a prospective observational study Cite
  Rostock M, Fischer J, Mumm A, Stammwitz U, Saller R, Bartsch HH. Black cohosh (Cimicifuga racemosa) in tamoxifen-treated breast cancer patients with climacteric complaints – a prospective observational study. Gynecological Endocrinology. Informa UK Limited; 2011; 27:844-848 10.3109/09513590.2010.538097
• Safety and efficacy of black cohosh and red clover for the management of vasomotor symptoms Cite
  Geller SE, Shulman LP, van Breemen RB, Banuvar S, Zhou Y, Epstein G, et al. Safety and efficacy of black cohosh and red clover for the management of vasomotor symptoms. Menopause. Ovid Technologies (Wolters Kluwer Health); 2009; 16:1156-1166 10.1097/gme.0b013e3181ace49b
• Effect of baseline serum vitamin D levels on aromatase inhibitors induced musculoskeletal symptoms: results from the IBIS-II, chemoprevention study using anastrozole Cite
  Singh S, Cuzick J, Mesher D, Richmond B, Howell A. Effect of baseline serum vitamin D levels on aromatase inhibitors induced musculoskeletal symptoms: results from the IBIS-II, chemoprevention study using anastrozole. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2011; 132:625-629 10.1007/s10549-011-1911-6
• Longitudinal Assessment of Chemotherapy-Induced Structural Changes in Cerebral White Matter and Its Correlation With Impaired Cognitive Functioning Cite
  Deprez S, Amant F, Smeets A, Peeters R, Leemans A, Van Hecke W, et al. Longitudinal Assessment of Chemotherapy-Induced Structural Changes in Cerebral White Matter and Its Correlation With Impaired Cognitive Functioning. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2012; 30:274-281 10.1200/jco.2011.36.8571
• Modulation by Melatonin of the Cardiotoxic and Antitumor Activities of Adriamycin Cite
  Kim C, Kim N, Joo H, Youm JB, Park WS, Cuong DV, et al. Modulation by Melatonin of the Cardiotoxic and Antitumor Activities of Adriamycin. Journal of Cardiovascular Pharmacology. Ovid Technologies (Wolters Kluwer Health); 2005; 46:200-210 10.1097/01.fjc.0000171750.97822.a2
• Widespread Mechanical Pain Hypersensitivity as a Sign of Central Sensitization after Breast Cancer Surgery: Comparison between Mastectomy and Lumpectomy Cite
  Fernández-Lao C, Cantarero-Villanueva I, Fernández-de-las-Peñas C, Del-Moral-Ávila R, Menjón-Beltrán S, Arroyo-Morales M. Widespread Mechanical Pain Hypersensitivity as a Sign of Central Sensitization after Breast Cancer Surgery: Comparison between Mastectomy and Lumpectomy. Pain Medicine. Oxford University Press (OUP); 2011; 12:72-78 10.1111/j.1526-4637.2010.01027.x
• New model system for testing effects of flavonoids on doxorubicin-related formation of hydroxyl radicals Cite
  Souček P, Kondrová E, Heřmánek J, Stopka P, Boumendjel A, Ueng Y, et al. New model system for testing effects of flavonoids on doxorubicin-related formation of hydroxyl radicals. Anti-Cancer Drugs. Ovid Technologies (Wolters Kluwer Health); 2011; 22:176-184 10.1097/cad.0b013e328341a17b
• Kaempferol protects against doxorubicin-induced cardiotoxicity in vivo and in vitro Cite
  Xiao J, Sun G, Sun B, Wu Y, He L, Wang X, et al. Kaempferol protects against doxorubicin-induced cardiotoxicity in vivo and in vitro. Toxicology. Elsevier BV; 2012; 292:53-62 10.1016/j.tox.2011.11.018
• Cranberry (Vaccinium macrocarpon) protects against doxorubicin-induced cardiotoxicity in rats Cite
  Elberry AA, Abdel-Naim AB, Abdel-Sattar EA, Nagy AA, Mosli HA, Mohamadin AM, et al. Cranberry (Vaccinium macrocarpon) protects against doxorubicin-induced cardiotoxicity in rats. Food and Chemical Toxicology. Elsevier BV; 2010; 48:1178-1184 10.1016/j.fct.2010.02.008
• Trastuzumab Adjuvant Chemotherapy and Cardiotoxicity in Real-World Women With Breast Cancer Cite
  Tarantini L, Cioffi G, Gori S, Tuccia F, Boccardi L, Bovelli D, et al. Trastuzumab Adjuvant Chemotherapy and Cardiotoxicity in Real-World Women With Breast Cancer. Journal of Cardiac Failure. Elsevier BV; 2012; 18:113-119 10.1016/j.cardfail.2011.10.015
• Cosmetic Outcomes and Complications Reported by Patients Having Undergone Breast-Conserving Treatment Cite
  Hill-Kayser CE, Vachani C, Hampshire MK, Di Lullo GA, Metz JM. Cosmetic Outcomes and Complications Reported by Patients Having Undergone Breast-Conserving Treatment. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2012; 83:839-844 10.1016/j.ijrobp.2011.08.013
• C-B2-01: Cardiotoxic Chemotherapy is Associated with Increased Heart Failure Risk Among Women with Breast Cancer in the Cancer Research Network Cite
  Bowles EA, Wellman R, Delate T, Allen L, Feigelson HS, Yood MU, et al. C-B2-01: Cardiotoxic Chemotherapy is Associated with Increased Heart Failure Risk Among Women with Breast Cancer in the Cancer Research Network. Clinical Medicine & Research. Marshfield Clinic Research Foundation; 2011; 9:148-148 10.3121/cmr.2011.1020.c-b2-01
• Breast tenderness and breast cancer risk in the estrogen plus progestin and estrogen-alone women’s health initiative clinical trials Cite
  Crandall CJ, Aragaki AK, Cauley JA, McTiernan A, Manson JE, Anderson G, et al. Breast tenderness and breast cancer risk in the estrogen plus progestin and estrogen-alone women’s health initiative clinical trials. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2011; 132:275-285 10.1007/s10549-011-1848-9
• Breast Cancer Affects Both the Hippocampus Volume and the Episodic Autobiographical Memory Retrieval Cite
  Bergouignan L, Lefranc JP, Chupin M, Morel N, Spano JP, Fossati P. Breast Cancer Affects Both the Hippocampus Volume and the Episodic Autobiographical Memory Retrieval. PLoS ONE. Public Library of Science (PLoS); 2011; 6:e25349 10.1371/journal.pone.0025349
• Final 5-year results of Z-FAST trial Cite
  Brufsky AM, Harker WG, Beck JT, Bosserman L, Vogel C, Seidler C, et al. Final 5-year results of Z-FAST trial. Cancer. Wiley; 2011; 118:1192-1201 10.1002/cncr.26313
• Bone mineral density in breast cancer patients treated with adjuvant letrozole, tamoxifen, or sequences of letrozole and tamoxifen in the BIG 1-98 study (SAKK 21/07) Cite
  Zaman K, Thürlimann B, Huober J, Schönenberger A, Pagani O, Lüthi J, et al. Bone mineral density in breast cancer patients treated with adjuvant letrozole, tamoxifen, or sequences of letrozole and tamoxifen in the BIG 1-98 study (SAKK 21/07). Annals of Oncology. Elsevier BV; 2012; 23:1474-1481 10.1093/annonc/mdr448
• Prognostic value of chemotherapy-induced neutropenia in early-stage breast cancer Cite
  Han Y, Yu Z, Wen S, Zhang B, Cao X, Wang X. Prognostic value of chemotherapy-induced neutropenia in early-stage breast cancer. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2011; 131:483-490 10.1007/s10549-011-1799-1
• Adjuvant Trastuzumab in HER2-Positive Breast Cancer Cite
  Slamon D, Eiermann W, Robert N, Pienkowski T, Martin M, Press M, et al. Adjuvant Trastuzumab in HER2-Positive Breast Cancer. New England Journal of Medicine. Massachusetts Medical Society; 2011; 365:1273-1283 10.1056/nejmoa0910383
• Efficacy of neoadjuvant therapy with trastuzumab concurrent with anthracycline- and nonanthracycline-based regimens for HER2-positive breast cancer Cite
  Bayraktar S, Gonzalez-Angulo AM, Lei X, Buzdar AU, Valero V, Melhem-Bertrandt A, et al. Efficacy of neoadjuvant therapy with trastuzumab concurrent with anthracycline- and nonanthracycline-based regimens for HER2-positive breast cancer. Cancer. Wiley; 2011; 118:2385-2393 10.1002/cncr.26555
• Synchronous Chemo-radiation Can Reduce Local Recurrence in Early Stage Breast Cancer: Results of the SECRAB Trial (ISRCTN: 84214355) Presented on Behalf of the SECRAB Steering Committee Cite
  Fernando I, Bowden S, Brookes C, Grieve R, Spooner D, Agrawal R, et al. Synchronous Chemo-radiation Can Reduce Local Recurrence in Early Stage Breast Cancer: Results of the SECRAB Trial (ISRCTN: 84214355) Presented on Behalf of the SECRAB Steering Committee. European Journal of Cancer. Elsevier BV; 2011; 47:2 10.1016/s0959-8049(11)70097-1
• Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: Converging results from multimodal magnetic resonance imaging Cite
  de Ruiter MB, Reneman L, Boogerd W, Veltman DJ, Caan M, Douaud G, et al. Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: Converging results from multimodal magnetic resonance imaging. Human Brain Mapping. Wiley; 2011; 33:2971-2983 10.1002/hbm.21422
• Prevalence of lymphoedema more than five years after breast cancer treatment Cite
  Lopez Penha T, Slangen J, Heuts E, Voogd A, Von Meyenfeldt M. Prevalence of lymphoedema more than five years after breast cancer treatment. European Journal of Surgical Oncology (EJSO). Elsevier BV; 2011; 37:1059-1063 10.1016/j.ejso.2011.09.001
• Direct effect of morphine on breast cancer cell function in vitro : role of the NET1 gene Cite
  Ecimovic P, Murray D, Doran P, McDonald J, Lambert D, Buggy D. Direct effect of morphine on breast cancer cell function in vitro : role of the NET1 gene. British Journal of Anaesthesia. Elsevier BV; 2011; 107:916-923 10.1093/bja/aer259
• Soy Isoflavones in the Prevention of Menopausal Bone Loss and Menopausal Symptoms Cite
  Levis S. Soy Isoflavones in the Prevention of Menopausal Bone Loss and Menopausal Symptoms. Archives of Internal Medicine. American Medical Association (AMA); 2011; 171:1363 10.1001/archinternmed.2011.330
• Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials Cite
  Early Breast Cancer Trialists' Collaborative Group (EBCTCG) . Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials. The Lancet. Elsevier BV; 2011; 378:771-784 10.1016/s0140-6736(11)60993-8
• Urinary symptoms in breast cancer Cite
  Donovan KA, Boyington AR, Ismail-Khan R, Wyman JF. Urinary symptoms in breast cancer. Cancer. Wiley; 2011; 118:582-593 10.1002/cncr.26324
• Drug switch because of treatment-related adverse side effects in endocrine adjuvant breast cancer therapy: how often and how often does it work? Cite
  Güth U, Myrick ME, Schötzau A, Kilic N, Schmid SM. Drug switch because of treatment-related adverse side effects in endocrine adjuvant breast cancer therapy: how often and how often does it work?. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2011; 129:799-807 10.1007/s10549-011-1668-y
• Incidence of heart disease in 35,000 women treated with radiotherapy for breast cancer in Denmark and Sweden Cite
  McGale P, Darby SC, Hall P, Adolfsson J, Bengtsson N, Bennet AM, et al. Incidence of heart disease in 35,000 women treated with radiotherapy for breast cancer in Denmark and Sweden. Radiotherapy and Oncology. Elsevier BV; 2011; 100:167-175 10.1016/j.radonc.2011.06.016
• Sympathetic and parasympathetic activity in cancer-related fatigue: More evidence for a physiological substrate in cancer survivors Cite
  Fagundes CP, Murray DM, Hwang BS, Gouin J, Thayer JF, Sollers JJ, et al. Sympathetic and parasympathetic activity in cancer-related fatigue: More evidence for a physiological substrate in cancer survivors. Psychoneuroendocrinology. Elsevier BV; 2011; 36:1137-1147 10.1016/j.psyneuen.2011.02.005
• Toxicity of Adjuvant Endocrine Therapy in Postmenopausal Breast Cancer Patients: A Systematic Review and Meta-analysis Cite
  Amir E, Seruga B, Niraula S, Carlsson L, Ocaña A. Toxicity of Adjuvant Endocrine Therapy in Postmenopausal Breast Cancer Patients: A Systematic Review and Meta-analysis. JNCI: Journal of the National Cancer Institute. Oxford University Press (OUP); 2011; 103:1299-1309 10.1093/jnci/djr242
• Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trial Cite
  Gianni L, Dafni U, Gelber RD, Azambuja E, Muehlbauer S, Goldhirsch A, et al. Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trial. The Lancet Oncology. Elsevier BV; 2011; 12:236-244 10.1016/s1470-2045(11)70033-x
• Cancer Therapy Associated Bone Loss: Implications for Hip Fractures in Mid-Life Women with Breast Cancer Cite
  Edwards BJ, Raisch DW, Shankaran V, McKoy JM, Gradishar W, Bunta AD, et al. Cancer Therapy Associated Bone Loss: Implications for Hip Fractures in Mid-Life Women with Breast Cancer. Clinical Cancer Research. American Association for Cancer Research (AACR); 2011; 17:560-568 10.1158/1078-0432.ccr-10-1595
• Pathology of late-onset anthracycline cardiomyopathy Cite
  Bernaba BN, Chan JB, Lai CK, Fishbein MC. Pathology of late-onset anthracycline cardiomyopathy. Cardiovascular Pathology. Elsevier BV; 2010; 19:308-311 10.1016/j.carpath.2009.07.004
• Effects of n-3 Polyunsaturated Fatty Acids on Left Ventricular Function and Functional Capacity in Patients With Dilated Cardiomyopathy Cite
  Nodari S, Triggiani M, Campia U, Manerba A, Milesi G, Cesana BM, et al. Effects of n-3 Polyunsaturated Fatty Acids on Left Ventricular Function and Functional Capacity in Patients With Dilated Cardiomyopathy. Journal of the American College of Cardiology. Elsevier BV; 2011; 57:870-879 10.1016/j.jacc.2010.11.017
• Abstract P3-15-05: Muscle and Joint Symptoms in Breast Cancer Patients Receiving Taxane-Based Chemotherapy Cite
  van Draanen J, Stacey E, Dent R, Gallo-Hershberg D, Pasetka M, Giotis A, et al. Abstract P3-15-05: Muscle and Joint Symptoms in Breast Cancer Patients Receiving Taxane-Based Chemotherapy. Poster Session Abstracts. American Association for Cancer Research; 2010; 10.1158/0008-5472.sabcs10-p3-15-05
• Abstract B10: Side effects associated with aromatase inhibitor treatment among breast cancer patients Cite
  Gallicchio LM, MacDonald R, Wood B, Rushovich E, Helzlsouer K. Abstract B10: Side effects associated with aromatase inhibitor treatment among breast cancer patients. Behavioral and Social Science. American Association for Cancer Research; 2010; 10.1158/1940-6207.prev-10-b10
• One-Year Longitudinal Study of Fatigue, Cognitive Functions, and Quality of Life After Adjuvant Radiotherapy for Breast Cancer Cite
  Noal S, Levy C, Hardouin A, Rieux C, Heutte N, Ségura C, et al. One-Year Longitudinal Study of Fatigue, Cognitive Functions, and Quality of Life After Adjuvant Radiotherapy for Breast Cancer. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2011; 81:795-803 10.1016/j.ijrobp.2010.06.037
• Sexual Function after Breast Cancer Cite
  Panjari M, Bell RJ, Davis SR. Sexual Function after Breast Cancer. The Journal of Sexual Medicine. Elsevier BV; 2011; 8:294-302 10.1111/j.1743-6109.2010.02034.x
• Specialty Supplements and Breast Cancer Risk in the VITamins And Lifestyle (VITAL) Cohort Cite
  Brasky TM, Lampe JW, Potter JD, Patterson RE, White E. Specialty Supplements and Breast Cancer Risk in the VITamins And Lifestyle (VITAL) Cohort. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2010; 19:1696-1708 10.1158/1055-9965.epi-10-0318
• Do Intraoperative Analgesics Influence Breast Cancer Recurrence After Mastectomy? A Retrospective Analysis Cite
  Forget P, Vandenhende J, Berliere M, Machiels J, Nussbaum B, Legrand C, et al. Do Intraoperative Analgesics Influence Breast Cancer Recurrence After Mastectomy? A Retrospective Analysis. Anesthesia & Analgesia. Ovid Technologies (Wolters Kluwer Health); 2010; 110:1630-1635 10.1213/ane.0b013e3181d2ad07
• Early identification of trastuzumab-related cardiotoxicity with speckle-tracking echocardiography. Cite
  Maurea N, De Lorenzo C, Coppola C, Ragone G, Di Pietro E, Schiattarella G, et al. Early identification of trastuzumab-related cardiotoxicity with speckle-tracking echocardiography.. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2010; 28:e11096-e11096 10.1200/jco.2010.28.15_suppl.e11096
• Hematologic toxicity with adjuvant docetaxel and cyclophosphamide in early breast cancer. Cite
  Santos FN, Cruz MR, Cezana L, Costa LA, de Azevedo CA, De Barros E Silva MJ, et al. Hematologic toxicity with adjuvant docetaxel and cyclophosphamide in early breast cancer.. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2010; 28:e11081-e11081 10.1200/jco.2010.28.15_suppl.e11081
• Late pancreatic toxicity in patients with breast cancer after taxane-anthracycline–based neoadjuvant and adjuvant chemotherapy. Cite
  Kopp MV, Koroleva I, Kasulin AN, Kucheryavyy JA, Byakhov MJ. Late pancreatic toxicity in patients with breast cancer after taxane-anthracycline–based neoadjuvant and adjuvant chemotherapy.. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2010; 28:e11043-e11043 10.1200/jco.2010.28.15_suppl.e11043
• Hepatotoxicity in breast cancer patients post-chemotherapy with docetaxel, doxorubucin, and cyclophosphamide. Cite
  Wills SM, Reid R, Jaiyesimi IA, Margolis JH. Hepatotoxicity in breast cancer patients post-chemotherapy with docetaxel, doxorubucin, and cyclophosphamide.. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2010; 28:e11031-e11031 10.1200/jco.2010.28.15_suppl.e11031
• Moderate neutropenia with adjuvant CMF confers improved survival in early breast cancer Cite
  Cameron DA, Massie C, Kerr G, Leonard RCF. Moderate neutropenia with adjuvant CMF confers improved survival in early breast cancer. British Journal of Cancer. Springer Science and Business Media LLC; 2003; 89:1837-1842 10.1038/sj.bjc.6601366
• Prognostic Significance of Neutropenia on Day One of Anthracycline-Based Neoadjuvant Chemotherapy in Operable Breast Cancer Cite
  Ishitobi M, Komoike Y, Motomura K, Koyama H, Inaji H. Prognostic Significance of Neutropenia on Day One of Anthracycline-Based Neoadjuvant Chemotherapy in Operable Breast Cancer. Oncology. S. Karger AG; 2010; 78:213-219 10.1159/000313702
• Abstract 3223: Severe dietary restriction enhances cancer treatment: Protecting normal cells and sensitizing malignant cells to chemotherapy by fasting Cite
  Lee C, Safdie F, Raffaghello L, Wei M, Longo V. Abstract 3223: Severe dietary restriction enhances cancer treatment: Protecting normal cells and sensitizing malignant cells to chemotherapy by fasting. Cellular and Molecular Biology. American Association for Cancer Research; 2010; 10.1158/1538-7445.am10-3223
• Changes in markers of ovarian reserve and endocrine function in young women with breast cancer undergoing adjuvant chemotherapy Cite
  Yu B, Douglas N, Ferin MJ, Nakhuda GS, Crew K, Lobo RA, et al. Changes in markers of ovarian reserve and endocrine function in young women with breast cancer undergoing adjuvant chemotherapy. Cancer. Wiley; 2010;:NA-NA 10.1002/cncr.25037
• Long-term endometrial effects in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES)—a randomised controlled trial of exemestane versus continued tamoxifen after 2–3 years tamoxifen Cite
  Bertelli G, Hall E, Ireland E, Snowdon C, Jassem J, Drosik K, et al. Long-term endometrial effects in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES)—a randomised controlled trial of exemestane versus continued tamoxifen after 2–3 years tamoxifen. Annals of Oncology. Elsevier BV; 2010; 21:498-505 10.1093/annonc/mdp358
• Weight gain is associated with increased risk of hot flashes in breast cancer survivors on aromatase inhibitors Cite
  Su HI, Sammel MD, Springer E, Freeman EW, DeMichele A, Mao JJ. Weight gain is associated with increased risk of hot flashes in breast cancer survivors on aromatase inhibitors. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2010; 124:205-211 10.1007/s10549-010-0802-6
• Effect of air travel on lymphedema risk in women with history of breast cancer Cite
  Kilbreath SL, Ward LC, Lane K, McNeely M, Dylke ES, Refshauge KM, et al. Effect of air travel on lymphedema risk in women with history of breast cancer. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2010; 120:649-654 10.1007/s10549-010-0793-3
• Effects of Tamoxifen and Exemestane on Cognitive Functioning of Postmenopausal Patients With Breast Cancer: Results From the Neuropsychological Side Study of the Tamoxifen and Exemestane Adjuvant Multinational Trial Cite
  Schilder CM, Seynaeve C, Beex LV, Boogerd W, Linn SC, Gundy CM, et al. Effects of Tamoxifen and Exemestane on Cognitive Functioning of Postmenopausal Patients With Breast Cancer: Results From the Neuropsychological Side Study of the Tamoxifen and Exemestane Adjuvant Multinational Trial. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2010; 28:1294-1300 10.1200/jco.2008.21.3553
• Aged garlic extract protects against doxorubicin-induced cardiotoxicity in rats Cite
  Alkreathy H, Damanhouri ZA, Ahmed N, Slevin M, Ali SS, Osman AM. Aged garlic extract protects against doxorubicin-induced cardiotoxicity in rats. Food and Chemical Toxicology. Elsevier BV; 2010; 48:951-956 10.1016/j.fct.2010.01.005
• Obesity is a Risk Factor for Developing Postoperative Lymphedema in Breast Cancer Patients Cite
  Helyer LK, Varnic M, Le LW, Leong W, McCready D. Obesity is a Risk Factor for Developing Postoperative Lymphedema in Breast Cancer Patients. The Breast Journal. Wiley; 2010; 16:48-54 10.1111/j.1524-4741.2009.00855.x
• Effectiveness of early physiotherapy to prevent lymphoedema after surgery for breast cancer: randomised, single blinded, clinical trial Cite
  Torres Lacomba M, Yuste Sanchez MJ, Zapico Goni A, Prieto Merino D, Mayoral del Moral O, Cerezo Tellez E, et al. Effectiveness of early physiotherapy to prevent lymphoedema after surgery for breast cancer: randomised, single blinded, clinical trial. BMJ. BMJ; 2010; 340:b5396-b5396 10.1136/bmj.b5396
• The effects of paclitaxel, dose density, and trastuzumab on treatment-related amenorrhea in premenopausal women with breast cancer Cite
  Abusief ME, Missmer SA, Ginsburg ES, Weeks JC, Partridge AH. The effects of paclitaxel, dose density, and trastuzumab on treatment-related amenorrhea in premenopausal women with breast cancer. Cancer. Wiley; 2010; 116:791-798 10.1002/cncr.24835
• Breast cancer seeding associated with core needle biopsies: A systematic review Cite
  Liebens F, Carly B, Cusumano P, Van Beveren M, Beier B, Fastrez M, et al. Breast cancer seeding associated with core needle biopsies: A systematic review. Maturitas. Elsevier BV; 2009; 62:113-123 10.1016/j.maturitas.2008.12.002
• Risk of needle tract seeding of breast cancer: cytological results derived from core wash material Cite
  Uematsu T, Kasami M. Risk of needle tract seeding of breast cancer: cytological results derived from core wash material. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2007; 110:51-55 10.1007/s10549-007-9685-6
• Effect of a switch of aromatase inhibitors on musculoskeletal symptoms in postmenopausal women with hormone-receptor-positive breast cancer: the ATOLL (articular tolerance of letrozole) study Cite
  Briot K, Tubiana-Hulin M, Bastit L, Kloos I, Roux C. Effect of a switch of aromatase inhibitors on musculoskeletal symptoms in postmenopausal women with hormone-receptor-positive breast cancer: the ATOLL (articular tolerance of letrozole) study. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2009; 120:127-134 10.1007/s10549-009-0692-7
• 622 Mammography screening and radiation-induced breast cancer among women with a familial or genetic predisposition: a meta-analysis Cite
  Jansen-van der Weide M, Greuter M, Jansen L, Oosterwijk J, Pijnappel R, Oudkerk M, et al. 622 Mammography screening and radiation-induced breast cancer among women with a familial or genetic predisposition: a meta-analysis. European Journal of Cancer Supplements. Elsevier BV; 2010; 8:239 10.1016/s1359-6349(10)70642-x
• Can Anesthetic Technique for Primary Breast Cancer Surgery Affect Recurrence or Metastasis? Cite
  Exadaktylos A, Buggy D, Moriarty D, Mascha E, Sessler D. Can Anesthetic Technique for Primary Breast Cancer Surgery Affect Recurrence or Metastasis?. Anesthesiology. Ovid Technologies (Wolters Kluwer Health); 2006; 105:660-664 10.1097/00000542-200610000-00008
• Chocolate consumption and bone density in older women Cite
  Hodgson JM, Devine A, Burke V, Dick IM, Prince RL. Chocolate consumption and bone density in older women. The American Journal of Clinical Nutrition. Oxford University Press (OUP); 2008; 87:175-180 10.1093/ajcn/87.1.175
• The Use of Herbal Preparations to Alleviate Climacteric Disorders and Risk of Postmenopausal Breast Cancer in a German Case-Control Study Cite
  Obi N, Chang-Claude J, Berger J, Braendle W, Slanger T, Schmidt M, et al. The Use of Herbal Preparations to Alleviate Climacteric Disorders and Risk of Postmenopausal Breast Cancer in a German Case-Control Study. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2009; 18:2207-2213 10.1158/1055-9965.epi-09-0298
• A randomized controlled trial of aromatherapy massage in a hospice setting Cite
  Soden K, Vincent K, Craske S, Lucas C, Ashley S. A randomized controlled trial of aromatherapy massage in a hospice setting. Palliative Medicine. SAGE Publications; 2004; 18:87-92 10.1191/0269216304pm874oa
• Interventions for preventing oral mucositis for patients with cancer receiving treatment Cite
  Worthington HV, Clarkson JE, Bryan G, Furness S, Glenny A, Littlewood A, et al. Interventions for preventing oral mucositis for patients with cancer receiving treatment. Cochrane Database of Systematic Reviews. Wiley; 2011; 10.1002/14651858.cd000978.pub5